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1. General introduction 
 
 
 
1.1. Bacillus thuringiensis 
 
1.1.1. A history of more than hundred years  
 
The first description of Bacillus thuringiensis dates back to the beginning of the last century when 
Ishiwata Shigetane isolated the microorganism from a deseased silk worm (Bombyx mori) 
(Lepidoptera: Bombycidae) in 1901 (Lambert & Peferoen, 1992; Glare & O’Callaghan, 2000). The 
original name Bacillus soto was replaced by B. thuringiensis when the bacterium was rediscovered 
ten years later by Ernst Berliner in a Mediterranean flour moth (Ephestia kuehniella) (Lepidoptera: 
Pyralidae) from a grain mill in Thuringen, Germany. Despite the early description of inclusion 
bodies and their insecticidal properties, one had to wait until 1938 for Sporein as the first B. 
thuringiensis based product. The commercial success was sparked by the isolation of the 
economically important B. thuringiensis subsp. kurstaki HD-1 by Dulmage in 1966. Many of the B. 
thuringiensis formulations that are still in use for lepidopteran control are based on this strain. With 
the discovery of B. thuringiensis subsp.. israelensis in 1977, the insecticidal spectrum was extended 
to the dipteran order. The unique activity of this strain allows for the control of mosquitos and other 
vectors of tropical diseases such as malaria and yellow fever. Finally, B. thuringiensis subsp. 
tenebrionis was found with insecticidal activity against Coleoptera. These discoveries stimulated 
the development of worldwide screening programs for new B. thuringiensis isolates which have led 
to more than 300 characterized crystal proteins (Crickmore et al., 2005). Besides insecticidal 
activity, certain B. thuringiensis strains with activity against protozoa, mites and nematodes have 
also been reported. 
The first gene coding for a B. thuringiensis crystal protein was cloned in 1981 by Ernest Schneph 
and Helen Whiteley. Since then, biotechnology has evolved rapidly and it did not take long for the 
first genetically modified plants expressing B. thuringiensis insecticidal proteins to be developed. 
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Since 1996, several B. thuringiensis cotton and corn varieties have entered the market and 
transformed cotton lines expressing multiple crystal proteins are waiting in the commercial pipeline. 
 
1.1.2. B. thuringiensis biology and insecticidal armory 
 
As a Gram-positive aerobe spore forming bacterium, B. thuringiensis belongs to the family of the 
Bacillaceae. Like other sporulating bacteria, nutrient deprivation causes the cells to shift to a 
stationary phase resulting in the formation of an endospore. At the same moment, parasporal 
crystals are formed in the cell that can make up to 35% of the total cell dry weight. These 
crystalline inclusion bodies are a common feature of the large B. thuringiensis community and 
consist of different insecticidal crystal proteins (ICPs) or delta-endotoxins, each with its own unique 
specificity (Van Frankenhuysen & Nystrom, 2005).  
Due to the production of insecticidal proteins, B. thuringiensis is generally considered to be an 
opportunistic pathogen of insects (Jensen et al., 2003). The presence of insecticidal proteins is 
thought to provide an evolutionary advantage allowing cells to germinate and proliferate rapidly in 
the infected insect host. In addition, the micro-organism is ubiquitous in the soil and has been found 
in the phyllosphere as well as in a large diversity of other micro-environments. 
Several other insecticidal proteins have been observed in B. thuringiensis cells as well (de Maagd et 
al., 2003). However, their economic value is limited or commercial applications remain restricted. 
The β-exotoxins are thermostable ATP analogs which disturb protein synthesis by interfering with 
the DNA dependent RNA polymerase enzyme during transcription. The broad toxicity for a large 
number of organisms including some vertebrates renders these molecules unsuitable for crop 
protection. The α-exotoxin is formed during the vegetative cell growth and also displays non 
specific activity. In addition, small binary insecticidal proteins related to the Bacillus sphaericus 
dipteran specific Bin proteins have been isolated from different B. thuringiensis strains (Ellis et al., 
2002). These were designated as Cry34/Cry35 and are tested to confer root protection to the 
Western corn rootworm (Diabrotica virgifera) (Coleoptera: Chrysomelidae) (Moellenbeck et al., 
2001). Enzymes such as chitinases, proteases and phospholipase C further enhance B. thuringiensis 
insect pathogenicity. Finally, vegetative insecticidal proteins (Vips) are secreted during vegetative 
growth by some B. thuringiensis and Bacillus cereus cells without forming crystals (Estruch et al., 
1996). The binary proteins Vip1-Vip2 are specific toward Coleoptera whereas the unrelated Vip3 is 
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active against Lepidoptera. Their activity to some agronomically important pests that are less 
susceptible to B. thuringiensis crystal proteins such as the black cutworm (Agrotis ipsilon) 
(Lepidoptera: Noctuidae) and differences in the mode of action make them interesting candidates to 
complement ICPs in resistance management strategies (Lee et al., 2003). The first genetically 
modified crops expressing Vip3 will be commercially available in 2006. 
 
1.1.3. B. thuringiensis insecticidal crystal proteins 
 
1.1.3.1. Genetic localization 
 
The ICP genes are generally located on large plasmids which can be exchanged between different 
B. thuringiensis strains during conjugation (Gonzalez et al., 1982). As a result, B. thuringiensis cells 
have been able to adapt, extend or optimize the pool of advantageous crystal proteins. In addition, 
many of the ICP genes are part of transposon elements which further adds to their genetic mobility 
(Lereclus et al., 1984). 
 
1.1.3.2. Nomenclature 
 
The first classification system as proposed by Höfte and Whiteley (1989) divided the crystal 
proteins according to their activity spectrum. However, analysis and comparison of the nucleotide 
sequences showed that this approach did not necessarily reflect the evolutionary divergence 
between the different ICPs. Especially highly similar proteins with different activities such as the 
CryIIA and CryIIB pair resulted in inconsistencies. On the other hand, ICPs with various other 
activity spectra were lumped into one pile in a separate group (cryV).  
In an effort to develop a uniform and standardized classification system for B. thuringiensis crystal 
proteins, Crickmore et al. (1998) based their nomenclature solely on amino acid sequence 
homology. This strategy eliminates the need for multiple bioassays and is recognized 
internationally. 
Currently, 48 primary groups have been reported uniting proteins with more than 45% sequence 
similarity: Cry1-46 and Cyt1-2 (Crickmore et al., 2005). Most crystal proteins in the Cry-set have 
molecular masses between 50 and 140 kDa. Proteins belonging to the Cry1 class are the most 
extensively studied and contain many of the commercial important ICPs that are used in sprays and 
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genetically modified crops for Lepidopteran control. Proteins belonging to the Cyt1 and Cyt2 
groups are unrelated to the Cry proteins. These small proteins (30 kDa) synergize the activity of Cry 
proteins and possess cytolytic activities against a wide variety of insect and vertebrate cells (Butko, 
2003). Secondary (capital letter) and tertiary ranks (small letter) are defined by boundaries that 
represent 78 and 95% sequence similarity respectively. Proteins with more than 95% sequence 
identity have a different quaternary rank, denoted by a number. In other words, each ICP protein 
has a unique name consisting of four different parts (e.g. Cry9Ca1). Proteins with the same primary 
rank typically affect the same order of insects or other invertebrates. Identical secondary and 
tertiary ranks often imply activity to the same family and insect species with differences in binding 
sites and potency. 
 
1.1.3.3. Mode of action 
 
Upon oral uptake by the larvae, B. thuringiensis crystals first pass through the insect foregut where 
ingested plant material is broken down into smaller pieces. The specific pH (weakly acidic in 
Coleoptera vs. highly alkaline in Lepidoptera) and reducing conditions in the lumen of midgut are 
responsible for the solubilization of the crystal inclusion bodies, thereby releasing large inactive 
protoxin molecules (Fig. 1.1A).  
In order to become active and exert their insecticidal activity, protoxin molecules have to be 
processed by trypsin and other insect midgut proteases. Proteolytic activation usually leads to rapid 
removal of the highly conserved C-terminal protoxin tail. Various cysteine residues in this part are 
involved in intramolecular disulfide bridges that crosslink the different protoxin molecules in the 
unsolubilized crystal. At the N-terminal end, a few residues are cleaved off more slowly resulting in 
a final toxic fragment between 40 and 60 kDa (Strizhov et al., 1996). Smaller protoxins lacking the 
conserved C-terminal region are minimally trimmed at both ends upon proteolytic activation. 
Before reaching the midgut epithelium, activated crystal proteins must first pass through the semi-
permeable peritrophic matrix (PM) that lines the midgut lumen and protects the epithelial cells. 
Recently, some selectivity of this step was demonstrated in a series of permeability studies using 
isolated B. mori PM (Hayakawa et al., 2004).  Compared to Cry1Aa, passage of the Cry1Ac protein 
occurred at a much slower rate which corresponded to the in vivo toxicity of both crystal proteins.  
After passing the midgut PM, the crystal proteins insert into the apical microvilli of the columnar 
cells in a two-step process (Fig. 1.1B) (Liang et al., 1995; Cooper et al., 1998). First, the ICP 
1. General introduction 
 5 
molecules interact with specific high affinity receptors in the midgut brush border membrane. This 
reversible binding triggers a conformational change allowing 4 ICP monomers to form a pre-pore 
tetramer complex, followed by the irreversible insertion of part of the crystal protein into the 
membrane (Li et al., 2001; Rausell et al., 2004ab). As a result, ion-selective channels with an 
internal diameter between 2 and 3 nm are formed that ultimately lead to the destruction of the 
epithelial cell layer (Lorence et al., 1995; Carroll & Ellar, 1997). Despite a large body of 
experimental work that has been dedicated in the last decade to the elucidation of the molecular 
basis for ICP specificity (Schnepf et al., 1998; Aronson & Shai, 2001) and recent insights into the 
mode of action of B. thuringiensis crystal proteins (see 1.1.3.5.), many details regarding receptor 
binding, oligomerization and the pore forming process still remain to be unraveled.  
Due to the crystal protein pores in the midgut membrane, the osmotic balance is disturbed. 
Epithelial cells undergo swelling within 15 minutes and ultimately lyse (Bravo et al., 1992b). After 
ingestion of B. thuringiensis crystals, larvae usually stop feeding. Gut paralysis is followed by death 
as the larvae succumb due to starvation and massive septicemia. Because nutrient rich hemolymph 
enters through perforated midgut, B. thuringiensis spores are able to germinate and proliferate (Fig. 
1.1C). Without the presence of crystal proteins, colonization of the insect midgut would be difficult 
due to the highly alkaline pH in Lepidoptera, fast food flow and nutrient scarcity.  
 
 
Fig. 1.1 Insecticidal mode of action of B. 
thuringiensis crystal proteins. (A) Crystals are 
solubilized in the insect midgut releasing inactive 
protoxin molecules that are proteolytically 
activated. (B) The ICPs bind to specific midgut 
receptors, undergo a conformational change and 
insert partly in the epithelium membrane. After 
oligomerization, pores are formed that perforate the 
midgut membrane. (C) Due to influx of 
hemolymph, ingested B. thuringiensis spores can 
germinate and colonize the insect. 
 
1. General introduction 
 6 
1.1.3.4. Midgut receptors 
 
The specific receptors in the insect midgut that are recognized by the activated crystal proteins are 
the subject of intense continuing research. The reversible interaction is an important determinant for 
the narrow specificity and knowledge regarding the nature of the ICP binding sites is crucial for the 
design of sustainable resistance management strategies as explained later. 
Receptor binding has been studied using a variety of techniques. Immunohistochemistry with 
midgut sections has revealed the apical epithelial membrane as the site of crystal protein binding 
(Bravo et al., 1992ab). Toxin overlay assays (ligand blot) using brush border membrane vesicle 
(BBMV) proteins, prepared from isolated larval midguts, have been the method of choice for the 
initial characterization of receptor molecules (Garczynski et al., 1991). Binding affinity and 
specificity are traditionally determined by homologous and heterologous competition binding 
experiments with labeled ICPs and BBMVs (Hofmann et al., 1988; Van Rie et al., 1989). Real time 
interaction analysis using immobilized receptors or BBMVs on a BIAcore sensorchip has allowed 
quantification of the kinetic binding constants (Masson et al., 1994; Masson et al., 1995; Cooper et 
al., 1998). However, binding data have to be regarded with caution because not all binding sites are 
functional and conflicting results have been noted in some cases (Masson et al., 1995; Lee et al., 
1995; Lee & Dean, 1996).  
Two main classes of membrane associated glycoproteins have been identified as B. thuringiensis 
ICP receptors in the midgut of susceptible insect species. The first group consists of high molecular 
weight proteins with 11 extracellular cadherin repeats (CR) such as the 210 kDa Cry1A receptor in 
Manduca sexta (Lepidoptera: Sphingidae). Their function in the insect gut is unknown but similar 
proteins mediate cell-cell adhesion in vertebrates. Transient expression in Drosophila S2 cell 
membranes resulted in susceptibility and identified CR12 as the high affinity binding region for the 
Cry1Ab crystal protein (Hua et al., 2004). Epitope mapping using a single-chain fragment variable 
(ScFv) phage display library resulted in ScFv and homologous cadherin peptides that could inhibit 
Cry1Ab binding to BBMVs and reduce M. sexta toxicity (Gomez et al., 2001). Evidence for 
cadherin-like midgut protein as a functional receptor first came from mapping studies with the 
Cry1Ac resistant Heliothis virescens YHD2 strain (Lepidoptera: Noctuidae). Gahan et al. (2001) 
demonstrated that high resistance levels were caused by a retrotransposon-mediated knockout of the 
HevCaLP cadherin-like receptor. Additional proof was provided by Xie et al. (2005). This group 
mapped the Cry1Ac binding site, identified residues critical for Cry1Ac binding and noted reduced 
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Cry1Ac toxicity when larvae were reared on anti-cadherin serum or partial cadherin proteins. 
Recently, three BtR cadherin alleles with internal deletions were detected in a field population of 
the pink bollworm (Pectinophora gossypiella) (Lepidoptera: Gelechiidae). Homozygous larvae 
were also resistant to Cry1Ac and survived on cotton plants expressing the crystal protein (Morin et 
al., 2003). 
Aminopeptidase-N (APN) digestive enzymes have been identified as a second putative receptor 
class with the 120 kDa Cry1A binding protein in the M. sexta posterior midgut as the most 
intensively studied example (Knight et al., 1995; Carroll et al., 1997). A C-terminal flexible 
glycosylphosphatidylinositol (GPI) tail anchors the APN molecule to the membrane (Lu & Adang, 
1996) where they are associated with cholesterol rich lipid raft microdomains (Zhuang et al., 2002). 
Glycosylation is especially important for Cry1Ac binding which recognizes an N-
acetylgalactosamine residue on the receptor surface (Knight et al., 2004b). Functionality of the 
APN class of ICP receptors was demonstrated by heterologous expression in the Drosophila midgut 
(Gill & Ellar, 2002) and silencing by injection of dsRNA in the hemocoel of Spodoptera littoralis 
larvae (Lepidoptera: Noctuidae) (Rajagopal et al., 2002). Moreover, reduced HvALP APN levels in 
H. virescens have been associated with Cry1Ac resistance (Jurat-Fuentes & Adang, 2004). 
Finally, Griffiths et al. (2005) have shown that the Cry5B receptor in Caenorhabditis elegans is a 
glycolipid with a conserved carbohydrate structure that is required for specific ICP binding and 
nematode activity. In addition, changes in BBMV glycolipid levels have been associated with 
Cry1Ac resistance in P. xylostella (Kumaraswami et al., 2001). 
Mostly, toxicity appears to be positively correlated to receptor affinity or the number of binding 
sites (Van Rie et al., 1989; Lee et al., 1996; Jenkins et al., 2000) but some binding studies have 
found an inverse relationship between affinity and activity (Wolfersberger, 1990; Wu & Dean, 
1996). On the other hand, the irreversible binding step which involves pore formation is better 
correlated with biological activity (Chen et al., 1995; Liang et al., 1995; Masson et al., 1999). 
Hence, receptor binding is crucial but not sufficient for insecticidal activity. In other words, not all 
Cry binding proteins are functional receptors that lead to pore formation and toxicity (Garczynski et 
al., 1991; Gould et al., 1992; Luo et al., 1997; Li et al., 2004). Still, the reversible interaction with 
midgut receptor molecules remains a key step in the complex mode of action and the specificity of 
B. thuringiensis crystal proteins.  
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1.1.3.5. Structure-function relationship 
 
B. thuringiensis ICPs are thought to adopt a highly similar tertiary fold as analogous three-domain 
structures have been resolved for the active fragments of the Cry3Aa and Cry3Bb coleopteran 
specific, Cry1Aa lepidopteran specific, Cry2Aa lepidopteran/dipteran specific and the Cry4Ba 
dipteran specific crystal proteins (Fig. 1.2A) (Li et al., 1991; Grochulski et al., 1995; Morse et al., 
2001; Galitsky et al., 2001; Boonserm et al., 2005). A multiple structural alignment of these 
proteins has illustrated their topological similarity despite being active under different midgut 
conditions, specificities encompassing three insect orders and amino acid sequence identities from 
39% to less than 20% (Boonserm et al., 2005). Furthermore, sequence alignment has revealed the 
presence of five conserved amino acid blocks in the toxic part of many Cry proteins and three 
additional regions in the protoxin C-terminal tail (Schnepf et al., 1998) (Fig. 1.2B). These 
correspond to the central part of the crystal protein domains or overlap with the connecting strands 
and contain various residues involved in interdomain interactions. Their conserved nature is 
consistent with a similar structure of all B. thuringiensis crystal proteins and suggests an important 
role for ICP structure or function.  
The highest sequence and structural similarity between different Cry proteins is found in the N-
terminal domain (Bravo, 1997; Boonserm et al., 2005). Its structure consists of a central 
hydrophobic helix α5 (Fig. 1.2B, depicted in yellow), surrounded by 6 amphipathic α-helices. The 
observation that isolated domain I is sufficient for ion channel formation (Von Tersch, 1994) 
whereas its elimination results in the absence of the irreversible binding step (Flores et al., 1997) 
has led to the speculation that this domain is implicated in the penetration of the midgut epithelium 
and pore formation. More in particular, the α4-α5 helical hairpin is believed to insert into the 
membrane while the other helices are spread out on the membrane surface (Schwartz et al., 1997). 
Several experiments have confirmed this ‘umbrella hypothesis’. Isolated α4-α5 peptides were 
found to insert into artificial phospholipids membranes (Gerber & Shai, 2000). Mutations in both 
helices have been described that resulted in reduced toxicity and loss of pore formation without a 
change in receptor binding properties (Masson et al., 1999; Soberon et al., 2000; Vachon et al., 
2004). Finally, indications exist that different α5 helices associate in order to form a functional pore 
in the insect midgut membrane (Aronson et al., 1999).  
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A long flexible linker connects the last helix α7 of domain I with the second ICP domain (Fig. 
1.2B, depicted in orange). The latter is composed by three anti-parallel β-sheets in a greek key 
motif, followed by two short α helices. It is the least conserved domain among all Cry proteins 
(Bravo, 1997) with variation largely situated in three exposed loop structures (β2-β3, β6-β7, β10-
β11) (Fig. 1.2B). A large number of mutagenesis, deletion and loop exhange studies have 
demonstrated that the specific high affinity interaction with the receptor molecules in the midgut 
membrane occurs to a large extent at these sites (Rajamohan et al., 1996a; Smedley & Ellar, 1996; 
Wu & Dean, 1996; Abdullah et al., 2003; Abdullah & Dean, 2004). Further evidence came from 
competition binding experiments with loop peptides, showing their importance for B. thuringiensis 
crystal protein specificity (Xie et al., 2005). Remarkably, Morse et al. (2001) identified a different 
putative receptor binding site at the Cry2Aa domain II surface. This epitope consists of a 
hydrophobic region surrounded by 3 other loops and is blocked by the N-terminal propeptide that is 
removed during proteolytic degradation. 
A lectin-like β-sandwich of two anti-parallel β-sheets in a jelly role conformation forms the well 
conserved third domain (Li et al., 1991). Its function is ambiguous as experimental data suggest an 
involvement in both pore formation and receptor interaction. The fourth conserved region which 
corresponds to strand β17 is important for membrane insertion and ion channel function (Chen et 
al., 1993) (Fig. 1.2, depicted in green). In addition, membrane permeability assays using Sf9 cells 
have shown that domain III can affect pore size and ion channel properties (Rang et al., 1999). On 
the other hand, targeted mutagenesis and domain III swapping between different crystal proteins 
have revealed specificity determining regions and domain III residues involved in receptor binding 
(de Maagd et al., 1996; Lee et al., 1999; de Maagd et al., 2000). Furthermore, mutation of a unique 
6 amino acid insertion present in domain III of the Cry1Ac crystal protein resulted in reduced 
binding to the 120 kDa M. sexta APN receptor and a loss of inhibition by N-acetylgalactosamine 
(GalNAc) (Burton et al., 1999; Jenkins et al., 2000; Li et al., 2001). 
The entire structure-function puzzle of B. thuringiensis crystal proteins is complex as site directed 
mutagenesis, alanine scanning and studies with chimeric proteins have revealed that the function of 
each ICP domain is not delineated and that interdomain interactions take place (Rang et al., 1999). 
Surprisingly, substitutions in Cry1Ab domain II loops 2 and 3 resulted in a reduced M. sexta 
toxicity by disturbing the irreversible interaction without compromising the reversible receptor 
binding step (Rajamohan et al., 1996b). Furthermore, removal of Cry1Ab domain I resulted in loss 
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of binding to the 120 kDa M. sexta APN receptor (Flores et al., 1997). Finally, residues involved in 
receptor binding vary depending on the insect and the nature of the crystal protein crystal protein 
(Lee et al., 1996; Rajamohan et al., 1996b). 
Recently, the general model describing the mode of action of B. thuringiensis ICPs was refined by 
Bravo et al. (2004) with distinct roles proposed for the cadherin and APN midgut receptor 
molecules. Binding of the crystal protein to the cadherin-like receptor leads to the proteolytic 
cleavage of helix α1 in domain I and the formation of a very stable tetrameric pre-pore structure 
(Gomez et al., 2002). Subsequent interaction of this ICP intermediate with the microdomain 
associated APN protein triggers a second conformational change resulting in the insertion of 
domain I into the membrane and the formation of a stable pore. Hence, oligomerization preceeds 
membrane insertion and three different successive forms can be distinguished (monomeric, pre-pore 
and membrane inserted ICP). 
 
 
A 
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Fig. 1.2 (A)  Structures of the B. thuringiensis Cry1Aa, Cry3Aa, Cry2Aa and Cry4Ba (lacking domain I helices α1-α2)  
crystal proteins (Boonserm et al., 2005). Domain I, II and III are coloured cyan, green and magenta respectively. (B) 
Cry1Aa  structure with conserved blocks 1-5 indicated in yellow, orange, red, green and blue respectively (after 
Grochulski et al., 1995). 
 
1.1.4. B. thuringiensis crop protection in the field  
 
B. thuringiensis ICPs have a long history of safe application as suspensions of crystal proteins and 
spores and continue to dominate the biological insecticide market. The highly selective activity of 
each crystal protein is particularly valuable for the implementation in integrated pest management 
programs. Only a limited number of insects are targeted whereas soil organisms (Saxena & Stotzky, 
2001; Al-Deeb et al., 2003) and beneficial arthropods such as predators (Romeis et al., 2004) or 
parasitoids (Haseeb et al., 2004) remain mostly unaffected. Moreover, numerous studies have 
shown that B. thuringiensis based products are safe to vertebrates (Siegel, 2001; Teshima et al., 
2002). Furthermore, crystal proteins are generally rapidly digested under simulated human gastric 
conditions (Betz et al., 2000), reducing the possibility of potential allergenic reactions upon 
ingestion. Because of this selective activity and the rapid degradation of crystal proteins by UV 
irradiation, B. thuringiensis sprays have a less disturbing effect on the environment compared to 
B 
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some classical chemical broad spectrum insecticides. However, the narrow specificity restricts the 
effectiveness of B. thuringiensis crystal proteins as a broad spectrum insecticide and the instability 
necessitates repeated applications throughout the growing season. By contrast, residues of B. 
thuringiensis cells and ICPs can persist for several years in the soil of sprayed fields (Vettori et al., 
2003). An additional limitation of B. thuringiensis sprays is the inability to target sap sucking, 
boring and soil dwelling pests that remain out of reach.  
Some of these problems have been circumvented by the development of genetically modified crops 
that constitutively express synthetic crystal proteins (Shelton et al., 2002; Sharma et al., 2004). 
Hence, protection is ensured in the entire plant throughout all growth stages resulting in higher 
yields, more effective pest control and reduced levels of carcinogeneous fungal mycotoxins 
(Sankula & Blumenthal, 2004).  
 
1.1.5. Mechanisms and delay of B. thuringiensis resistance  
 
As with all insecticides, the benefits of B. thuringiensis ICPs are threatened by resistance 
development. Especially in current times, the number and area of B. thuringiensis engineered crops 
are increasing worldwide annually. In addition, second generation plants that express multiple 
crystal proteins such as Bollgard II (Monsanto) and Wide strike cotton (Dow AgroSciences) have 
recently entered the market. Technological advances such as Pseudomonas fluorescens 
encapsulation (Peng et al., 2003) and improvements in B. thuringiensis crystal protein stability, 
potency, plant expression and formulation could also lead to increased selection pressures on field 
populations. Moreover, some reports have indicated that resistance allele frequencies can be as high 
as 1.2 10-1 (Tabashnik et al., 1997a). Hence, a thorough understanding of resistance development 
and the devise of delay strategies are important in order to guarantee the efficacy of B. thuringiensis 
ICPs as a biological insecticide in the future.  
 
1.1.5.1. Mechanism of ICP resistance  
 
Since B. thuringiensis sprays have been used for over 30 years without the occurrence of field 
resistance, it was believed long time that the complex mode of action and low stability would 
prevent any resistance development. However, selections under laboratory conditions have yielded 
significant resistant levels in a dozen insect species demonstrating a general capacity to develop 
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resistance to B. thuringiensis crystal proteins (MacIntosh et al., 1991; Gould et al., 1992; Liu & 
Tabashnik, 1997; Georghiou & Wirth, 1997). Such results, however, can not be extrapolated 
directly to the field. Genetic variability in laboratory populations is usually limited, culture 
conditions can influence resistance stability and other factors such as behavior can delay or 
encourage resistance in the field (Cerda et al., 2003). 
So far, the ciamondback moth (Plutella xylostella) (Lepidoptera: Plutellidae) is the only insect that 
has developed B. thuringiensis resistance in the field after intensive spraying. This major pest of 
crucifer crops is quite susceptible to ICPs. However, several field populations on different locations 
developed high resistance levels as a result of intensive B. thuringiensis spraying. Resistance 
proved to be quite diverse. Differences in the spectrum, mechanism, heritability, levels and cross-
resistance patterns were detected, suggesting a broad genetic basis for resistance in this insect 
(Tabashnik et al., 1997b; Ballester et al., 1999). Recently, the ability to develop multiple resistance 
mechanisms has also been found in two Cry1Ac resistant H. virescens laboratory strains (Jurat-
Fuentes et al., 2003). 
Due to the multi step mode of action of B. thuringiensis crystal proteins in the midgut of susceptible 
insects, several mechanisms can lead to the development of resistance. Considering the importance 
of the reversible binding step for toxicity, it is not surprising that the most frequent and best 
characterized resistance mechanism involves a disturbed interaction between the ICPs and their 
specific receptors in the insect midgut. Loss of specific ICP binding or reduced affinities due to a 
change in the receptor molecule have been observed in a Dipel resistant P. xylostella strain (Ferre et 
al., 1991), Plodia interpunctella larvae (Lepidoptera: Pyralidae) (Van Rie et al., 1990) and other 
insects (MacIntosh et al., 1991; Gonzalez-Cabrera et al., 2003). On the other hand, lower numbers 
of midgut receptor molecules have been reported in resistant P. xylostella and H. virescens strains 
(Masson et al., 1995; Jurat-Fuentes & Adang, 2004). Moreover, altered receptor glycolysation 
patterns due to the loss of a β-1,3-galactosyltransferase in C. elegans have been associated with 
acquired Cry5B resistance after selection (Griffiths et al., 2001).  
Resistance to B. thuringiensis ICPs that can not be explained by altered receptor binding has also 
been described (Luo et al., 1997; Tabashnik et al., 1997b; Jurat-Fuentes et al., 2003). Changes in the 
gut physiology and protease arsenal have been demonstrated to hinder normal protoxin 
solubilization and activation (Oppert et al., 1997; Huang et al., 1999b). In addition, activated ICPs 
can be detoxified by proteolytic degradation (Keller et al., 1996; Bah et al., 2004). Based on the 
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observation that endogeneous phospholipase can release the APN receptor molecules from the 
midgut membrane by cleavage of the GPI anchor, it has been hypothesized that a similar process in 
vivo could also lead to B. thuringiensis resistance (Lu & Adang, 1996). On the other hand, 
premature termination of translation could result in loss of the GPI-anchor and secretion of the ICP 
receptor molecules in the midgut lumen. Such mutations have been observed in a laboratory strain 
of Culex pipiens (Diptera: Culicidae) after selection with B. sphaericus binary toxins (Darboux et 
al., 2002). Finally, increased regeneration of damaged midgut epithelium in resistant strains has 
been proposed as a possible resistance mechanism explaining the similar initial histophathological 
damage observed in a susceptible and Cry1Ac resistant H. virescens strain (Martinez-Ramirez et al., 
1999; Forcada et al., 1999).   
 
1.1.5.2. Resistance management 
 
It is almost 10 years since the first B. thuringiensis plants have been grown by farmers. Still, neither 
field resistance in B. thuringiensis field crops nor increased resistance allel frequencies have been 
observed (Fox, 2003). Nevertheless, several strains of P. xylostella, P. gossypiella and Helicoverpa 
armigera (Lepidoptera: Noctuidae) were able to thrive on B. thuringiensis cultivars after laboratory 
selection with soluble crystal proteins, underscoring the need for efficient resistance management 
programs (Tabashnik et al., 2003).  
Several strategies have been developed that should delay the emergence of resistance to B. 
thuringiensis crystal proteins (Bates et al., 2005). By reducing selection pressures in time or space, 
resistance alleles should take longer to accumulate in the exposed field populations. The high dose 
– refuge strategy has received the most attention and is currently imposed by the US Environmental 
Protection Agency when growing B. thuringiensis crops (US EPA, 2001). High expression levels 
should ensure the elimination of the heterozygous population which forms the largest source of 
resistance alleles. Alternative approaches under investigation could be the use of tissue specific or 
inducible promoters. This way, expression could be restricted to the economically important plant 
parts during sensitive growth stages or triggered after damage while reducing exposure and 
selection pressures in other tissues. Untreated or wild type plants are used in rotation with B. 
thuringiensis crops, planted as a mosaic or more frequently grown in the vicinity of the treated area. 
Such refugia should preserve a sufficient number of susceptible insects which can mate afterwards 
with the few resistant homozygous individuals surviving selection. Thus, resistance alleles are 
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diluted in the next generation, delaying their accumulation and fixation in the field population. 
Greenhouse and field studies have demonstrated the efficacy of spatial and temporal refugia 
(Shelton et al., 2000; Tang et al., 2001).  However, the success of this strategy is based on several 
requirements. First, wild susceptible insects have to migrate into the B. thuriengiensis field and 
mate in a random way with the resistant individuals. Asynchronal larval development in refugia and 
treated plots can undermine the effectiveness of the high dose strategy (Liu et al., 1999). More 
importantly, the alleles have to be recessive, at least at high doses, which is the case in most B. 
thuringiensis resistance crops reported (Liu & Tabashnik, 1997; Huang et al., 1999a; Morin et al., 
2003; Sayyed et al., 2003).  
Instead of using a single crystal protein, multiple ICPs can be applied in rotation. If resistance is 
genetically unstable or associated with a fitness cost such as the reduced fecundity in Cry1Ac 
resistant P. xylostella (Cerda et al., 2003), the effect and sustainability of this strategy is greatly 
improved. Multiple crystal proteins can also be applied simultaneously in pesticide mixtures or 
stacked in a single transgenic crop (pyramiding) as mentioned earlier. The efficacy of this strategy 
is reflected in the limited resistance that has emerged so far to traditional B. thuringiensis sprays 
after decades of use. Moreover, efficient delay of resistance has been confirmed in laboratory 
selection experiments (Georghiou & Wirth, 1997; Zhao et al., 2003) whereas theoretical models 
have shown 3-4 times smaller refugia are required when expressing two or more crystal proteins in 
a single cultivar (Roush et al., 1998). However, crystal proteins applied simultaneously or in 
rotation need to be chosen carefully since similar receptor specificities can lead to rapid cross-
resistance in the population under selection. In fact, crystal proteins often bind to multiple 
membrane proteins and single binding sites are sometimes recognized by different ICPs (Hofmann 
et al., 1988; Van Rie et al., 1989; Ballester et al., 1999; Luo et al., 1999; Hua et al., 2001; Jurat-
Fuentes & Adang, 2001; Estela et al., 2004). Therefore, insight in receptor specificities is required 
to uncover possible cross-resistance patterns in various target insects and a prerequisite for the 
successful use of multiple ICPs in the field. 
Alternatively, B. thuringiensis crystal proteins can be combined with other insecticidal compounds, 
thereby benefiting from the different mode of action (Sharma et al., 2004). Potential candidates, 
some of which already been expressed and tested in plants, include the B. thuringiensis Vips and 
the Cry34/Cry35 binary toxin complex, B. sphaericus BinA/B toxins, the broad spectrum toxin A 
produced by Photorhabdus luminescens (Liu et al., 2003), Xenorhabdus nematophila pilin subunit 
(Khandelwal et al., 2004), neurotoxins from insect predators (Wang et al., 2000), peritrophic matrix 
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degrading chitinases, protease inhibitors that disturb protein or carbohydrate metabolism, various 
plant derived lectins, recombinant antibodies that can block the function of essential insect 
polypeptides. However, efficacy and safety of these ICP alternatives for pest management in the 
field has still to be demonstrated. 
 
1.1.6. Tailoring B. thuringiensis crystal proteins 
 
B. thuringiensis crystal proteins have been improved either by chance as a result of targeted 
mutagenesis studies or deliberately in a few cases by rational design. Examples cover loop 
exchanges or mutations resulting in enhanced toxicity, specificity and binding affinity (Rajamohan 
et al., 1996a; Wu & Dean, 1996; De Roeck, 1999; Jenkins et al., 2000; Wu et al., 2000; Dean et al., 
2002; Abdullah et al., 2003; Abdullah & Dean, 2004), elimination of proteolytic sites thereby 
improving stability and toxicity (Lambert et al., 1996; Audtho et al., 1999; Abdullah et al., 2003; 
Bah et al., 2004) and insertion of a diphtheria toxin motif leading to increased pore size (Chandra et 
al., 1999). Occasionally, chimeric Cry proteins with higher toxicity (Ge et al., 1991; de Maagd et 
al., 1996; de Maagd et al., 2000) and a broader insecticidal spectrum (Naimov et al., 2003) have 
also been described which has aid in pinpointing the specificity determining regions of B. 
thuringiensis crystal proteins.  
The need for a thorough structure-function understanding when rationally engineering B. 
thuringiensis ICPs can be circumvented by following a more random evolutionary pathway, 
mimicking the in vivo mutation and domain recombination events which have led to the current 
variety in the large B. thuringiensis crystal protein family. 
 
1.2. Directed molecular evolution 
 
1.2.1. Protein evolution in a test tube 
 
Proteins and enzymes are the result of a long selection process in vivo which makes them highly 
specialized for biological functions within the context of a living organism. As a result, they are less 
optimized for other specific applications, in vitro tasks or industrial processes. Therefore, much 
laboratory effort has been spent into the altering and fine-tuning of the properties and the 
performance of these macromolecules. 
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Traditionally, optimization through rational protein engineering involves the targeted mutagenesis 
of specific residues or the design of functionality from scratch (Dahiyat & Mayo, 1997; Dwyer et 
al., 2004). However, success is often hampered by the limited understanding of the complex 
principles that govern structure, function, folding and stability. Especially tailoring one or multiple 
traits simultaneously without compromising other critical properties is far from trivial and the 
influence of mutations distant from the active site is difficult to predict. Predictions are further 
complicated by networks of multiple coupled residues exhibiting synergism or by the absence of 
additivity observed in many cases. As such, a priori success of designed mutations or polypeptide 
sequences is not guaranteed and complex mutational solutions remain labor, resource and time 
intensive. 
In contrast to rational design, directed molecular evolution is a highly flexible in vitro strategy that 
mimics the natural Darwinian process (Steipe, 1999; Schmidt-Dannert, 2001). Instead of being 
forced to wait for many generations in vivo, the entire process is performed in the laboratory in a 
matter of weeks allowing a scientist to start from multiple parents and even trespass species barriers 
(Ostermeier et al., 1999; Sieber et al., 2001). This is achieved by a series of alternating cycles in 
which random mutagenesis or recombination processes generate a pool of variants (library) and the 
evolved protein offspring is subsequently screened. Selected variants can be used as starting 
material for the next generation resulting in an overall stepwise improvement of the protein’s 
performance.  
The random nature of in vitro evolution offers several advantages compared to the rational protein 
design approach. Most importantly, little prior information is required regarding the structure and 
function of the protein under selection. In fact, sequencing of the selected clones can broaden the 
understanding of wild type protein structure and function by highlighting new important residues 
and structural elements or by giving insight in the mutational tolerance of a protein (Spiller et al., 
1999; Stoop et al., 2000; Rossenu et al., 2003). Furthermore, the method is relatively fast and 
allows for large functional progression if multiple selection and randomization rounds are 
performed. Its power is reflected in the possibility to combine different optimized traits in a single 
protein (Cherry et al., 1999; Coco et al., 2001), the isolation of multiple synergistic mutations 
(Cherry et al., 1999), novel folds (Lo Surdo et al., 2004), additional properties absent in the parent 
population (Campbell et al., 1997) and the selection of mutations that were unlikely to be predicted 
in advance (Moore & Arnold, 1996; Crameri et al., 1997). 
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1.2.2. A library of applications 
 
Directed evolution has been used to tackle protein engineering problems in several fields such as 
medicine (vaccines, diagnostics, therapeutics) (Vasserot et al., 2003), industrial processes (enzyme 
and whole cell biocatalysts, metabolic engineering) (Petrounia & Arnold, 2000), agriculture 
(Lassner & McElroy, 2002), nanotechnology (Sarikaya et al., 2003) and environmental applications 
(bioremediation and detoxification). The properties targeted are diverse and include binding affinity 
(pM – fM) (Boder et al., 2000; Zahnd et al., 2004), protein stability (Jermutus et al., 2001), correct 
folding and increased solubility (Sieber et al., 2001), heterologous expression levels and product 
yields (Patnaik et al., 2002; Zhang et al., 2002), substrate specificity (Chang et al., 1999; Song et 
al., 2002) and product diversity (Schmidt-Dannert et al., 2000), inverted enantioselectivity (May et 
al., 2000), cofactor requirements, fluorescence (Murakami et al., 2002; Wang et al., 2004a); activity 
under standard or altered reaction conditions (organic solvents, pH, temperature, detergents, 
oxidants) (Moore & Arnold, 1996; Ness et al., 2002), control of gene expression (Park et al., 2003).  
In addition, searching protein databases using the identified consensus sequence after directed 
evolution can reveal functional and structural similarities between proteins with low sequence 
homology (Christ & Winter, 2003). As protein variants arising from random libraries represent 
microevolutionary timelines, directed evolution has also been used to mimic and predict the 
outcome of in vivo evolutionary processes (Salipante & Hall, 2003). 
 
1.2.3. Theoretical vs practical diversity 
 
So far, the full potential of protein optimization through directed evolution has only been exploited 
to a small extent due to limited numbers of variants that can be created and evaluated. This 
limitation becomes obvious when one considers the theoretical number of possible mutants of a 
given protein with n amino acid residues. The entire population of variants constitutes an n-
dimensional sequence space which is extremely vast in nature (20n different sequences) (Voigt et 
al., 2001a). Defining all mutants by their corresponding performance yields a so-called fitness 
landscape. The geography of the dispersed local and global minima and maxima is unique for each 
protein-property combination with sequence space in-between generally considered to be largely 
void of functionality.  
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When translated to this concept of the fitness space, the entire directed evolutionary process can be 
viewed as a hill climbing walking trip with improvements decreasing as a sequence approaches a 
local optimum (Yano & Kagamiyama, 2001). Finite library sizes and practical limitations inherent 
to current screening assays, however, are responsible for the sparse sampling of the huge sequence 
space. A combination of molecular evolution and site directed or saturation mutagenesis for fine-
tuning enables more efficient searches of functional diversity around local optima (Wu et al., 1998; 
Cherry et al., 1999; Miyazaki & Arnold, 1999). In silico prescreening methods allow exploring a 
larger fraction of the theoretical diversity and thereby aid in the construction of smaller protein 
libraries with maximal encoded functionality (Voigt et al., 2001b; Hayes et al., 2002). 
 
1.2.4. Generation of genetic diversity 
 
1.2.4.1. Random mutagenesis 
 
Random point mutagenesis is the most straightforward way to create genetic diversity and the 
method of choice when starting from a single gene. Different methodologies have been described 
allowing the randomization process to occur either in vivo or in vitro. In the first case, cells are 
simply exposed to UV irradiation or chemical mutagens (Ghribi et al., 2004). An alternative 
strategy consists of propagating the target gene in mutator strains (Greener et al., 1994) or in the 
presence of a mutator plasmid (Selifonova et al., 2001; Camps et al., 2003). Random mutations are 
incorporated as a result of a low fidelity DNA polymerase I variant or by the disruption of one or 
more mut genes that are involved in the DNA mismatch repair pathway. Recently, somatic 
hypermutation occurring in B cells during the affinity maturation of immunoglobulin gene 
fragments has been exploited for the random mutagenesis of heterologous genes (Wang et al., 
2004a). However, several disadvantages are inherent to mutagenesis in vivo which so far have 
rather limited their application for directed evolutionary experiments. First of all, the process is 
rather slow with mutation frequencies up to 0.05%. This complicates the optimization of smaller 
genes (< 100 bp) and higher mutational levels typically require multiple passages through the 
mutator strain. In addition, most in vivo systems do not discriminate between the gene of interest 
and surrounding vector or genomic sequences.  
Both drawbacks are overcome by performing mutagenesis in vitro during PCR amplification. Error-
prone polymerase chain reaction (EP-PCR) has been widely used as an elegant way to generate 
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random protein libraries (Fig. 1.3A). The use of low fidelity DNA polymerases which lack 
proofreading activity and careful choice of the reaction conditions allow one to control the 
incorporation of single base substitutions, as elaborated in more detail in chapter 3. On the other 
hand, saturation mutagenesis aims to replace a small set of preselected amino acids in a protein by 
all other residues. Codons are hereby replaced using double-stranded DNA cassettes, degenerate 
oligonucleotides or universal ambiguous bases (Kegler-Ebo et al., 1994; Wong et al., 2004). As 
mentioned earlier, this strategy is particularly useful when trying to fine tune certain functionally 
important positions in binding pockets or catalytic sites by changing them to non-conservative 
residues. However, only a small part of the protein can be fully randomized as the number of genes 
increases exponentially.  
Finally, diversity does not need to be restricted to substitutions and natural amino acid residues. 
Recent advancements in translation engineering have sparked the incorporation of various unnatural 
analogs with novel properties (Cropp & Schultz, 2004). The expanded genetic code results in 
functional diversity beyond what is possible in nature (Cirino et al., 2003). Secondly, random 
insertions, deletions and truncations can also yield functional and even improved protein variants as 
illustrated by directed evolution of the β-lactamase and green fluorescent protein genes (Murakami 
et al., 2002; Chopra & Ranganathan, 2003).  
 
1.2.4.2. Sexual vs asexual diversity 
 
A common feature of the randomization methods described above is the absence of recombination 
between the different gene variants. Like evolution in asexual populations, adaptation is impeded by 
the low quality of the random mutations. Almost all individuals bear a heavy genetic load after 
several generations due to the persistence of deleterious mutations (Muller’s ratchet). In addition, 
beneficial mutations only accumulate sequentially and are not combined since only the best clone is 
selected and used as the parent for the next generation. In the absence of recombination, 
competition between positive mutations is known to drive the majority of them into extinction 
(clonal interference) (Rowe et al., 2003). Another drawback is the possible fixation of certain 
mutants in local minima of the fitness landscape. Escape requires large jumps in the sequence space 
which is difficult to achieve with random mutagenesis (Bogarad & Deem, 1999). Hence a large 
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portion of the sequence space remains unexplored (Fig. 1.3B), comparable to trying to rephrase a 
text by editing individual letters rather than shuffling words or parts of sentences.  
The evolutionary benefit of sexual recombination in vivo has been demonstrated using model 
systems (Rice & Chippindale, 2001; Colegrave, 2002) and theoretical simulations (Gerrish & 
Lenski, 1998). Because positive mutations can be combined, they are less likely to be trapped in 
individuals displaying reduced fitness and able to accumulate at an increased rate in the population. 
At the same time, recombination allows flushing out deleterious mutations more efficiently 
preventing their cumulative fixation in each generation. Just like sexual populations in vivo have 
been shown to adapt with increased efficiency to changes in the environment, improvement through 
directed evolution in vitro is also accelerated when a recombination step is introduced during 
diversity generation (Bogarad & Deem, 1999; Rowe et al., 2003). Instead of retaining the single 
best parent for a new selection round, multiple proteins can make up the new generation. 
Consequently, different properties can be combined in a single molecule and a larger region is 
covered in the sequence space (Fig. 1.3B).  
 
1.2.4.3. DNA shuffling   
 
Homologous recombination in vitro is obtained through DNA shuffling, also known as ‘sexual 
PCR’ or ‘molecular breeding’ (Tobin et al., 2000). In the simplest scenario, random variants 
generated by EP-PCR are used as templates for DNA shuffling in order to broaden the diversity in 
the library (Fig. 1.3B). On the other hand, a backcross of the selected variants with wild type DNA 
leads to the uncoupling of remaining deleterious and neutral mutations (Stemmer et al., 1994b; 
Cherry et al., 1999). 
Comparative in vitro (Crameri et al., 1998) and in silico studies (Bogarad and Deem, 1999) have 
pointed out that shuffling of homologous genes instead of random mutants of a single gene 
dramatically accelerates evolution (Fig. 1.3C). Such family shuffling benefits from the fact that the 
genes are already the result of a long selection process for optimized performance. Because the 
sequences represent preselected functional diversity for the construction of a library, a larger 
fraction of active individuals is generated after shuffling.  
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Fig. 1.3 Power of sexual and asexual directed molecular evolution. (A) Principle of error-prone PCR, single gene 
shuffling of random mutants and family shuffling of homologous genes. (B) Schematic representation of the sequence 
space and the diversity sampled in each corresponding library. (C) Outcome after several selection rounds for improved 
fitness (after Schmidt-Dannert, 2001 and Crameri et al., 1998). 
 
The original standard shuffling protocol as developed by Stemmer (1994ab) uses DNaseI to cleave 
the double-stranded target DNA into smaller-sized random fragments. After purification, a PCR 
without primers reassembles the entire sequence with crossovers in regions of high homology. 
Several variants of the technique were developed, aimed at increasing the crossover frequency in 
the shuffled clones. These alternative protocols include the reassembly starting from a 3’ primer 
(MURA shuffling) or a set of skewed primers (Kaper et al., 2002, Song et al., 2002), DNaseI 
digestion of a single-stranded DNA template molecule (Kikuchi et al., 2000) or the use of a 
heterologous single-stranded scaffold for the reassembly of the gene segments (RACHITT) (Coco 
et al., 2001). In all cases, these methods have the disadvantage that DNaseI has to be removed from 
the reaction before reassembly. In addition, DNaseI cleavage hot spots have been observed 
(Murakami et al., 2002) which can be circumvented by restriction via a chosen sets of restriction 
enzymes (Kikuchi et al., 1999). By contrast, the staggered extension process (StEP) of Zhao et al. 
(1998) is an elegant PCR-like reaction with short combined annealing and extension steps at low 
temperatures (< 72°C). Primers are gradually elongated resulting in the stepwise generation of full 
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length chimeric genes. Derivatives of the StEP protocol include a the application of a pool of 
random primers (RPR) (Shao et al., 1998) or the use of a skewed set of primers recognizing 
different parental strands (RDA-PCR) (Ikeuchi et al., 2003). Other strategies that are less used 
include degenerate oligonucleotide gene shuffling (DOGS) with degenerate primers in conserved 
crossover regions (Gibbs et al., 2001) and in vivo recombination of in vitro generated heteroduplex 
molecules (Volkov et al., 1999). 
 
1.2.4.4. Homology-independent recombination 
 
Standard shuffling protocols such as DNaseI fragmentation and StEP amplification suffer from a 
general inability to recombine genes sharing low sequence identity. This restriction is reflected in a 
recombination bias at sites of high similarity, limited number of crossovers (1-4/gene) and a 
prevalence of reconstituted wild type sequences which can make up to 20% of the library after 
family shuffling (Joern et al., 2002). As a rule of thumb, only closely related genes with ≥ 70% 
overall sequence identity can be readily shuffled and sequence stretches of less than 7-15 identical 
nucleotides are more difficult to recombine (Stemmer et al., 1994b; Joern et al., 2002).  
However, non-homologous recombination would be very useful for exploration of inaccessible yet 
functional relevant regions in the sequence space. Swapping of secondary motifs or protein domains 
sharing little sequence identity could lead to the evolution of new tertiary binding folds (Bogarad 
and Deem, 1999; Kolkman et al., 2001). This process resembles the reorganization of protein 
domains in vivo by exon shuffling as exons encode separate folded domains in many genes. 
A number of recent techniques have been devised enabling recombination to occur in regions 
displaying low or no sequence homology. Original protocols based on random cleavage with 
exonuclease III (ITCHY) (Ostermeier et al., 1999) or DNaseI (SHIPREC) (Sieber et al., 2001) only 
resulted in a single cross-over. Subsequent shuffling of these libraries by conventional methods has 
yielded random variants containing multiple sequence homology independent recombinations 
(SCRATCHY), starting from genes having sequence identities as low as 33% (Lutz et al., 2001). 
Recombination can also be brutally forced by including synthetic oligo’s with sequences from 
different templates (Coco et al., 2002; Ness et al., 2002) or the insertion of overlapping marker tags 
which can be removed prior to ligation (SISDC) (Hiraga et al., 2003). However, these methods 
suffer from the extensive oligonucleotide design that is required. 
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1.2.5. Fishing the protein sequence pool  
 
In order to identify functionally improved variants that are present in the random protein library, a 
coupling between genotype (mutant gene) and the resulting phenotype (protein variant) has to be 
established. Such a linkage is usually obtained by logistics, physical coupling or in vitro 
compartmentalization.  
When relying on logistics, protein variants are screened on selective media, filter membranes or in 
separate microwells with the aid of high-throughput robotics. Based on unique coordinates, positive 
mutants can be recovered afterwards for their genetic characterization. Physical coupling and in 
vitro compartmentalization techniques, on the other hand, allow the entire protein library to be 
selected simultaneously in a process called biopanning. Positive variants are gradually enriched 
during several repetitive selection rounds whereas irrelevant and inactive mutants are depleted from 
the population by extensive washing. Because this strategy requires reamplification of the selected 
library after each round, genes have to be associated physically or spatially with the corresponding 
protein molecules during the panning process. Furthermore, as with library screening, the linkage is 
necessary for direct identification of the interesting protein variants that have survived the selection 
experiment.  
A large array of different methods has been developed that allow the physical coupling of protein 
and gene, required for panning of random protein libraries. In most cases, the protein of interest is 
expressed as a fusion protein resulting in its attachment to the coat of viruses and spores or leading 
to the incorporation into bacterial or eukaryotic cell membranes. On the other hand, the 
corresponding gene is contained within the virion, spore or cell. The popular viral display strategy 
is based on the fusion with specific coat proteins and uses bacteriophages as the preferred display 
vehicle, hence the name phage display (see 1.3.). Similar expression on the surface of B. subtilis 
spores has been reported, exploiting the outer coat protein CotB (Isticato et al., 2001). Bacterial 
surface display with Gram-negative or -positive cells has been achieved through the coupling with 
various proteins residing in the outer membrane and cell wall or alternatively through a fusion to 
the F pilus (Francisco et al., 1992; Malmborg et al., 1997; Wang et al., 2004b). Eukaryotic cell 
surface has been achieved using yeast cells (Boder & Wittrup, 1997), insect (Ernst et al., 1998) and 
mammalian cells (Wolkowicz et al., 2005). Coupling to encoding plasmid molecules has been 
obtained by fusion with the LacI repressor or the NFκ-B p50 protein (Cull et al., 1992; Speight et 
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al., 2001). Ultimately, different display systems can be combined allowing library – library 
interaction panning as shown by the selection experiments of a phage displayed antibody library on 
bacterial surface expressed antigens (Benhar et al., 2000). 
A distinctive advantage of cell surface display systems is the possibility of high-throughput 
screening of large bacterial or yeast populations by flow cytometric cell sorting (Daugherty et al., 
2000), allowing real-time quantitative multiparameter analysis of each library member. 
Furthermore, post-translational modifications together with folding and secretory machineries that 
are homologous to mammalian cells are more suited for the functional expression of complex 
eukaryotic proteins. However, lower transformation efficiencies usually restrict the library sizes in 
yeast to a billion (Feldhaus et al., 2003).  
Expression methods working entirely in vitro are compatible with very large libraries since the 
transformation-bottleneck is bypassed. Two promising techniques are based on the coupling of the 
mRNA molecule to the protein during translation, either directly through a puromycin linker 
(covalent mRNA display) (Roberts & Szostak, 1997; Nemoto et al., 1997) or indirectly by means of 
a stalled ribosome-complex (ribosome display) (Hanes & Plückthun, 1997; He & Taussig, 1997). 
Alternative in vitro display methods include ribosome arrest by coupling to the ricin A chain 
(RIDS) (Zhou et al., 2002), fusion to the DNA binding proteins RepA (CIS display) or VirD2 
(DARTs) (de Figueiredo et al., 2004; Odegrip et al. 2004), attachement to streptavidin (STABLE) 
(Doi & Yanagawa, 1999), blocking of transcription and translation termination (Liu et al., 2000) 
and display on streptavidin coated microbeads (Nord et al., 2003). By contrast, in vitro 
compartmentalization does not involve a physical coupling. Instead, transcription and translation 
are performed in water in oil emulsions (Tawfik & Griffiths, 1998). As each droplet contains a 
single gene, different variants remain separated as in a cellular population.  
Because cell-free display systems require a simple PCR for library amplification, affinity 
maturation through EP-PCR or DNA shuffling between the selection rounds is relatively 
straightforward and efficient. In addition, in vivo selection pressures that are typical for display 
systems requiring amplification in a biological host are overcome. Such inherent selection forces 
are known to prevent the enrichment of proteins that are toxic in nature, poorly translated, 
improperly folded, sensitive to proteolytic degradation and incompatible with viral infection or 
secretion processes (Maenaka et al., 1996; Bothmann & Pluckthun, 1998; Wind et al., 1999) and 
can result in genetic instability or the enrichment of clones carrying deletions (de Bruin et al., 
1999). 
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1.3. Filamentous phage display 
 
1.3.1. Biology of the filamentous bacteriophage  
 
1.3.1.1. Viral structure and genome  
 
When heterologous proteins are fused to certain coat proteins, they can be expressed on the surface 
of viral particles upon their assembly. Although several viruses such as phage λ (Maruyama et al., 
1994), adeno-associated virus type 2 (Müller et al., 2003), murine leukemia retrovirus (Buchholz et 
al., 1998) or a baculovirus (Grabherr et al., 2001) have been engineered this way, display systems 
based on filamentous bacteriophages remain by far the most widely used (Smith & Petrenko, 1997; 
Azzazy & Highsmith, 2002). 
Filamentous Ff coliphages M13K07, fl and fd (Inoviridae) resemble long flexible rod-like 
structures around 7 nm in diameter and 900 nm in length (Fig. 1.4A) (Gray et al., 1981). The bulk 
of this structure is composed of 2700 copies of the major coat protein pVIII which represents 99% 
of the total protein mass. Both ends of the filamentous phage are formed by a pair of minor coat 
proteins. One side contains 3-5 copies of pIX and pVII each whereas the other possesses a similar 
organization of pIII and pVI proteins (Fig. 1.4B). Studies with antibodies have revealed that pIII 
and pIX are exposed on the viral surface burying the pVI and pVII coat proteins respectively 
(Endemann & Model, 1995). All coat proteins except for pVI are embedded with their C-terminus 
in the phage coat which is important for the display of foreign proteins later on. 
The genomes of M13K07, f1 and fd show 98% sequence identity and consist of a single-stranded 
circular DNA molecule (Webster, 2001). In M13K07, the 6407 bp genome encodes 11 proteins 
which are grouped together according to their function (Fig. 1.4C). A first set is composed of the 
genes gpI, gpIV and gpXI. The corresponding proteins form the export complex in the bacterial 
membrane where newly assembled phage particles are extruded from the host. The genes gpII, gpV 
and gpX from the second group code for proteins that are involved in replication of the viral 
genome. Both gpX and gpXI are noteworthy as they correspond to the 3’ parts of the larger gpII and 
gpI genes respectively. Expression of pX and pXI is the result of translation from an internal 
methionine codon. The remaining genes gpIII, gpVI, gpVII and gpIX encode the minor and major 
capsid proteins of the filamentous phage coat. Finally, two intergenic regions (IR) of 59 bp and 508 
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bp lay between gpII-gpIV and gpIII-gpVIII respectively. The second IR contains the viral origins of 
replication, as well as a hairpin structure that holds the packaging signal (PS) where viral assembly 
is initiated.   
 
Fig. 1.4 Structure and genome of the filamentous Ff bacteriophage. (A) Electron micrograph of a fd virion together with 
a segment of the fd DNA – pV complex (Gray et al., 1981). (B) Schematic representation of the filamentous phage 
structure with the location of major and minor coat proteins indicated (Hinfray, 1998). (C) Diagram of the Ff genome 
showing the organization of the genes according to their function (Webster, 2001). The noncoding IR refers to the 
intergenic region which contains the PS and the origins of replication for the viral (+) and complementary (-) DNA 
strands.  
 
1.3.1.2. Bacteriophage life cycle 
 
Phages belonging to the Ff family are characterized by the F-pilus mediated infection of bacterial 
host cells. Following initial binding, pilus contraction is thought to bring the phage in close 
proximity to the bacterial surface leading to membrane penetration and release of the viral genome 
in the Escherichia coli cytosol. Inside the cell, replication of the viral DNA is mediated by pII 
whereupon pV proteins cover the newly formed single-stranded DNA-molecules. The different 
viral coat proteins that become expressed insert into the inner membrane prior to assembly 
(Endemann & Model, 1995). 
Assembly and extrusion of progeny phage particles is located at zones of close contact between the 
inner and outer bacterial membrane where a large complex consisting of pI, pIV and pXI form a 
gated channel (Lopez & Webster, 1985; Feng et al., 1999). Because membrane integrity and cell 
viability are preserved in the absence of phage assembly, the infected bacterial host is not lysed but 
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instead continuously secretes filamentous phage particles. As a result, each cell is able to produce 
around 100 to 300 new phage particles per generation yielding final titers exceeding 1012 plaque-
forming units per ml (Rasched and Oberer, 1986).  
Filamentous phage assembly is assumed to be triggered by the interaction between the cytoplasmic 
part of the inner membrane associated pI protein and the PS that is exposed on one end of the pV-
DNA complex (Russel, 1995). After a tip has been formed by the pVII and pIX coat proteins, the 
viral DNA slides through the assembly complex while the 1400 pV dimers that cover the DNA 
strand are gradually replaced by pVIII coat proteins. When the other end of the DNA molecule is 
reached, the pIII-pVI tip is formed and the phage is released in the medium.  
 
1.3.2. pIII, key to infection and display 
  
The pIII minor coat protein is the preferred fusion partner for the display of heterologous proteins 
on the filamentous phage surface. It is expressed as a preprotein with an 18-residue signal sequence 
that is removed after insertion in the inner bacterial membrane. The remaining 406 amino acids of 
the mature protein are organized in three domains, each with a distinct function and separated by 
stretches rich in glycine residues. 
Domain I, composed of the N-terminal 66 amino acid residues, is indispensable for infection and 
appears to assist in the release of the viral DNA into the host cytoplasm. Expression of pIII and a 
peptide corresponding to the N-terminal 24 residues resulted in altered membrane characteristics as 
cells leak periplasmic components in the medium, display increased susceptibility to detergents and 
are resistant to filamentous phage infection (Boeke et al., 1982; Rampf et al., 1991). These 
phenotypic changes are probably caused by sequestering the bacterial TolQRA receptor proteins in 
the cytosol, thereby preventing them to associate with the bacterial membrane where they normally 
assist in the filamentous phage infection process (Karlsson et al., 2003). 
The second domain is formed by residues 86-216 and mediates the initial binding to the F-pilus on 
the bacterial surface (Deng et al., 1999; Deng & Perham, 2002). Its elimination typically results in a 
low infection level which is pilus independent but requires Ca2+ as well as domain I. 
A third domain corresponding to residues 257-377 anchors the pIII capsid protein into the phage 
coat (Weiss et al., 2003). In addition, a short C-terminal region is responsible for pIII insertion in 
the cytoplasmic membrane where it waits until being packaged into a new phage particle (Boeke & 
Model, 1982). 
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1.3.3. Bacteriophage surface expression 
 
1.3.3.1. From basics to beyond 
 
Phage display technology exploits the flexibility of the filamentous bacteriophage assembly 
process. Because longer DNA molecules simply result in the addition of more pVIII proteins along 
the viral surface, foreign genes can be cloned into the IR of the phage genome without 
compromising infectivity or concerns regarding size constraints. 
All five M13K07 coat proteins have been engineered for the expression of proteins or peptides on 
the bacteriophage surface. Generally, heterologous proteins are fused to the N-terminus of the 
minor coat protein pIII. Phage display systems using the major coat protein pVIII are usually 
restricted to peptides as larger pVIII fusion proteins seem to interfere with the viral assembly 
process. However, exceptions have been reported (Weiss et al., 2000) and pVIII has been 
engineered for higher display levels (Weiss & Sidhu, 2000). Some groups have successfully used 
the other coat proteins pVI, pVII and pIX as well although applications remain to be seen (Gao et 
al., 1999). The inverse orientation of the pVI protein in the phage coat is noteworthy. Proteins can 
be fused to the solvent exposed C-terminus of this capsid protein (Jespers et al., 1995) which is 
particularly interesting when screening genomic and cDNA expression libraries for cellular protein-
protein interaction analyses (Rodi et al., 2001). However, similar fusions to the C-termini of pIII 
(Fuh & Sidhu, 2000) and pVIII (Weiss & Sidhu, 2000) have been made possible through the use of 
coat protein variants, obtained after directed evolution. 
Besides coupling to full length capsid proteins, truncated pIII constructs or insertion between 
different pIII domains have also resulted in the successful expression on the filamentous 
bacteriophage surface. In fact, the first described phage display experiment performed by Smith 
(1985) illustrated that EcoRI endonuclease could be inserted inside the glycine stretch that separates 
domains II and III without compromising f1 infectivity.  
 
1.3.3.2. Phage versus phagemid vectors 
 
Two types of vectors have been developed for bacteriophage surface expression of heterologous 
polypeptides. They are classified as type ‘3’ or ‘8’ depending on the viral coat protein used (pIII or 
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pVIII respectively) and result in a few to several thousand fusion proteins on each filamentous 
phage particle (Fig. 1.5). 
 
 
 
Phage vectors are simple in design and were the first to be constructed. They correspond to the Ff 
genome with the foreign gene cloned upstream of the gpIII (type 3) or gpVIII gene (type 8). As a 
result, all capsid proteins are coupled to the protein of interest and each progeny phage contains 
multiple fusion proteins. More in particular, multivalent pVIII display has resulted in high 
expression levels yielding ‘landscape phages’ that have up to 50% of their surface covered with 
random peptides (Petrenko & Smith, 2000). Fusion protein expression levels with pIII phage 
vectors have been estimated between 50 and 70% of the total pIII amount (Kassner et al., 1999; 
Huie et al., 2001).   
Not all polypeptides, however, are compatible with a multivalent display system. Especially large 
and bulky proteins (> 100 amino acids) can interfere with phage infection or stability due to steric 
hindrance or impaired pIII folding. Monovalent display can alleviate such problematic display and 
allows for the expression of larger proteins on the viral surface. Since recombinant phage particles 
contain a mixture of wild type and chimeric capsid proteins, negative effects of the displayed 
Fig. 1.5 Monovalent and multivalent 
display systems based on phage and 
phagemid vectors. Heterologous genes and 
surface displayed proteins are indicated in 
black (after Armstrong et al., 1996). 
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protein on the viral coat are reduced. Phage vectors can easily be adapted to this end by including 
an additional copy of the gpIII (type 33) or gpVIII (type 88) gene. By contrast, phagemid vectors 
can be regarded as a hybrid between a phage vector and a conventional plasmid. A plasmid origin 
of replication and a selectable marker allow for the proliferation of the phagemid vectors in the 
bacterial host cells. The gpIII (type 3+3) or gpVIII gene (type 8+8) is preceded by a 
multicloningsite and a signal sequence that direct the fusion proteins to the periplasm. The entire 
cassette is placed under the control of an inducible promoter in order to reduce possible negative 
effects due to fusion protein expression prior to assembly. The presence of the Ff origin of 
replication together with the PS allows a single-stranded phagemid copy to be incorporated into the 
recombinant progeny viruses. 
Because phagemid vectors lack all other viral genes necessary for filamentous phage production, E. 
coli cells require infection by a helper phage to trigger assembly. Helper phages deliver in trans the 
missing capsid and assembly proteins (phage rescue) but contain a defective origin of replication 
and mutated packaging signal themselves. Consequently, phagemid vector molecules are more 
efficiently replicated and packaged into new extruding phage particles. In addition, pIII or pVIII 
fusion proteins encoded by the phagemid vector are diluted by the excess wild type coat proteins 
that originate from the helper phage genome. As a result, viral coat structures display on average 
less than one pIII fusion protein or somewhere around hundred pVIII fusion proteins on their 
surface, depending on the polypeptide and phagemid vector used (Huie et al., 2001; Azzazy & 
Highsmith, 2002; Baek et al., 2002).  
An additional advantage of phagemid based expression systems is the possibility to construct larger 
random protein libraries due to their higher transformation efficiencies in E. coli. The diversity 
contained within a library is a critical parameter that determines the outcome of molecular evolution 
event and the extent of binding affinity maturation. Usually, repertoires have been restricted to 108 
– 1010 different variants (O’Connell et al., 2002; Hust & Dubel, 2004). However, library sizes as 
vast as 1011 – 1012 have been attained by brute force cloning and optimization of bacterial 
transformation (Sidhu et al., 2000), the use of mutator strains (Low et al., 1996) or recombinatorial 
library construction (Fisch et al., 1996; Sblattero & Bradbury, 2000). Such high diversity repertoires 
generally result in subnanomolar binding affinities as shown in theoretical models (Rosenwald et 
al., 2002) and numerous experiments (Vaughan et al., 1996; Sheets et al., 1998; O’Connell et al., 
2002). 
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1.3.4. Biopanning: finding a needle in the molecular haystack 
 
During biopanning, the library is exposed to the labeled or immobilized target protein (Fig. 1.6). 
High affinity binding variants in the population are retained whereas the large excess of non 
specific clones is removed. Bound particles are subsequently recovered by alkaline or acid elution, 
proteolytic cleavage of the fusion protein or a competition with excess soluble ligand or antigen 
(Mutuberria et al., 1999; Yu et al., 2004). After reinfection and amplification, the process is 
repeated in order to further enrich the elite variants in the population. Usually, selection stringency 
is increased in later rounds by performing binding in the presence of a competitor, decreasing 
antigen concentrations, extensive washing and subsequent selection rounds without reamplification 
(Kretzschmar et al., 1995; Levitan, 1998). The overall result is a selection for tighter binding, 
primarily based on slower dissociation kinetics (Schier et al., 1996; Wu et al., 1998; Boder et al., 
2000) although assays for the improvement of association rates have also been described (Vasserot 
et al., 2003).  
Display levels can have an important outcome on the selection result. Monovalent pIII display is 
especially useful for the discrimination of variants based on their intrinsic binding affinity. Despite 
higher expression levels, multivalent display complicates the selection of high affinity clones due to 
increased valency and avidity effects (Levitan, 1998). As a result, moderate affinity binders display 
higher apparent affinities and are better retained, impairing the enrichment of the scarce tight 
binding variants during panning (de Wildt et al., 2002; O’Connell et al., 2002). Based on these 
findings, Deshayes et al. (2002) have used multivalent pVIII display in the first selection rounds in 
order to retain a broad diversity of specific clones with various affinities. Subsequent monovalent 
pIII display was applied to further improve the affinity of the most promising peptide candidates. 
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Fig. 1.6 Phage display selection of a random protein library. (A) A population of random gene mutants is cloned within 
a phagemid vector. (B) The corresponding protein variants are expressed on the surface of filamentous phage particles. 
(C) The phage library is selected against an immobilized antigen. (D) Non specific phages are removed during washing 
resulting in the enrichment of specific high affinity binding clones. (E) The retained phage particles are eluted and used 
to reinfect E. coli host cells (F). (G) The selected library is reamplified and may be subjected to new panning cycles. 
(H) After several selection rounds, the surviving clones are analyzed individually for their improved performance (after 
Willats, 2002). 
2. Objectives 
 34 
 
 
2. Objectives 
 
 
 
 
In the coming years, a considerable growth is expected for B. thuringiensis ICP based pest 
management. First of all, recent pesticide restrictions have been imposed in the US and the 
European Union (US Food Quality Protection Act, European Council Directive 91/414), aimed at 
reducing the application of conventional chemical broad-spectrum insecticides (Whalon & 
Wingerd, 2003). Secondly, adoption levels of genetically modified crops expressing B. 
thuringiensis crystal proteins have increased ever since their introduction in 1996 (James, 2004). 
Moreover, second generation plants providing even higher protection levels are ready for 
commercialization. Furthermore, a thorough safety reassessment of B. thuringiensis crops after 5 
years of use has demonstrated the safety for non target organisms, including men (Mendelsohn et 
al., 2003). This makes the B. thuringiensis crystal proteins an interesting tool for the 
implementation in integrated pest management programs.  
However, improved protection levels in all plant parts throughout the entire growing season pose 
severe selection pressures on the pest populations in the field and could accelerate the onset of 
resistance. The high dose – refuge strategy or the combination of multiple ICPs with different 
receptor specificities have shown to delay the development of overall resistance in the field (Tang et 
al., 2001; Zhao et al., 2003). Thus, the improvement of crystal protein properties including receptor 
specificity, activity and host range would mean a significant asset for the sustainability of B. 
thuringiensis based crop protection in the future. Moreover, the ability to engineer and optimize 
crystal proteins could provide an alternative for the screening of large B. thuringiensis collections 
for novel target specificities. 
B. thuringiensis crystal proteins with improved properties such as stability, expression level, 
receptor affinity, specificity and activity have been obtained in the past by targeted mutagenesis of 
critical residues and the construction of chimeric proteins. However, rational design is rather 
complex, labor intensive and depends on our understanding of the structure-function relationship. 
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By contrast, a random evolutionary approach mimicking the mutagenesis and recombination 
processes in vivo is more straightforward and has already proven its efficacy in a large variety of 
protein engineering challenges. Furthermore, insights into crystal protein structure and mechanism 
of action resulting from such directed evolution projects can aid in future optimization of ICPs 
through rational design.  
Optimization of B. thuringiensis crystal proteins through DNA shuffling has been reported by 
Lassner & Bedbrook (2001). Limited screening yielded several ICP variants with improved toxicity 
or altered specificity. We decided to tap into the true potential of directed molecular evolution in 
vitro by using the phage display expression system. This strategy allows for the selection of large 
populations consisting of billions of random mutants. As a result, inherent protein diversity can be 
rapidly prospected for novel or improved functionality, without the need to analyze each mutant 
separately. 
In view of this rationale, we wanted to develop an efficient phage display system that could be used 
for the optimization of B. thuringiensis ICPs through the selection of large random libraries. As a 
model protein, we opted for the Cry9Ca1 crystal protein (Lambert et al., 1996). The receptor 
specificity of this ICP differs from that of the Cry1A group, making it an ideal candidate for 
combined application in the field. In contrast to other ICPs, however, its relative gastric stability has 
limited the application of genetically modified plants expressing the Cry9Ca1 crystal protein. 
First, a large cry9Ca1 library was constructed by random mutagenesis using the Taq and Mutazyme 
DNA polymerases. Subsequently, we shuffled amplified DNA from both reactions to level 
mutational biases, introduced by each DNA polymerase (chapter 3). Preliminary attempts at 
displaying B. thuringiensis crystal proteins on the filamentous bacteriophage surface demonstrated 
instability and partial proteolysis of the ICP fusion proteins (Marzari et al., 1997; Kasman et al., 
1998). Therefore, much effort was directed towards optimization of vector and culture conditions in 
order to obtain stable and functional ICP expression on the viral coat (chapter 4). In addition, we 
devised an integrated phage display expression and selection protocol that allows for a rapid 
characterization of selected ICP and other protein variants (chapter 6). Finally, a limited number of 
clones from the cry9Ca1 library were screened for reduced gastric stability (chapter 5). Combined 
with the findings of Lassner & Bedbrook (2001), our screening results demonstrate the feasibility of 
directed molecular evolution in vitro for the isolation of ICP variants with predefined properties. 
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3.1. Introduction 
 
Random mutagenesis and strategies that allow gene recombination in vitro have become important 
tools for exploring and optimizing protein properties. In vitro random mutagenesis is hereby mostly 
the result of an EP-PCR using low-fidelity buffer conditions in combination with a DNA 
polymerase lacking exonuclease proofreading activity. Because Taq DNA polymerase has a high 
intrinsic error rate between 8 x 10-6 and 2 x 10-4 errors/nucleotide synthesized depending on the 
reaction conditions (Eckert & Kunkel, 1990; Cline et al., 1996), it is the preferential choice for most 
EP-PCR mutagenesis studies. The rate of single base substitutions during DNA polymerase action 
can be deliberately increased by elevated Mg2+ concentrations relative to the total dNTP 
concentration, by adding Mn2+ up to 5 mM to the reaction buffer, or by changing the ratio of the 
different dNTPs (Eckert & Kunkel, 1990). Lower template concentrations or higher numbers of 
PCR cycles on the other hand result in more target duplications and consequently higher mutation 
frequencies in the amplified DNA. Using this set of altered conditions, mutation frequencies 
ranging from 0.01 to 10% have been reported (Leung et al., 1989; Cadwell & Joyce, 1992; Fromant 
et al., 1995; Vartanian et al., 1996; Lin-Goerke et al., 1997; Shafikhani et al., 1997).  
Although Taq polymerase has been widely used for EP-PCR experiments, it has the major 
drawback that certain types of basepair changes are preferred, independent of the MnCl2 
concentration used. It is well documented that mutations generated by this enzyme are dominated 
by AT → GC transitions and AT → TA transversions (Lin-Goerke et al., 1997; Shafikhani et al., 
1997; Casson & Manser, 1995). The overall result is a strong bias toward dAMP and dTMP 
substitutions, making these nucleotides two- to fourfold fold more likely to be mutated compared to 
G and C residues. Consequently, all types of mutations are not equally represented and a high GC 
3. Reducing mutational bias in random protein libraries 
 37 
genetic content can further significantly reduce the average mutation frequency and library 
variation (Moore & Maranas, 2000).  
Like Taq polymerase, the recently developed Mutazyme DNA polymerase has a high error rate of ± 
3.3 x 10-4 errors/nucleotide synthesized and a general predisposition for the generation of 
transitions. In addition to its strong preference for GC → AT transitions, GC → TA transversions 
are introduced at a higher rate, which explains its overall tendency to mutate G and C residues 
nearly three times more frequently (Cline & Hogrefe, 2000). The complementary mutational 
spectrum of this polymerase makes it an ideal candidate to offset the mutational bias inherent to 
randomization with Taq DNA polymerase which may result in a library with a more balanced 
mutational profile as suggested by Patrick et al. (2003) and Neylon (2004).  
Here we employed the two low-fidelity DNA polymerases Taq and Mutazyme in separate reactions 
and shuffled the amplicons generated with both enzymes. Following this approach, the inherent 
nucleotide biases of each EP-PCR were reduced in the final library. 
 
3.2. Material & methods 
 
3.2.1. EP-PCR  
 
The pCANTAB5E-derived phagemid construct pTV16 containing the B. thuringiensis cry9Ca1 
gene (Lambert et al., 1996) and an upstream sequence coding for the hemagglutinin (HA) peptide 
tag (see table 4.1) was isolated from E. coli TG1 cells (Wizard Plus Midipreps DNA purification 
system; Promega) and used as a template for EP-PCR with the Taq and Mutazyme DNA 
polymerases. Both PCRs were performed in a PTC-200 thermocycler (MJ Research) with the 
primer pair PCANTHP2210FOR (5’-TATGCTTCCGGCTCGTATGTTGTG-3’) and 
PCAN3725REV (5’-GGATGTGCTGCAAGGCGATTAAGT-3’). The cycling parameters were 
94°C for 2 minutes, 33 cycles of 94°C for 30 seconds, 67°C for 30 seconds, and 72°C for 3 minutes 
20 seconds, and an additional 72°C for 5 minutes extension step. The Taq PCR mixture contained 
50 mM KCl, 10 mM Tris–HCl (pH 9.0 at 25°C), 1.5 mM MgCl2, 0.2 mM each dNTP, 50 pmol of 
each primer, 5 U Taq DNA polymerase (Amersham Biosciences), 0.25 mM MnCl2, 200 ng of 
pTV16 template, and milliQ up to a final volume of 50 µl. The Mutazyme PCR consisted of 1x 
Mutazyme reaction buffer, 0.2 mM each dNTP, 15 pmol of each primer, 2.5 U Mutazyme DNA 
3. Reducing mutational bias in random protein libraries 
 38 
polymerase (GeneMorph PCR Mutagenesis Kit, Stratagene), 20.5 ng pTV16 template, and milliQ 
up to a final volume of 50 µl.  
Amplified DNAs (2849 bp) obtained by both PCRs were purified from a low-melt agarose gel 
(1.2%) using the QIAquick Gel Extraction Kit (Qiagen). Their concentrations were determined by 
spotting an aliquot on a 1.2% agarose gel and comparing with a lambda DNA standard dilution 
series. 
 
3.2.2. StEP shuffling  
 
The original StEP protocol of Zhao et al. (1998) was slightly modified to increase shuffling yield. 
Template consisted of 0.15 pmol (∼285 ng) DNA obtained by EP-PCR with Taq DNA polymerase, 
together with an equal amount of Mutazyme-amplified DNA. The StEP reaction contained 50 mM 
KCl, 10 mM Tris–HCl (pH 9.0 at 25°C), 1.5 mM MgCl2, 0.2 mM each dNTP, 15 pmol of each 
primer, 5 U Taq polymerase (Amersham Biosciences), and milliQ up to a final reaction volume of 
100 µl. Shuffling was performed in a PTC-200 thermocycler (MJ Research) with nested primers 
PCANTHPHA2384FOR (5’-CCATGGCCGCGTATCCGTATGA-3’) and PCANTHP3073REV 
(5’-CGCCAGCATTGACAGGAGGTTG-3’) and a cycling program of 94°C for 5 minutes, 100 
cycles of 94°C for 30 seconds and 40°C for 5 seconds, concluded by 72°C for 5 minutes.  
Shuffled DNA (2025 bp) was purified (Qiaquick Gel Extraction Kit, Qiagen) and the concentration 
was determined as described earlier. Aliquots containing 50 ng shuffled DNA were further 
amplified in a standard PCR with the seminested primer pair PCANNCOIHAFOR (5’-
CATACCATGGCCGCGTATCCGTATGATGTTCCGGATTATGCGC-3’) and PCAN1928REV 
(5’-CACAAACGAATGGGCTACCT-3’). Purification of the amplified DNA and subsequent 
determination of the concentration were performed as described earlier. 
 
3.2.3. Cloning and sequencing 
 
Following a NcoI–NotI digest, the EP-PCR products and the shuffled DNA (1912 bp) were cloned 
back into the dephosphorylated pTV16 vector backbone. Ligations were electroporated into E. coli 
XL1-Blue cells and positive clones containing the cry9Ca1 insert were identified in a standard PCR 
using the primers PCANFOR2 (5’-CCAGGCTTTACACTTTATGC-3’) and 9C1472REV (5’-
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GATATCTTAACCAACTTTCAGTA-3’). Plasmid DNA from 10 positive clones obtained either 
by StEP shuffling or by each of the separate EP-PCRs with Taq or Mutazyme DNA polymerase 
was isolated (Wizard Plus Midipreps DNA purification system, Promega) and used for the 
sequencing of the entire randomized cry9Ca1 gene.  
Theoretical AT and GC substitution frequencies after StEP shuffling were calculated according to 
the formula [(C x S x M)Taq + (C x S x M)Mutazyme] x 100 / MStEP where C represents the estimated 
fractions of Taq (0.43) and Mutazyme (0.53) PCR products that participated in the shuffling 
reaction (see 3.3.), M is the total number of mutations, and S denotes the AT or GC substitution 
frequency, respectively (Table 3.1).  
 
3.3. Results 
 
The gene encoding the B. thuringiensis Cry9Ca1 crystal protein (1845 bp) was used as a model 
system for the construction of a random library with reduced mutational bias. In the first step, two 
separate EP-PCRs were carried out using Taq or Mutazyme DNA polymerase. In the second step, 
the resulting PCR products were shuffled in a single StEP reaction, thereby combining the 
complementary mutational spectra of both enzymes.  
EP-PCR with Taq DNA polymerase was performed by adding 0.25 mM MnCl2 to the reaction 
buffer since a higher concentration resulted in greatly reduced yields (results not shown). Contrary 
to earlier publications describing random mutagenesis by Taq DNA polymerase (Cadwell & Joyce, 
1992; Shafikhani et al., 1997), the use of an unbalanced mixture of dNTPs with elevated 
concentrations of dCTP and dTTP (1 mM) did not result in amplified DNA (results not shown). 
Therefore, we added each nucleotide in a final concentration of 0.2 mM to the reaction similar to 
standard nonmutagenic PCR conditions. When using Mutazyme DNA polymerase, the desired 
mutation level is achieved by careful choice of the initial amount of template. We opted for 20.5 ng 
plasmid template, which should result in a mutation frequency between 0.21 and 0.35% according 
to the manufacturer’s instructions. This corresponds to an average of four to seven mutations in the 
cry9Ca1 gene. The PCR products obtained with Taq and Mutazyme DNA polymerase were 
shuffled according to the optimized StEP protocol described under Materials and methods. 
Amplicons from the two different EP-PCRs and shuffled DNA generated by StEP were cloned into 
the pTV16 vector backbone. For each of the three libraries synthesized, 10 clones representing 
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approximately 19 kb were sequenced. The data compiled from the DNA sequence analysis are 
summarized in table 3.1. 
Random mutagenesis with Taq DNA polymerase exhibited the highest mutation frequency. 
Mutation levels obtained with Mutazyme polymerase were sixfold lower and corresponded to the 
lower limit of the expected range. Subsequent StEP shuffling of Taq and Mutazyme PCR products 
resulted in an intermediate mutation frequency of 0.63% or on average 12 mutations in the cry9Ca1 
gene. This mutation frequency was very close to the expected 0.66%, indicating that the shuffled 
genes represented almost equal amounts of Taq (47%) and Mutazyme (53%) EP-PCR products.  
Random mutations in the EP-PCR clones appeared to be uniformly distributed and no mutational 
hot spots were detected (Fig. 3.1). Remarkably, the number of mutations within the first 435 
shuffled basepairs was higher than expected. This could point to a reduced shuffling efficiency in 
this particular region, resulting in a lower number of recombinations and a preference for Taq PCR 
products.  
 
 
 
Fig. 3.1 Distribution of random mutations in 10 clones after EP-PCR with Taq DNA polymerase, EP-PCR with 
Mutazyme DNA polymerase, or subsequent StEP shuffling. Straight lines represent an ideal distribution without 
mutational hot spots and are based on the total number of mutations in 10 sequenced clones from each library.  
 
As expected the predominant mutations generated by Taq DNA polymerase were AT → GC and 
AT → TA substitutions. This clear bias was also reflected in a 5.1-fold excess of AT over GC 
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changes, indicating that library diversity was skewed. On the other hand, GC → AT transitions and 
GC → TA transversions were favored by Mutazyme DNA polymerase, demonstrating its 
preference to mutate G and C nucleotides. However, the total number of GC changes was 
surprisingly low, compared to the previously reported 72.5% GC substitution frequency (Cline & 
Hogrefe, 2000). As explained in more detail under Discussion, this could be attributed to the high 
AT content of the cry9Ca1 gene.  
Following StEP shuffling, transition mutations were still overrepresented in the shuffled library as a 
result of the preference of both Taq and Mutazyme polymerases for this kind of mutation. In 
contrast, the AT bias of the Taq polymerase was reduced as indicated by the intermediate AT → 
GC/GC → AT ratio and the reduced level of AT substitutions. In addition, the observed number of 
AT and GC changes after shuffling was in close agreement with the theoretical values 73.8 and 
21.1%, respectively, which are based on the observed EP-PCR mutation frequencies and the 
amount of both PCR products in the shuffling reaction as determined earlier. This result supports 
the earlier finding that both PCR templates contributed equally to the final shuffled library. 
 
3.4. Discussion 
 
Despite the recent development of in silico prescreening algorithms, exploration of sequence 
diversity during directed evolution remains severely limited as a result of library size upper limits 
and practical restrictions inherent to current screening and display technologies. These constraints 
necessitate efficient randomization methods lacking major mutational biases that could reduce and 
skew library diversity.  
The number of mutations that we observed after amplification with Taq polymerase (1.13%) was 
relatively high compared to those in previous publications describing the use of unbalanced sets of 
nucleotides or elevated concentrations of MnCl2 (Cadwell & Joyce, 1992; Fromant et al., 1995; Lin-
Goerke et al., 1997; Shafikhani et al., 1997; Casson & Manser, 1995). However, the exact number 
of target duplications is often not reported nor exactly known, making a direct comparison of 
mutation frequencies difficult. Our Taq EP-PCR protocol uses an equimolar mixture of nucleotides 
in combination with a lower concentration of MnCl2, two factors that have been reported to increase 
PCR product yield (Vartanian et al., 1996). 
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Random mutagenesis with the Mutazyme DNA polymerase yielded fewer GC substitutions than 
expected. Because the mutational spectrum of this polymerase is invariable over a wide range of 
mutation frequencies, we reasoned that the composition of the cry9Ca1 gene could be responsible 
for the shifted mutational bias. Like other B. thuringiensis crystal protein genes, cry9Ca1 is rich in 
A and T residues (60.4%). Based on this composition and the reported mutational spectrum of the 
Mutazyme DNA polymerase (Moore & Maranas, 2000), we estimated the fraction of AT and GC 
substitutions at around 39.1 and 47.5%, respectively. This corresponds well with the observed data 
in table 3.1. Therefore, we suggest that the nucleotide composition of a target gene should be taken 
into account and stated in future mutagenesis studies. 
Shuffling of the EP-PCR products generated with both DNA polymerases resulted in a library with 
AT and GC substitution frequencies that could be predicted from the EP-PCR sequencing data. 
Compared to standard mutagenesis using Taq DNA polymerase alone, shuffled clones displayed a 
smaller proportion of AT substitutions. Due to the sixfold lower mutation frequency obtained with 
the Mutazyme DNA polymerase, the effect of its mutational spectrum in the shuffled library was 
reduced. However, equal mutation frequencies or a sixfold higher concentration of Mutazyme PCR 
template in the shuffling reaction should result in a further reduction of the mutational bias in the 
final library. Calculations based on either assumption predict an outcome of 60% AT substitutions. 
This would correspond to unbiased mutagenesis of the AT-rich cry9Ca1 gene with each nucleotide 
having an equal chance to be mutated.  
The simultaneous use of Taq and Mutazyme polymerases during EP-PCR (GeneMorph II Random 
Mutagenesis Kit, Stratagene) or DNA shuffling (Castle et al., 2004) has been reported. These two 
approaches combine both DNA polymerases in a single reaction to reduce mutational bias in 
random libraries. The strategy presented here offers more flexibility to control the final mutation 
level and bias in a random library. Performing separate EP-PCRs with Taq and Mutazyme DNA 
polymerases allows for the selection of the appropriate mutagenesis frequencies without the 
additional optimization required when both enzymes are used simultaneously in a single reaction. 
The possibility to vary the amount of template in the subsequent shuffling reaction can compensate 
for or introduce novel biases in the mutational spectrum as shown by the theoretical calculations. 
In a recent paper, van der Veen et al. (2004) used a similar protocol for the isolation of 
amylosucrase variants with enhanced activity although another shuffling method was used. 
However, the authors did not provide mutagenesis data nor report on the effect on the mutational 
bias in the final library and therefore our results complement their study. Based on sequence 
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analysis data, we show that libraries with reduced mutational bias can be generated. Furthermore, in 
principle any desired sequence variation can be obtained by carefully adjusting the experimental 
conditions and taking the GC content of the target genes into account. This should allow for a more 
efficient sampling of the functional sequence space in future directed molecular evolution studies. 
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4. Phage display of the B. thuringiensis Cry9Ca1 
insecticidal crystal protein 
 
 
 
4.1. Introduction 
 
B. thuringiensis crystal proteins have been successfully applied in the field as sprays and more 
recently in insect resistant crops. Optimizing properties like ICP stability, expression level, activity 
and specificity may have enormous economic and agricultural advantages. Furthermore, tailoring of 
ICPs could provide an interesting alternative to the traditional screening programs of natural B. 
thuringiensis isolates. 
The potential of directed molecular evolution for the improvement of B. thuringiensis crystal 
proteins was revealed to some extent by Lassner and Bedbrook (2001). Screening of 4000 shuffled 
cry1Ca clones yielded some variants which combined increased toxicity against Spodoptera exigua 
larvae (Lepidoptera: Noctuidae) with newly acquired Helicoverpa zea (Lepidoptera: Noctuidae) 
activity. Hybrid crystal protein variants with a broadened activity spectrum have also been 
generated by homologous recombination in vivo (Bosch et al., 1994). More recently, Knight et al. 
(2004a) successfully applied DOGS shuffling with degenerate primer pools matching the conserved 
cry block sequences. However, limited screening of a small number of recombinants (600) failed to 
yields Cry1Ba variants with improved activity towards Lucilia cuprina (Diptera: Calliphoridae), 
one of the causative agents of flystrike.  
The latter example demonstrates the necessity of an efficient screening system with a sufficient 
throughput. Phage display offers the potential of going through millions of clones simultaneously. 
As a result, the possibility and chance of isolating optimized crystal protein variants with novel or 
broadened host ranges, improved binding affinities and higher activities is significantly expanded. 
Combinatorial ICP libraries could be selected against immobilized cloned receptor molecules, 
cultured midgut epithelial cells, brush border membrane vesicles, midgut sections or homogenates 
prepared from non-susceptible or resistant insect species (Killeen et al., 2003). Alternatively, 
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selection might be performed directly in vivo by feeding larvae and recovery from the epithelium 
membrane (Ghosh et al., 2001) if the peritrophic matrix barrier can be overcome. We therefore 
wanted to investigate whether a molecular evolutionary approach using phage display as an 
expression and selection system would be an efficient designer’s tool for B. thuringiensis crystal 
proteins. Because the entire process does not require detailed knowledge regarding the crystal 
protein structure-function relationship, it is relatively straightforward provided an efficient display 
in a biologically active conformation and a powerful selection system are available.  
Two groups previously reported the expression of B. thuringiensis crystal proteins on the 
filamentous phage surface via fusion to the viral minor coat protein pIII. When Marzari et al. (1997) 
attempted to display the entire Cry1Aa crystal protein using the pHEN1 phagemid, they observed 2 
x 104 fold lower viral titers compared to the negative vector control. This was probably a result of 
the severely impaired viability of the E. coli host cells, visible as extensive lysis of the bacterial 
cultures following helper phage infection. Western blotting revealed a 94 kDa Cry1Aa fusion 
protein that was much smaller than the theoretical calculated mass of 150 kDa. This observation 
suggested that the Cry1Aa fusion proteins were subjected to some proteolytic degradation leading 
to a truncated Cry1Aa N-terminus. Bacteria expressing several shorter Cry1Aa fusion constructs on 
the other hand did not show a reduced growth rate. Rescued phages had higher titers and the 
different Cry1Aa fragments were entirely displayed on the viral surface. Similar observations were 
reported by Kasman et al. (1998) with the related Cry1Ac protein. Monovalent display of this 
crystal protein resulted in a 117 kDa fusion protein that migrated lower than expected. Only 
multivalent display using the fUSE5 phage vector led to a 130 kDa fusion protein of the correct size 
besides a shorter fragment of 104 kDa, suggesting some intact Cry1Ac proteins on the viral coat. 
Again, crystal protein display appeared to have a negative effect on the bacterial cell growth. 
Finally, the Cry1Ac crystal protein has also been expressed on the surface of phage λ. In a model 
biopanning experiment, Vilchez et al. (2004) showed that Cry1Ac phages were enriched on M. 
sexta brush border membrane protein fraction (BBMP) and selection could be competed by the 
addition of GalNAc. This suggests that the displayed crystal protein is able to bind to its natural 
receptor in the insect midgut. However, doubts concerning vector integrity, intact display and the 
specific interaction of the surface displayed Cry1Ac protein molecules with their midgut receptors 
still exist (Denolf P., personal communication). In adition, only low recombinant phage titers were 
obtained after rescue limiting the size of future ICP libraries. 
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We chose to investigate the expression of the Cry9Ca1 crystal protein on the filamentous phage 
surface. This crystal protein shares less than 40% amino acid sequence identity with ICPs belonging 
to the economically important Cry1-family and has a broad spectrum against many agronomically 
important lepidopteran pests such as Ostrinia nubilalis (European corn borer) (Lepidoptera: 
Pyralidae), H. virescens (tobacco budworm) and P. xylostella (diamondback moth) (Lambert et al., 
1996). In addition, it possesses considerable activity against several species of the Noctuidae family 
including S. exigua (beet armyworm), S. littoralis (Egyptian cotton leafworm) and cutworms 
(Agrotis spp.). More importantly, the Cry9Ca1 receptor in the larval midgut differs from the widely 
studied Cry1Ab and Cry1Ac binding proteins in many insect species. This was demonstrated by 
several competition binding experiments using BBMVs from P. xylostella (Lambert et al., 1996), 
O. nubilalis (De Roeck, 1999; Hua et al., 2001), H. virescens (De Roeck, 1999), Diatraea 
grandiosella (Southwestern corn borer) (Lepidoptera: Pyralidae) (De Roeck, 1999) and other 
insects (González-Cabrera et al., 2003; Estela et al., 2004; Alcantara et al., 2004). Furthermore, 
field populations of P. xylostella that developed resistance to Cry1Ab (Lambert et al., 1996) or were 
selected against Cry1C (Zhao et al., 2001) were still susceptible to Cry9Ca1 in bioassays. Also, 
several O. nubilalis strains selected for Cry1Ab resistance in the laboratory exhibited no cross-
resistance to the Cry9Ca1 protein (Siqueira et al., 2004). These findings prove that the Cry9Ca1 
crystal protein is an invaluable tool for resistance management because of the low potential risk for 
cross-resistance when applied with other B. thuringiensis ICPs in the field.  
The Cry9Ca1 protoxin as produced by B. thuringiensis tolworthi consists of 1157 residues and has a 
molecular mass of 129.8 kDa. Digestion with trypsin releases the 68.7 kDa toxic fragment by 
removing the first 43 amino acids and the entire C-terminal part following the fifth conserved 
region. An extra trypsin site at arginine 64 is responsible for further degradation resulting in a 
stable, non toxic 55 kDa fragment. Substitution by alanine eliminated this inactivation without 
affecting toxicity (Lambert et al., 1996). We therefore used the toxic fragment of this alanine 
mutant (R164A), corresponding to residues 44-658, for the expression on the filamentous phage 
surface as a fusion with the minor coat protein pIII.  
Because phage display of Cry1Aa and Cry1Ac had demonstrated proteolytic degradation of the 
ICP-pIII fusion proteins, we focused our initial efforts on the intact and functional expression of the 
Cry9Ca1 crystal protein before advancing to the selection of ICP variants with improved properties 
from a random phage library. It was reasoned that the expression of the entire active crystal protein 
instead of separate protein domains, subdomain structures or a truncated ICP fusion protein would 
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allow assessing the entire sequence space and potential of B. thuringiensis crystal proteins. 
Moreover, Flores et al. (1997) observed that binding to the M. sexta 120 kDa aminopeptidase N 
receptor was lost when Cry1Ab domain I was removed. Furthermore, model panning experiments 
with M. sexta BBMV and purified APN midgut receptors have shown that the Cry1Ac fusion 
proteins in their truncated form were not able to bind specifically to their natural receptors. Only 
full length Cry1Ac fusion proteins were detected in the membrane of M. sexta midgut vesicles after 
Western blotting (Kasman et al., 1998). 
 
4.2. Material & methods 
 
4.2.1. E. coli strains 
 
E. coli strains JM109 (e14-(mcrA-) recA1 end A1 gyrA96 thi-1 hsdR17 (rk- mk-) supE44 relA1 ∆(lac-
proAB) [F’ traD36 proAB lacIqZ∆M15]), TG1 (supE thi-1 ∆(lac-proAB) ∆(mcrB-hsdSM)5 (rk- mk-) 
[F’ traD36 proAB lacIqZ∆M15]), WK6 (galE strA nalr ∆(lac-proAB) [F’ proAB lacIqZ∆M15]), Able 
C and Able K (E. coli C lac(LacZω-) [Kanr mcrA- mcrCB- mcrF- mrr- hsdR (rk- mk-)] [F’ proAB 
lacIqZ∆M15 Tn 10 (Tetr)]), BL21-Gold (E. coli B F- dcm+ Hte ompT hsdS (rB- mB-) gal endA Tetr), 
BL21(DE3) (E. coli B F- dcm ompT hsdS (rB- mB-) gal λ(DE3)) were obtained from Stratagene. E. 
coli ElectroMAX DH12S cells (φ80dlacZ∆M15 mcrA ∆(mrr-hsdRMS-mcrBC) araD139 ∆(ara, 
leu)7697 ∆lacX74 galU galK rpsL deoR nupG recA1 [F’ proAB+ lacIqZ∆M15]) were supplied by 
Invitrogen.   
Electrocompetent E. coli TG1, JM109, Able C and Able K cells were prepared by inoculating 400 
ml LB medium (1% bacto-trypton, 0.5% bacto yeast extract, 170 mM NaCl) with 4 ml of an 
overnight culture. The culture was incubated at 18°C till the optical density at 600 nm (OD600) 
reached 0.5 and chilled on ice for 15 to 30 minutes. Bacterial cells were harvested by centrifugation 
(8000 g – 10 minutes) and resuspended in 1 l ice-cold H2O. After a second centrifugation, cells 
were resuspended in 500 ml of ice-cold H2O and centrifuged again. The bacterial pellet was 
resuspended in 20 ml 10% glycerol, centrifuged a last time and resuspended in 2 ml 10% glycerol. 
Aliquots of 40 µl were frozen on dry ice and stored at -80°C until electroporation. 
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4.2.2. pCANTAB5E constructs  
 
All pCANTAB5E derivatives designated by pPD (Table 4.1) were created by P. Denolf 
(unpublished results) except for the pPD45 and pPD46 phagemid vectors which were made by G. 
Verhaege (2000). The construction of the different pTV constructs is explained in more detail 
below. Abbreviations used in table 4.1 and throughout the text are mentioned between brackets. 
 
4.2.2.1. pTV10 and pTV11 
 
Residues 3-256 of the minor coat protein pIII were deleted (pIII257) by overlap extension PCR (Ho 
et al., 1989) using primers G3P257-2 (5’-TGCCGCATAGGATTTTGATTATGAAAAAATG-
GCAAACGCT-3’) and G3P257-1 (5’-TTCATAATCAAAATCCTATGCGGCACGCGGTTCC-
3’) with the overlap indicated in bold. Flanking primers used in the separate and assembly reactions 
were G3P198-3 (5’-ACAGCTATGACCATGATTACGC-3’) and G3P198-8 (5’-
CAGTCACGACGTTGTAAAACGAC-3'). The PCR product was gel purified (QIAquick gel 
extraction kit) and cloned into the pPD21 vector backbone using the HindIII – EcoRI restriction 
sites. E. coli TG1 transformants were screened after electroporation with primers PCANFOR2 (5’-
CCAGGCTTTACACTTTATGC-3’) and PCAN3372REV (5’-CACCAGTAGCACCATTACCA-
3’). The resulting construct was named pTV10 and served as a template for construction of the 
pTV11 vector containing the cry9Ca1 gene. 
An NcoI – NotI fragment coding for the Cry9Ca1 protein and the N-terminal pentahistidyl tag was 
obtained from the pPD29 phagemid and cloned into the pTV10 construct, resulting in the pTV11 
vector. After electroporation, E. coli TG1 colonies were screened with primers PCANFOR2 and 
9C1603REV. 
 
4.2.2.2. pTV4 and pTV5 
 
Alanine residues were substituted for arginine residues at positions 272 (R272A) and 273 (R273A) 
in Cry9Ca1 using the mutagenic primer pairs 9CR272AFOR (5’-
GATATCATCAATTCGCTAGAGAAATGACTTTAGTGGTATTAGATGTTG-3’), 
9CR273AREV (5’-AGTCATTTCTCTAGCGAATTGATGATATCTTAACCAACTTTCAG-3’) 
and 9CR273AFOR (5’-CAATTCCGTGCAGAAATGACTTTAGTGGTATTAGATGTTGTGG-
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3’), 9CR273AREV (5’-CTAAAGTCATTTCTGCACGGAATTGATGATATCTTAACCAAC-3’) 
respectively (mutated nucleotides indicated in bold). Flanking primers used in the overlap extension 
PCR were 9C872FOR (5’-GCAGTTCAGACTGCGCTTACTGTTG-3’) and 9C2538REV (5’-
GGCGGATTGAACGGACCAGTAGTAG-3’). Both fragments were gel purified (QIAquick gel 
extraction kit), digested with MscI – BglII and cloned into the pPD29 vector. E. coli TG1 
transformants obtained after electroporation were screened with primers PCANFOR2 and 
9C1603REV (5’-TACAATCGGATCTGTATATACCTC-3’), resulting in the pTV4 
(Cry9Ca1R272A) and pTV5 (Cry9Ca1R273A) vectors respectively.  
 
4.2.2.3. pTV24 
 
The pPD41 phagemid containing the supF gene (SupF) and an amber codon inserted in the β-
lactamase gene was digested with NcoI and NotI. The NcoI – NotI cry9Ca1 fragment flanked by the 
coding sequence for the pentahistidyl epitope was derived from the pPD29 vector, gel purified 
(QIAquick gel extraction kit) and cloned into the pPD41 backbone. E. coli BL21-Gold colonies 
obtained after heat shock transformation were screened with primers PCANFOR2 and PCANREV2 
(5’-GTTTTGTCGTCTTTCCAGAC-3’), yielding the pTV24 vector construct. 
 
4.2.2.4. pTV16 
 
For the insertion of the cry9Ca1 gene into the pPD46 vector containing the sequence coding for the 
hemagglutinin epitope tag (HA), a PstI restriction site had to be introduced at the 5’ end of the 
crystal protein gene first. After a PCR with primers 9CPSTIFOR (5’-
ACTGCTGCAGGATTACTTACAAATGACAGATGAGG-3’) and PCANREV2 (PstI site 
indicated in bold), the amplified gene was gel purified (QIAquick gel extraction kit) and cloned into 
the pPD46 vector through a PstI – NotI digest. E. coli TG1 transformants were screened for the 
presence of the cry9Ca1 gene and the HA encoding sequence using primers PCANHA2384FOR 
(5’-CCATGGCCGCGTATCCGTATGA-3’), 9C1603REV, 9C2296FOR (5’-ACTCCGAAGAAC-
AACTAATG-3’) and PCAN3725REV (5’-GGATGTGCTGCAAGGCGATTAAGT-3’). The 
resulting vector was designated pTV16. 
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4.2.2.5. pTV18 and pTV19 
 
A short sequence coding for the cleavage sites of enteropeptidase, thrombin and factor Xa (Prot) 
was inserted downstream of the multicloning site of the pPD46 vector by overlap extension PCR. 
Primers containing the introduced sequence (indicated in bold) were PROTFOR (5’-
AAAGCTCTTGTCCCTCGTGGTTCTATTGAGGGTCGTGGTGGCCCTGGTGGTGCGC-
CGGTGCCGTATCC-3’) and PROTREV (5’-AACCACGAGGGACAAGAGCTTTGTCATC-
GTCATCACCGCCAGGACCTGCGGCCGCCCGTTTGATCTC-3’). Flanking primers used in 
the separate and overlap PCR were PCAN2210FOR (5’-TATCGTTCCGGCTCGTATGTTGTG-3’) 
and PCAN3846REV (5’-ACCGCACAGATGCGTAAGGAGAA-3’). The assembled fragment was 
gel purified (QIAquick gel extraction kit) and cloned into the pPD46 vector using the NotI and 
EcoRI restriction sites. Single E. coli XL1-Blue colonies obtained following electroporation were 
screened with primers PCAN2473FOR (5’-TCCTGGCGGTGATGACGATG-3’) and 
PCAN3846REV, resulting in the pTV18 construct. 
The cry9Ca1 gene from pTV16 was cloned into the pTV18 vector by a PstI – NotI digest. E. coli 
XL1-Blue transformants were screened with primers 9C817FOR (5’-
TGAGGACTACACTGATTCTT-3’) and PCAN3073REV (5’-CGCCAGCATTGACAGGAG-
GTTG-3’), resulting in the pTV19 vector. 
 
4.2.3. BL21-Gold conjugation  
 
Introduction of the F episome into E. coli BL21-Gold cells was obtained by conjugation with E. coli 
WK6. Overnight cultures of both strains in 10 ml 2xYT medium (1.7% bacto-trypton, 1% bacto 
yeast extract, 85.5 mM NaCl), supplemented with triacillin (100 µg/ml) were diluted 1/5 in 1 ml 
fresh medium and mixed. The combined culture was incubated for about 22 hours at 28°C. 
Afterwards, 200 µl of a 1/104 dilution was plated on LB medium, supplemented with tetracycline 
(25 µg/ml). Single colonies that developed after overnight incubation at 37°C were analyzed in a 
standard PCR with primers FPILA (5’-CTGAAGGCCGATAAGATGGATCTGC-3’) and FPILB 
(5’-CCGTCAGACCAGCCTCGAAGATAAT-3’), specific for the traT gene. E. coli BL21-Gold 
cells that had acquired the F episome were transformed by heat shock according to the protocol 
provided by Stratagene. 
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4.2.4. Subcellular localization of heterologous proteins after induction 
 
A 10 ml E. coli preculture was diluted 1/100 in 2xYT medium, supplemented with triacillin and 2% 
glucose, and incubated at 37°C till OD600 0.5. Before centrifugation (3000 g – 5 minutes), 1 ml of 
the culture was kept aside serving as the uninduced control. The cell pellet was resuspended in 100 
ml 2xYT medium containing triacillin and 100 µM IPTG. After overnight induction for 
approximately 18 hours at 28°C, a second 1 ml sample was collected (induced control). The 
remaining culture was divided into two parts and used either for sonication or isolation of the 
periplasmic protein fraction. 
Total cellular fractions before and after induction were obtained by centrifugation (10000 g – 10 
minutes) of the recovered 1 ml samples. Cell pellets were resuspended in 500 µl phosphate buffered 
saline (PBS) (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4) and heated for 5 
minutes at 95°C. Boiled samples were centrifuged (10000 g – 10 minutes) and supernatant was 
stored at -20°C. 
Prior to sonication, the induced cultures were centrifuged (4000 g – 10 minutes) and the bacterial 
cell pellet was resuspended in 5 ml sonication buffer (50 mM Na2HPO4 pH 7.8, 300 mM NaCl). 
Samples were frozen in liquid nitrogen and thawed in ice-cold water. After 4 sonication cycles (10 
seconds pulse followed by a 20 seconds interval), cell lysates were centrifuged (10000 g – 20 
minutes). The supernatant was recovered and stored at -20°C. The insoluble protein pellet was 
resuspended in 5 ml sonication buffer and stored at -20°C until further analysis. 
Proteins located in the bacterial periplasm were isolated by centrifugation of the induced cell 
culture (4000 g – 10 minutes) and resuspending the pellet in 10 ml 30 mM Tris-HCl pH 8 + 20% 
sucrose. After addition of 1 mM EDTA, cells were incubated for 5 minutes on a shaking platform at 
room temperature (RT). Samples were centrifuged at 4°C (8000 g – 10 minutes) and supernatants 
were discarded. The pellet fractions were resuspended in ice-cold 5 mM MgSO4 and shaken for 10 
minutes in ice-cold water. The supernatants obtained after centrifugation at 4°C (8000 g – 10 
minutes), which represent the osmotic shock fraction, were stored at -20°C.  
Total protein concentrations of the different E. coli subcellular protein fractions were determined by 
the method of Bradford (1976) using BioRad protein assay dye reagent and bovine serum albumine 
(BSA) as a standard. 
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4.2.5. Filamentous phage rescue 
 
Recombinant phage particles were purified from a bacterial overnight culture by polyethylene 
glycol (PEG) precipitation as previously described (Kay & Hoess, 1996), with some minor 
modifications. Briefly, a 10 ml overnight culture of E. coli cells containing the phagemid vector 
was diluted 1/100 in 50 ml 2xYT medium supplemented with 2% glucose and grown at 28°C. At 
OD600 0.5, cells were infected with M13K07 helper phage from Invitrogen (multiplicity of infection 
= 2), incubated for 90 minutes and centrifuged (3,000 g - 10 minutes). The bacterial cells were 
resuspended in 400 ml 2xYT containing triacillin and kanamycin (50 µg/ml) and the culture was 
incubated overnight at 28°C till the OD600 exceeded 1.5. Bacterial cells were removed by 
centrifugation (3,000 g - 20 minutes). The supernatant was mixed with 100 ml 20% PEG-8000 + 
2.5 M NaCl and chilled on ice for 1 hour. Phage particles were pelleted by centrifugation (6000 g - 
20 minutes) and resuspended in 10 ml PBS supplemented with the Complete EDTA-free protease 
inhibitor cocktail (Roche Diagnostics). The precipitation procedure was repeated and the final pellet 
was resuspended in 1 ml PBS with Complete EDTA-free protease inhibitor cocktail and 10% 
glycerol. Any residual bacterial cells were removed by filtering through a 0.45 µm filter (Millipore) 
and viral samples were stored at –20°C. The phage concentration was determined by measuring the 
absorbance at 260 nm and using the formula OD260 x 22.42 x 50 x 2 x 1010 colony forming units 
(CFU)/ml (Jespers L., personal communication). 
 
4.2.6. Insect feeding experiments  
 
Phage samples were diluted in PBS up to a final concentration of 1.2 x 1013 CFU/ml. Purified 
Cry9Ca1 protein control, produced in E. coli,  was exchanged to PBS buffer by two spins (4500g – 
50 minutes) using a Centricon centrifugal filter device (molecular weight cut-off 30 kDa) 
(Millipore) according to the manufacturer’s instructions. The final protein concentration was 
determined by the method of Bradford using BioRad protein assay dye reagent and BSA as a 
standard.  
For insect bioassays, approximately 1.5 ml of general S. littoralis food (2% agar, 11.2% cornflour, 
2.8% wheatgerm, 3% yeast, 0.48% ascorbic acid, 0.12% benzoic acid, 0.1%, nipagin, 0.006% 
aureomycin, 0.003% nystatin) was poured into individual wells of a 24 multiwell plate (Costar), 
corresponding to a feeding surface area of 2 cm² per well. Phage and control samples were diluted 
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in PBS with 0.1% BSA. Dose groups for the pPD46 and pTV16 phage samples were 3 x 1011, 1011, 
3.3 x 1011, 1.1 x 1010, 3.7 x 109 and 1.2 x 109 CFU/cm². Concentrations of the purified Cry9Ca1 
protein were 1350 ng, 450 ng, 150 ng, 50 ng, 16.7 ng and 5.6 ng/cm². Blanks consisted of PBS and 
PBS supplemented with 0.1% BSA. For each dilution, aliquots of 50 µl were applied to 12 wells 
and allowed to dry. Two O. nubilalis L1 larvae were placed in each well on the treated diet. 
Mortality was scored after incubation for 7 days at 25°C. The 50% lethal concentration (LC50) of 
the Cry9Ca1 control was calculated by probit analysis using Genstat 6.1 (VSN International, 
Oxford). 
 
4.2.7. Western blotting and immunodetection 
 
Phage and protein samples (see figure legends for amounts) were mixed with ½ volume sample 
buffer (150 mM Tris-HCl pH 6.7, 6% sodium dodecyl sulfate (SDS), 30% glycerol, 0.075% 
bromophenol blue, 3% β-mercaptoethanol), boiled for 3 minutes and recovered by a short 
centrifugation spin. If concentrations were too low, phage or protein samples were concentrated in 
advance by PEG or TCA precipitation respectively and resuspended in 20 µl PBS, supplemented 
with 0.1% SDS. Denatured samples were loaded on a 7.5% polyacrylamide gel and separated by 
electrophoresis. Subsequently, proteins were transferred to a polyvinylidene difluoride (PVDF) 
membrane (BioRad) by wet blotting for 2 hours at 100 volt in Towbin’s buffer (25 mM Tris-base, 
192 mM glycine, 20% methanol, 0.05% SDS). Membranes were rinsed with water and incubated in 
blocking buffer (100 mM maleic acid pH 7.5, 150 mM NaCl, 1% non fat dried milk) for minimal 12 
hours at 4°C on a shaking platform. Antibody dilutions (see figure legends for dilutions used) and 
membrane washing steps were performed in Tris-buffer (20 mM Tris-base pH 8.7, 150 mM NaCl), 
supplemented with 0.1% BSA and 0.1% Tween 20. After each antibody incubation step, 
membranes were rinsed with water and incubated three times in fresh Tris-buffer on a shaking 
platform during 10 minutes. Western blots were developed with Enhanced Chemiluminescence 
(ECL Plus) detection reagent (Amersham Biosciences) according to the manufacturer’s instructions. 
In order to reuse the membrane blot, bound primary and secondary antibodies were removed by 
incubation in stripping buffer (62.5 mM Tris-HCl pH 6.7, 2% SDS, 100 mM β-mercaptoethanol) 
for 50 minutes at 50°C with regular shaking. Membranes were washed for 10 minutes in PBS 
supplemented with 0.1% Tween 20 on a shaking platform and detected with ECL Plus reagent in 
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order to ensure complete removal of antibodies. After a second wash step, membranes were blocked 
and developed as described above.  
 
4.2.8. Phage ELISA 
 
A high binding 96-well polystyrene plate (Corning) was coated overnight at RT with the antibody 
diluted in PBS (see figure legends for concentrations applied). Wells were washed three times with 
300 µl PBS, blocked for 2 hours at RT with blocking buffer and washed again as described above. 
Subsequently, a dilution series of PEG-purified phage particles in 100 µl PBS was added per well. 
After two hours of incubation at RT, wells were washed three times with 300 µl PBS containing 
0.05% Tween 20 and three times with PBS alone. Next, 100 µl of the peroxidase-conjugated anti-
M13K07 antibody (Amersham Biosciences), diluted 1/5000 in PBS supplemented with 0.2% 
Tween 20, was added to the microwells. Following incubation (RT - 45 minutes), the plate was 
washed as described in the previous washing step. Finally, bound phage particles were detected 
with 100 µl 3,3´,5,5´-tetramethylbenzidine peroxidase substrate (Kirkegaard & Perry). The reaction 
was stopped after five minutes with 100µl 1 M H3P04 and the absorbance was measured at 450 nm. 
 
4.2.9. BBMV binding experiments  
 
Midguts were isolated from P. xylostella, H. zea and H. virescens final instar larvae, rinsed in ice-
cold MET buffer (17 mM Tris-HCl pH 7.5, 300 mM mannitol, 5 mM EGTA) and quickly frozen in 
liquid nitrogen. BBMVs were prepared from the midguts by the Mg2+ precipitation and differential 
centrifugation method of Wolfersberger et al. (1987) and stored at -80°C until further use. The total 
protein content of the BBMV preparation was quantified by the method of Bradford with BSA as a 
standard.  
Crystal proteins were biotinylated using the biotin-N-hydroxysuccinimide ester reagent (40 µl/mg 
ICP) (Amersham Biosciences) as described by Denolf et al. (1993) except that a NaHCO3 buffer 
(100 mM NaHCO3 pH 9, 150 mM NaCl2) was used instead of borate buffer. 
Ligand blot analysis was performed on 30 µg BBMV, separated by SDS-PolyacrylamideAGE on a 
7.5% polyacrylamide gel and transferred to a PVDF membrane by wet blotting in Towbin’s buffer 
as described earlier. The membranes were subsequently rinsed with water and incubated for 90 
minutes in blocking buffer. Purified Cry9Ca1 protein was diluted up to a final concentration of 2 
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µg/ml in Tris-buffer, supplemented with 0.1% BSA and 0.1% Tween 20. Volumes corresponding to 
5 x 1011 CFU of recombinant or M13K07 control phages were mixed with 10 ml of the same buffer. 
Membranes were incubated with the Cry9Ca1 protein, recombinant phages or the M13K07 control 
for 60 minutes under constant shaking. After washing, bound Cry9Ca1 was detected with rabbit 
anti-Cry9Ca1 (1/3000) and peroxidase labeled goat anti-rabbit (1/5000) antibodies as described 
under 4.2.7. Filamentous phage binding was visualized by using the peroxidase conjugated anti-
M13K07 antibody (1/5000).  
Competition binding assays were performed with various amounts of BBMVs (20-500 µg) in a final 
volume of 100 µl PBS, supplemented with 0.1% BSA. Binding of recombinant phages (2 x 1011 
CFU), biotinylated Cry9Ca1 or Cry1Ac (10 ng) was competed by adding an excess of unlabeled 
Cry9Ca1 or Cry1Ac protein (4 µg). Vesicles and different ligands were incubated for 60 minutes at 
RT on a shaking platform. The BBMVs were pelleted by centrifugation at 4°C (14000 g – 10 
minutes) and washed with 500 µl PBS containing 0.1% BSA. After a second centrifugation step, the 
vesicles were resuspended in 20 µl PBS and mixed with 10 µl sample buffer. Membrane proteins 
and bound ligands were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and 
blotted to a PVDF membrane as described above. Biotinylated ICPs were detected using peroxidase 
labeled avidin (1/2000) (Amersham Biosciences) whereas detection of the recombinant phages was 
exactly as for the ligand blot analysis.    
 
4.2.10. Library construction  
 
The generation of random cry9Ca1 mutants by EP-PCR and DNA shuffling is described in detail in 
chapter 3. A total of 12.2 µg shuffled DNA was cloned into 12.7 µg pTV16 vector DNA by a NcoI 
and NotI digest. Eight ligation reactions were prepared, each containing 0.6 pmol pTV16 vector 
DNA and 1.2 pmol of the shuffled cry9Ca1 insert. After isopropanol precipitation, the pellets were 
resuspended in 10 µl mQ each. Every ligation was further divided into eight 1.25 µl aliquots which 
were electroporated separately into 50 µl E. coli ElectroMAX cells (Invitrogen) using an optimized 
transformation protocol (0.1 cm cuvette, 200 Ω, 25 µF, 1.8 kV). Immediately following each 
transformation, 1 ml SOC medium (2% bacto-trypton, 0.5% bacto yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose) was added. All eight cultures were 
pooled and an additional 2 ml SOC medium was added. Each 10 ml cell culture was incubated for 1 
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hour at 37°C before plating on three 22x22 cm² screening plates (Nunc), filled with SOBAG (2% 
bacto-trypton, 0.5% bacto-yeast extract, 1 mM NaCl, 0.25 mM KCl, 1 mM MgCl2•6H2O, 1 mM 
MgSO4•7H2O, 2 mM glucose). The library size of each transformed ligation reaction was 
estimated by plating serial dilutions of the ElectroMAX cells on SOBAG growth medium. In total, 
transformation of E. coli ElectroMAX with the entire cry9Ca1 library comprised 64 
electroporations. Transformants that developed on the 24 SOBAG screening plates were collected 
in 100 ml 2xYT, supplemented with triacillin and glucose.  Based on the OD600, the total number of 
cells in the library was estimated at 9.6 x 1012. Aliquots of 1 ml were mixed with an equal volume 
of 50% glycerol and stored at -80°C until further use. 
 
4.2.11. Library selection 
 
4.2.11.1. Selection of model libraries 
 
Spiked model libraries were constituted by mixing pPD43 and pPD46 phage particles as outlined in 
table 4.5 and adding PBS up till 100 µl. Each library was prepared in duplo with 100 µl used as 
input for the first selection round and the residual 100 µl stored at -20°C for enzyme-linked 
immunosorbent assay (ELISA) afterwards. 
Microwells were coated overnight at RT with 100 µl of the anti-HA antibody (Roche Diagnostics), 
diluted in PBS (5 µg/ml). Wells were washed three times with 300 µl PBS, blocked for 4 hours with 
blocking buffer at RT and washed again as described. Subsequently, 100 µl of each library was 
applied to a single coated well and incubated for 2 hours at RT. Wells were washed three times with 
300 µl PBS containing 0.05% Tween 20 and 180 mM MgCl2 and three times with 300 µl PBS 
alone. Bound phages were eluted by adding 80 µl elution buffer (0.2 M glycine pH 2.2) to each well 
and placing the microplate on an orbital shaking platform for 10 minutes at RT. Eluted phage were 
recovered and mixed with 20 µl neutralization buffer (1 M Tris-HCl pH 8). 
A 10 ml overnight culture of E. coli TG1 cells was diluted 1/100 in 50 ml 2xYT medium and grown 
at 28°C. At OD600 0.3-0.5, cells were infected with 80 µl of the eluates and incubated for 90 
minutes at 28°C. Next, cultures were infected with M13K07 helper phage (Invitrogen) (multiplicity 
of infection = 2) and supplemented with triacillin (10 µg/ml) and glucose. After 90 minutes at 28°C, 
the bacterial cells were centrifuged (3000 g – 10 minutes) and resuspended in 80 ml 2xYT 
containing triacillin (10 µg/ml) and kanamycin. The infected cultures were incubated overnight at 
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28°C till the OD600 exceeded 1. Newly formed filamentous phages were purified from the medium 
by a double PEG precipitation, as described under 4.2.5. The final phage pellet was resuspended in 
500 µl PBS, supplemented with Complete EDTA-free protease inhibitor cocktail (Roche 
Diagnostics) and glycerol (10%). In order to minimize losses, phage samples were not filtered 
through a 0.45 µm filter. Instead, viral titers were calculated from the OD260 and volumes 
corresponding to 1011 CFU were used as input for the next panning round or ELISA.  
After each selection round, serial dilutions of the rescued input samples and output eluates were 
made in PBS. Mid-log E. coli TG1 cells (100 µl, OD600 0.3-0.5) were infected with 50 µl of each 
dilution and incubated for 20 minutes at 37°C. Input and output titers were determined by counting 
the number of colonies that developed after plating 100 µl of each TG1 culture on SOBAG. The 
enrichment of pPD46 phages during subsequent selection rounds was followed by ELISA on 5 x 
1010 CFU after overnight rescue of the phage eluates, as well as by the screening of single colonies 
in a standard PCR with primers PCANHA2384FOR and PCAN3846REV (5’-
ACCGCACAGATGCGTAAGGAGAA-3’). 
 
4.2.11.2. Selection of the cry9Ca1 library  
 
Panning of the cry9Ca1 library differed to some extent from the model selection protocol as 
outlined above. The cry9Ca1 library was rescued in 3-fold according to the standard protocol. 
Recombinant phage particles were purified by PEG precipitation according to the standard protocol. 
The phage pellets of the three libraries were resuspended in a final volume of 1 ml PBS with 
Complete EDTA-free protease inhibitor cocktail (Roche Diagnostics). Similar to the rescue of the 
spiked model libraries, purified phages were not filtered in order to minimize yield losses. The 
filamentous phage concentration was determined by measuring the OD260 and using the formula 
stated earlier.  
A microwell was coated overnight at RT with 100 µl of the anti-HA antibody or BSA, diluted in 
PBS (5 µg/ml). Washing and blocking of the coated well were performed exactly as outlined for the 
model selection experiment. Subsequently, 95 µl of the library was transferred to the coated well, 
together with 5 µl PBS containing 2% BSA and 4% Tween 20. After two hours at RT, the well was 
washed three times with 300 µl PBS, supplemented with 0.05% Tween 20 and 180 mM MgCl2, and 
three times with PBS. Bound phages were eluted as described earlier and incubated for 10 minutes 
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at 65°C in order to eliminate any remaining bacterial cells that might have been copurified and 
selected.  
The eluted phage particles were added to a 50 ml 2xYT culture of mid-log E. coli XL1-Blue cells 
(OD600 0.3-0.5) since this bacterial strain was used for the optimization of the selection conditions. 
Glucose was added up to a final concentration of 2% and the bacterial cells were incubated for 90 
minutes at 28°C. Next, the culture was infected with M13K07 helper phage (Invitrogen) 
(multiplicity of infection = 2) and supplemented with triacillin (50 µg/ml). After 90 minutes at 
28°C, the cells were pelleted (3000 g – 10 minutes) and resuspended in 400 ml 2xYT containing 
triacillin (100 µg/ml) and kanamycin. When the OD600 of the rescue culture exceeded 1.5, phage 
particles were purified as described above.  
Subsequent panning rounds involved reduced selection times in combination with a preceding 
counterselection step in a blocked but uncoated microwell, as summarized in table 4.6. 
Furthermore, the 1 ml rescued library was divided into 95 µl aliquots, which were selected in 
parallel in separate coated microwells. Afterwards, the eluates were pooled and used to infect a 50 
ml E. coli XL1-Blue culture for overnight rescue as described earlier. Eluates after the fourth round 
of selection were pooled and added to a 10 ml E. coli XL1-Blue (OD600 0.3) culture. Cells were 
incubated for 20 minutes at 37°C and plated on a 22x22 cm² SOBAG screening plate for subsequent 
PCR analysis of single colonies.  
The number of filamentous bacteriophages in input and output fractions during each panning round 
was determined by infecting E. coli XL1-Blue cells with serials dilutions in PBS, as described 
under 4.2.11.1. Single colonies were screened in a standard PCR for the presence of the cry9Ca1 
gene and the HA encoding sequence using the primer couple PCANHA2384FOR and 
PCAN3073REV. 
 
4.3. Results 
 
4.3.1. Phagemid constructs  
 
Compared to the monovalent display format, multivalent expression using a phage vector or pIII 
deletion helper phage often yields protein variants with lower affinities after selection. In order to 
select clones based on their true binding affinities, we therefore opted for a monovalent expression 
system using the pCANTAB5E phagemid vector (Recombinant Phage Antibody System, 
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Amersham Biosciences). Heterologous proteins are hereby expressed on the filamentous phage 
surface through a fusion with the minor coat protein pIII (Fig. 4.1A). In addition, we introduced 
several modifications in order to improve the display of B. thuringiensis crystal proteins (Fig. 
4.1B). These changes are described in more detail below and a summary of the different 
pCANTAB5E constructs used for the display of the B. thuringiensis Cry9Ca1 crystal protein can be 
found in table 4.1. 
 
 
 
Fig 4.1 pCANTAB5E phagemid (A). The heterologous gene is inserted upstream of the viral pIII gene under the control 
of a lac-promotor resulting in fusion proteins that can be assembled into the filamentous phage coat. (B) Modifications 
to the original vector include a transcription termination signal (tHP), His tags, HA epitope, elimination of the amber 
stopcodon upstream of the pIII sequence and truncation of the pIII minor protein (pIII198 and pIII257).  
 
In the pCANTAB5E phagemid, the expression of the pIII fusion proteins is controlled by a lac-
promotor. Due to its leaky nature, adding glucose in combination with the overexpression of the 
B 
A 
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LacI repressor in E. coli strains with the lac Iq genotype is not sufficient for complete blocking of 
transcription. However, tight regulation of fusion protein expression during rescue of recombinant 
phage particles often is very important because the pIII coat protein disrupts the bacterial outer 
membrane (Boeke et al., 1982; Rampf et al., 1991) and therefore affects bacterial growth 
(Beekwilder et al., 1999). In addition, pIII is known to inhibit any superinfection by filamentous 
bacteriophages (Deng et al., 1999; Karlsson et al., 2003). Moreover, both Cry1Aa and Cry1Ac 
display resulted in lysis or reduced development of the E. coli host cells, accompanied by lower 
phage titers compared to the negative vector controls (Marzari et al., 1997; Kasman et al., 1998). 
Similarly, when the active Cry1Ca fragment was expressed in the bacterial cytoplasm, poor 
expression levels (Strizhov et al., 1996) and a reduced cell growth were observed (Kouskoura et al., 
2001). The negative influence of B. thuringiensis ICP expression in E. coli could be explained by 
the absence of the N-terminal propeptide that normally caps the active toxic fragment. Exposing the 
N-terminus of the activated ICP could result in interactions and insertion within the E. coli 
membrane, as hypothesized by Marzari et al. (1997) and Kouskoura et al. (2001). Because such 
negative effects could reduce vector stability and compromise the integrity of future phage libraries, 
an upstream termination signal (tHP) was inserted in the pCANTAB5E vector between the lacI gene 
and the CAP binding site. Based on the findings of Krebber et al. (1996), it was hoped that this 
sequence would result in premature termination of transcription starting from cryptic upstream 
promoter sequences, thereby reducing a possible source of background fusion protein expression.  
A second strategy aimed to reduce the negative effects of pIII expression consisted of the fusion 
with two truncated forms of the pIII coat protein. Elimination of the first 197 residues in pIII 
resulted in the pIII198 protein (residues 198-406) lacking domain I and the majority of the second 
domain but retaining the second glycine rich stretch. The absence of the pIII domain I should 
prevent resistance to helper phage infection upon fusion protein expression (Barbas et al., 1991) and 
reduce toxic effects on bacterial cell viability (Szardenings et al., 1997). In addition, fusion to the 
truncated pIII198 coat protein has been reported to improve accessibility of the displayed proteins 
(Lowman et al., 1991). Furthermore, the smaller fusion protein size could lead to facilitated 
assemblage and passage through the viral export complex resulting in higher display levels. The 
pIII257 construct (residues 257-406), missing both domains I and II, was also evaluated since 
negative effects have still been reported for pIII198 display of the immunoglobulin antigen binding 
fragment (Fab) (Orum et al., 1993). In this case, the Cry9Ca1 crystal protein is directly fused to the 
C-terminal domain which is necessary for encapsulation into the phage particle. Elimination of both 
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glycine stretches in the pIII257 construct possibly results in the normal electrophoretic migration of 
the Cry9Ca1 fusion proteins according to their calculated molecular mass (see 4.3.2.).   
 
Table 4.1 Overview of the different pCANTAB5E constructs 
 
Vector name Composition * 
pPD21 
pPD22 
pCANTAB5E-tHP 
pCANTAB5E-tHP-Cry9Ca1 
pPD23 
pPD34 
pPD25 
pPD27 
pPD26 
pPD28 
pPD43 
pCANTAB5E-pIII198 
pCANTAB5E-Cry9Ca1-pIII198 
pCANTAB5E-Amber-pIII198 
pCANTAB5E-Cry9Ca1-Amber-pIII198 
pCANTAB5E-tHP-pIII198 
pCANTAB5E-tHP-Cry9Ca1-pIII198 
pCANTAB5E-tHP-Amber-pIII198 
pPD29 
pTV4 
pTV5 
pPD45 
pPD46 
pTV16 
pTV18 
pTV19 
pCANTAB5E-tHP-5His-Cry9Ca1  
pCANTAB5E-tHP-5His-Cry9Ca1(R272A) 
pCANTAB5E-tHP-5His-Cry9Ca1(R273A) 
pCANTAB5E-tHP-6His-Amber-pIII198 
pCANTAB5E-tHP-HA-Amber-pIII198  
pCANTAB5E-tHP-HA-Cry9Ca1-Amber-pIII198 
pCANTAB5E-tHP-HA-Prot-Amber-pIII198                               
pCANTAB5E-tHP-HA-Cry9Ca1-Prot-Amber-pIII198 
pTV10 
pTV11 
pCANTAB5E-tHP-pIII257 
pCANTAB5E-tHP-Cry9Ca1-pIII257 
pPD41 
pTV24 
pCANTAB5E-tHP-SupF 
pCANTAB5E-tHP-SupF-Cry9Ca1 
*: tHP: transcription termination signal, 5HIS: pentahistidyl tag, 6HIS: hexahistidyl tag, HA: hemagglutinin epitope, 
Prot: multiple protease site, Amber: eliminated amber stopcodon, pIII198 and pIII257: truncated pIII protein constructs, 
SupF: cloned supF gene, Cry9Ca1(R272A) and Cry9Ca1(R273A): alanine mutants. 
 
4.3.2. Monovalent display of the Cry9Ca1 crystal protein 
 
The minor coat protein pIII has a calculated molecular mass of approximately 42 kDa. However, a 
62 kDa protein is detected in Western blots using anti-pIII specific antibodies (Vanhercke, 1999; 
Verhaert et al., 1999; Tesar et al., 1995; Wind et al., 1999). The difference in size could be caused 
by two clusters consisting of glycine and serine residues at positions 68-85 and 217-255 
respectively (Rasched & Oberer, 1986). Based on this unusual mobility, we estimated the molecular 
mass of Cry9Ca1-pIII fusion proteins around 134 kDa (Table 4.2). Our assumption was 
strengthened by the monovalent display of the 63 kDa penicillin G acylase resulting in fusion 
proteins of > 113 kDa (Verhaert et al., 1999).  Moreover, the size of a typical ScFv-pIII fusion is 
around 100 kDa which confirms the higher apparent mass of the pIII protein in Western blots 
(Tesar et al., 1995).  
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Table 4.2 Calculated, expected and observed molecular masses (kDa) of the different Cry9Ca1 fusion protein constructs 
 
 Control  without Cry9Ca1 Cry9Ca1 fusion protein 
 Calculated a Observed Calculated a Expected b  Observed  
pIII 42.4 60-65 110.9 128.7-133.7 90-100 
pIII198 21.2 40-45 89.9 108.7-112.7 55-60  
pIII257 16.2  84.9  45-50 
a: molecular mass based on protein sequence. 
b: approximate expected molecular mass of the Cry9Ca1 fusion protein, based on the observed mass of the 
corresponding pIII control without Cry9Ca1. 
 
Immunodetection with a polyclonal rabbit anti-Cry9Ca1 antibody revealed a Cry9Ca1 fusion 
protein with an apparent molecular mass between 90 and 100 kDa (Fig. 4.2 lanes 2 and 3). This 
suggests a degradation of the Cry9Ca1-pIII fusion proteins when expressed on the filamentous 
phage surface. Coupling of the Cry9Ca1 protein to the shorter pIII198 and pIII257 variants resulted 
in analogous truncated fusion proteins on the viral coat (Fig. 4.2 lanes 9 and 11). Based on the 
observed mass of the pIII198 truncation (45 kDa) (Fig. 4.3 lane 2), the Cry9Ca1-pIII198 fusion 
protein was expected to migrate as a 113 kDa protein (Table 4.2). Instead, only a fragment around 
55-60 kDa was detected. Calculations for the pIII257 construct are more difficult since the apparent 
molecular mass of the pIII257 protein is not exactly known. Nevertheless, the 45-50 kDa fusion 
protein that was observed in this case also demonstrates proteolytic degradation since even the 
calculated theoretical mass of a full length Cry9Ca1-pIII257 protein is still 84.9 kDa (Table 4.2). 
 
 
 
Fig. 4.2 Immunodetection of control and Cry9Ca displaying phages (5 x 1011 CFU) with rabbit anti-Cry9Ca1 (1/1727) 
and goat anti-rabbit peroxidase conjugated antibody (1/30000). 1: pPD21 phages, 2: pPD22 phages, 3: pPD29 phages, 
4-7: Cry9Ca1 crystal protein (200, 100, 50 and 25 ng), 8: pTV10 phages, 9: pTV11 phages, 10: pPD43 phages, 11: 
pPD27 phages, 12: pPD27 phages (0.5 mM ZnCl2), 13: Cry9Ca1 crystal protein (100 ng). 
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In an attempt to quantify the amount of fusion protein expressed on the viral coat, we compared the 
signals of the fusion proteins with a purified Cry9Ca1 standard (55 kDa fragment) in a Western 
blot. Several independent estimations yielded display levels between 0.66 and 2.8 fusion proteins 
per phage particle (Fig. 4.2 lanes 10 and 12) (Vanhercke, 1999).  
In order to determine whether the Cry9Ca1 crystal protein is entirely displayed on the filamentous 
bacteriophage surface, histidyl peptides and a HA epitope derived from the human influenza 
hemagglutinin protein were separately attached to the N-terminus of the Cry9Ca1 fusion protein. As 
could be expected, tagged Cry9Ca1 fusion proteins could not be detected in a Western blot with 
anti-His (results not shown) and anti-HA antibodies (Fig. 4.3 lane 3) as a result of the proteolytic 
cleavage inside the crystal protein part upon display. Incubation with anti-His resulted in a non 
specific interaction with a 70 kDa protein that was also recognized in the pPD22 negative control, 
making the histidyl peptides less interesting for the visualization of displayed B. thuringiensis 
crystal proteins (results not shown). On the other hand, anti-HA immunodetection of pPD46 phages 
displaying the HA epitope without the Cry9Ca1 protein resulted in a fragment of 45 kDa (Fig. 4.3 
lane 2), which confirms earlier findings of Marzari et al. (1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the detection of the fusion proteins in a sandwich ELISA, PEG purified phage particles were 
applied to coated microwells and detected with a peroxidase labeled antibody against the major coat 
protein pVIII. Coating with the polyclonal anti-Cry9Ca1 antibody resulted in the specific detection 
of Cry9Ca1 expressing phages at concentrations that were 100 fold lower compared to standard 
Western blot analysis (Fig. 4.4). Whereas pPD45 phages were negative in an anti-His ELISA 
(results not shown), coating with anti-HA did result in the specific detection of HA displaying 
pPD46 phages when compared to two negative controls (Fig. 4.5). Similar to the Western blot 
Fig. 4.3 Immunodetection of HA displaying 
phages (5 x 1011 CFU) with anti-HA 
peroxidase conjugated antibody (1/1000). 1: 
pPD43 phages, 2: pPD46 phages, 3: pTV16 
phages. 
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results, pTV16 phages displaying the HA-Cry9Ca1 fusion protein were not detected, indicative of 
proteolytic truncation and hence loss of the N-terminal HA epitope.  
 
 
 
Fig. 4.4 ELISA detection of Cry9Ca1 displaying phage particles with rabbit anti-Cry9C as the coating antibody (5 
µg/ml). Values are the result of a duplo experiment and corrected for non specific background in uncoated 
microwells. : pPD46 phages, : pPD21 phages, : pTV16 phages, : pPD28 phages. 
 
 
 
Fig. 4.5 ELISA detection of phage particles displaying the HA peptide with anti-HA as the coating antibody (5 µg/ml). 
Values are the result of a duplo experiment and corrected for non specific background in uncoated microwells : 
pPD46, : pPD21 phages, : pTV16 phages, : pPD28 phages. 
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4.3.3. Functionality of the Cry9Ca1 fusion protein 
 
Biological activity of the displayed Cry9Ca1 crystal protein was investigated in a bioassay with 
larvae of O. nubilalis (Table 4.3). The highest concentration of pTV16 phages tested (3 x 1011 
CFU/cm²) resulted in a low mortality of 17% whereas around 50% was expected, based on the 
quantified fusion protein levels. In fact, the absence of growth inhibition normally observed among 
surviving larvae at low Cry9Ca1 doses and the background mortality observed in some dilutions of 
pTV16 and the pPD46 negative control suggested that the actual mortality was lower than 17%. 
Because a significant part of the Cry9Ca1 crystal protein is lost when displayed on the phage 
surface, it is unlikely that the truncated fusion proteins are responsible for this low toxicity. A small 
amount (< 5 ng) of free Cry9Ca1 and/or intact fusion proteins being too low to be detected in an 
anti-Cry9Ca1 Western blot could also explain the observed mortality.  
Despite the extensive truncation of the Cry9Ca1 fusion proteins resulting in the loss of the pore 
forming domain I, receptor binding of the displayed crystal protein could still be unaffected. 
Therefore, ligand blot (toxin overlay assay) and competition binding assays were performed with 
BBMVs prepared from P. xylostella, H. virescens and H. zea isolated midguts. When compared to a 
M13K07 negative control, no specific binding of Cry9Ca1 displaying pPD22 phages could be 
demonstrated in a ligand blot (results not shown). Furthermore, pPD22 phages and purified 
Cry9Ca1 control protein recognized a 116 kDa protein present in the H. zea vesicles. This protein is 
not a functional receptor since this insect is unsusceptible to the B. thuringiensis Cry9Ca1 crystal 
protein.  
 
Table 4.3 Bioassay results of Cry9Ca1 displaying phages on O. nubilalis larvae 
 
 Mortality (%) of highest dose LC50 (ng/cm²)* 
pPD46 phages 0 / 
pTV16 phages 17 / 
PBS control 6  
PBS-BSA control 0  
Cry9Ca1 crystal protein 100 48.2 (26.1 – 88.9) 
*: 90% confidence interval between brackets 
 
Competition binding experiments with 1011 CFU Cry9Ca1 expressing pPD22 phages and an excess 
of purified Cry9Ca1 protein did not result in specific binding or detectable displacement of the 
phages to H. virescens BBMVs (results not shown). In a similar assay, minor displacement of 
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biotinylated Cry9Ca1 by the same unlabeled competitor excess was observed, whereas Cry1Ac 
competition was as expected. Surprisingly, midgut vesicles of unsusceptible H. zea larvae exhibited 
high levels of non specific Cry9Ca1 binding compared to H. virescens BBMV, confirming the 
earlier H. zea ligand blot data.  
 
4.3.4. Characterization of fusion protein degradation 
 
4.3.4.1. N-terminal sequence determination  
 
In order to gain insight into the proteolytic processing of the Cry9Ca1-pIII fusion proteins during 
filamentous phage rescue, 5 x 1012 pPD22 phage particles corresponding to approximately 5.4 pmol 
fusion proteins were separated by SDS-PAGE and transferred to a PVDF membrane. A small band 
corresponding to the Cry9Ca1-pIII fusion protein was excised and used for N-terminal sequencing 
by Edman degradation. Surprisingly, no Cry9Ca1 sequence could be identified and only an 
AEGDDP predominant sequence was obtained that represented the N-terminus of the major coat 
protein pVIII. Comigration of the pVIII protein was also observed during attempts to sequence a 
similar truncated Cry1Ab-pIII fusion protein (Denolf P., personal communication). Apparently, the 
major capsid protein migrates as a 90-100 kDa complex despite its low monomer mass of 5 kDa. 
Strong interactions between filamentous phage proteins that can resist denaturation have also been 
described for the pIV protein that was still largely present as a multimers after incubation at 100°C 
in the presence of 4% SDS (Russel et al., 1997).   
In an effort to eliminate the pVIII background based on the different isolectric point value, 7.7 x 
1012 CFU of a concentrated pPD29 sample containing approximately 225 pmol Cry9Ca1 fusion 
proteins were separated by 2D electrophoresis. However, no fusion proteins could be detected after 
blotting and incubation with the anti-Cry9Ca1 or anti-pIII antibody. 
 
4.3.4.2. Introduction of protease cleavage sites 
 
Separation of the truncated Cry9Ca1 fusion proteins from the phage surface prior to N-terminal 
sequencing was evaluated as an alternative strategy for the elimination of the pVIII protein 
background. The proteases enteropeptidase, thrombin and factor Xa specifically recognize unique 
amino acid sequences. Therefore, a short sequence coding for their cleavage sites was inserted 
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between the cry9Ca1 and pIII198 genes in pTV16 (Fig. 4.7). This should allow for a specific 
cleavage of the Cry9Ca1 fusion proteins, thereby releasing the truncated crystal protein part from 
the phage particle. Furthermore, the peptide was flanked by a glycine rich stretch in order to 
minimize possible sterical constraints, increase structural flexibility and improve protease 
accessibility (Matthews & Wells, 1993). Finally, an extra alanine residue was incorporated directly 
after the enteropeptidase cleavage site since this residue has been shown to enhance cleavage 
efficiency of the enzyme (Hosfield et al., 1999).  
Preliminary protease experiments using varying incubation times and temperatures showed that the 
purified Cry9Ca1 protein is unaffected by factor Xa or thrombin (results not shown). No 
conclusions could be made with enteropeptidase due to buffer problems when samples were 
denatured before SDS-PAGE.  
 
 
Fig. 4.7 Schematic representation of the pTV18 construct containing the cleavage sites of enteropeptidase, thrombin and 
factor Xa. 
 
Rescue of pTV18 and pTV19 phages containing the protease cleavage sites was hampered by 
severe growth reduction of the E. coli TG1 host cells. As expected, Western blotting and ELISA 
with the anti-HA antibody only resulted in the detection of the HA epitope in the pTV18 control 
phages lacking the cry9Ca1 gene. Surprisingly, pTV19 phages were negative in an anti-Cry9Ca1 
ELISA. Moreover, very few Cry9Ca1 fusion proteins were found in the bacterial cytosol after IPTG 
induction in the absence of helper phage. On the other hand, a strong 70 kDa fragment was 
observed in cytoplasmic and total cellular protein fractions of E. coli pTV16 control cells under 
similar conditions (Fig. 4.8 lanes 8, 12 and 16). These results suggest that the introduced protease 
cleavage sites exerted a negative influence on the expression or stability of the Cry9Ca1 fusion 
proteins. 
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Fig. 4.8 Imunodetection of Cry9Ca1 fusion proteins in E. coli periplasm and cell lysates. Unless otherwise stated, 40 µg 
total protein was separated by SDS-PAGE and detected with rabbit anti-Cry9Ca1 (1/1727) and goat anti-rabbit 
peroxidase conjugated antibody (1/30000). 1-4: E. coli total cellular fractions before induction (7.2 µg pTV18, 13.8 µg 
pTV19, pPD46, pTV16), 5-8: E. coli cellular fractions following induction (11.6 µg pTV18, 30.5 µg pTV19, 30 µg 
pPD46, 24.9 µg pTV16), 9-12: E. coli periplasmatic fractions (pTV18, pTV19, pPD46, pTV16), 13-16: E. coli soluble 
protein fraction following sonication (pTV18, pTV19, pPD46, pTV16), 17-20: E. coli insoluble protein fraction 
following sonication (pTV18, pTV19, pPD46, pTV16). 
 
4.3.5. Strategies for improved Cry9Ca1 display  
 
4.3.5.1. Multivalent display  
 
Because the M13K07 helper phage genome contains the pIII gene, newly assembled phage particles 
contain a mixture of wild type pIII coat proteins and pIII fusion proteins encoded by the phagemid 
vector. Phage display of the B. thuringiensis Cry9Ca1 crystal protein using the pCANTAB5E 
vector thus results in monovalent expression of the ICP on the viral surface.  
Based on the findings of Kasman et al. (1998), we hypothesized that multiple Cry9Ca1 copies 
present on each phage particle should significantly improve fusion protein expression levels and 
possibly lead to some intact Cry9Ca1 on the filamentous bacteriophage surface that can be detected 
in a Western blot. Such multivalent Cry9Ca1 display was achieved by infecting the bacterial host 
cells with the M13K07∆p3 ‘hyperphage’ developed by Rondot et al. (2001).  By eliminating the 
wild type pIII gene in the helper phage genome, only pIII fusion proteins are produced and 
incorporated during phage assembly. Moreover, this helper phage is compatible with phagemid 
vectors like pCANTAB5E, eliminating laborious recloning strategies into phage vectors. 
Unlike the results in the original paper of Rondot et al., infection of E. coli TG1 cells bearing 
pPD46 and pTV16 phagemid vectors with the M13K07∆p3 hyperphage resulted in 6-10 fold lower 
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viral titers. Despite increased display levels, the size of the Cry9Ca1-pIII198 fusion proteins proved 
to be 60 kDa which is identical to earlier monovalent display results (Fig. 4.6 lane 4). 
 
 
 
 
4.3.5.2. E. coli host strain 
 
In the experiments described above, recombinant phage particles were rescued from E. coli TG1 
cell cultures. Electrocompetent cells from this strain have transformation efficiencies which is 
important to ensure maximal diversity of large phage libraries. Since Cry9Ca1 fusion proteins were 
subjected to proteolysis and exerted negative effects on cell viability, however, we examined the 
possibility of using alternative E. coli host strains for filamentous phage rescue.  
Despite their altered cell wall where filamentous phage assembly and extrusion take place, E. coli 
JM109 cells did not yield full length Cry1Ac or Cry9Ca1 fusion proteins (Kasman et al., 1998, 
Vanhercke, 1999). Secondly, Stratagene’s E. coli ABLE C and ABLE K cells were evaluated. Both 
strains are engineered for the expression of toxic proteins by reducing the copy number of ColE1 
derived plasmids 4 and 10 fold respectively. Because pCANTAB5E contains this origin of 
replication, a reduced copy number could result in reduced background expression and increased 
cell viability during incubation and phage rescue (Beekwilder et al., 1999). As expected, E. coli 
ABLE cells transformed with plasmids pPD21 and pPD29 displayed an increased growth. 
However, phage titers were three orders of magnitude less compared to the standard E. coli TG1 
rescue results. As a consequence, no fusion proteins could be detected in a Western blot (results not 
Fig. 4.6 Western blot of phage particles (5 x 1011 CFU), 
rescued with M13K07 helper phage or hyperphage. 
Immunodetection was performed with rabbit anti-Cry9Ca1 
(1/1727) and goat anti-rabbit peroxidase conjugated antibody 
(1/30000). 1: pPD46 phages (M13K07), 2: pPD46 phages 
(Hyperphage), 3: pTV16 phages (M13K07), 4: pTV16 
phages (Hyperphage), 5: Cry9Ca1 crystal protein (200 ng).  
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shown). Finally, E. coli BL21-Gold and BL21(DE3) cells were used as alternative hosts in an 
attempt to reduce the degradation of the Cry9Ca1 fusion proteins as discussed below. 
 
4.3.5.3. A role of OmpT in Cry9Ca1 proteolysis? 
 
Expression of the Cry1Ab crystal protein on the filamentous phage surface resulted in a truncated 
fusion protein with a size comparable to that of the displayed Cry9Ca1-pIII fusion protein (Denolf 
P., unpublished results). Sequence determination of the N-terminus identified a proteolytic site 
between two consecutive arginine residues, located in the last helix α7 of the Cry1Ab domain I and 
at the interface with the second ICP domain. This arginine couple is conserved in the Cry1A and 
Cry9Ca1 crystal proteins which could be an explanation for their similar fusion protein sizes.  
The E. coli outer membrane protease OmpT (protease VII or A) resides in the bacterial outer 
membrane and typically cleaves between couples of the basic amino acids arginine or lysine 
(Sugimura & Higashi, 1988; Sugimura & Nishihara, 1988; McCarter et al., 2004). Transcription of 
its gene has been shown to be induced by stress factors like heat shock and overexpression of 
recombinant proteins in E. coli (Gill et al., 2000). Phage rescue in the presence of the OmpT 
protease inhibitor ZnCl2 or using the OmpT deficient E. coli strain BL21(DE3)F as the bacterial 
host resulted in intact Cry1Ab fusion proteins on the phage surface. Another indication for OmpT 
involvement is the higher molecular mass of Cry9Ca1 fusion proteins in the bacterial cytoplasm and 
periplasm after IPTG induction (see chapter 5). Because fusion proteins are incorporated into the 
coat of extruding phages during the membrane associated assembly process, they may come into 
close contact with outer membrane proteases like OmpT. This could explain the intact and 
functional expression, claimed for the B. thuringiensis Cry1Ac1 crystal protein on the surface of 
phage λ (Vilchez S., 2004). In contrast to filamentous bacteriophages, assembly of this lytic phage 
takes place in the E. coli cytoplasm where fusion proteins are probably more protected from 
membrane associated proteases.  
Combining our findings with those from other groups suggests that OmpT might be the common 
protease responsible for the degradation of B. thuringiensis ICP fusion proteins on the filamentous 
phage coat. Therefore, we explored several strategies in order to try to eliminate OmpT mediated 
proteolysis of the Cry9Ca1 crystal protein. 
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4.3.5.4. OmpT protease inhibitors 
 
The enzymatic activity of the OmpT outer membrane protease is inhibited by divalent cations (0.5 
mM) like CuCl2 (85% inhibition) and ZnCl2 (100% inhibition). Benzamidin (5 mM), an inhibitor of 
trypsin-like proteases, reduces OmpT proteolysis by 68% whereas the effect of the serine protease 
inhibitors diisopropylfluorophosphate and phenyl methyl sulfonyl fluoride is more dependent on the 
nature of the substrate (Sugimura & Nishihara, 1988).   
In a first experiment, we added various concentrations of ZnCl2 to the medium during filamentous 
phage rescue. Incubation in the presence of ZnCl2 had a negative effect on the phage yield, 
compared to a standard rescue without the inhibitor. Immunodetection with the anti-Cry9Ca1 
antibody only revealed the truncated Cry9Ca1 fusion proteins between 90 and 100 kDa which were 
absent at the highest ZnCl2 concentration tested (Fig. 4.9 lanes 2-5). 
Other protease inhibitors that were evaluated include a combination of benzamidin (5 mM) and 
ZnCl2 (0.5 mM), the broad spectrum ‘Complete protease inhibitor set’ (Roche Diagnostics) and 
ectoin (MBI Fermentas) which stabilizes and protects macromolecules against proteolysis. 
Nevertheless, none of the inhibitors could reduce the degradation as only truncated Cry9Ca1 fusion 
proteins between 90-100 kDa were detected in a Western blot (results not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.9 Effect of ZnCl2 addition during filamentous phage 
rescue on the display of the Cry9Ca1 crystal protein. 
Immunodetection of 5 x 1011 CFU was performed with 
rabbit anti-Cry9Ca1 (1/1727) and goat anti-rabbit 
peroxidase conjugated antibody. 1: pPD21 phages, 2: 
pPD29 phages (no ZnCl2), 3: pPD29 phages (0.5 mM 
ZnCl2), 4: pPD29 phages (1 mM ZnCl2), 5: pPD29 phages 
(5 mM ZnCl2), 6: Cry9Ca1 crystal protein (100 ng).  
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4.3.5.5. Mutation of possible OmpT cleavage sites  
 
The arginine couple identified in the Cry1Ab fusion protein as the site where truncation occurs is 
conserved in the Cry9Ca1 crystal protein (residues 272-273). This potential cleavage site was 
eliminated by overlap extension PCR resulting in two Cry9Ca1 mutants, each with one arginine 
replaced by an alanine residue. Rescue of pTV4 and pTV5 phages containing the R272A and 
R273A mutations respectively, did not result in intact Cry9Ca1 display upon phage rescue. Instead, 
the same extent of fusion protein degradation was observed leading to the 90-100 kDa protease 
stable core fragment observed earlier (Fig. 4.10 lanes 1-3). 
 
          
 
The negative results obtained with both Cry9Ca1 alanine mutants could be attributed to two 
additional neighboring arginine couples in domain II helix α8 (residues 323-324) and sheet β3 
(residues 376-377), which are absent in the Cry1 ICP family. Both pairs form potential sites of 
OmpT proteolysis and are absent in the B. thuringiensis Cry1A crystal proteins.  
 
4.3.5.6. Medium pH during phage rescue 
 
The OmpT protease has a pH optimum of 6 - 7 whereas 80% of its activity is lost at pH <5 or >8 
(Sugimura & Nishihara, 1988). The 2xYT culture medium, used for the rescue of filamentous 
phages, has a pH of 6.8 which is within the optimal range for OmpT activity. Therefore, we 
attempted to evaluate the effect of a pH change on the expression of the Cry9Ca1 fusion proteins.  
After infection with M13K07 helper phage, bacterial cells were pelleted and resuspended in 2xYT 
medium with varying pH values (pH 5, pH 8, pH 9). In order to compensate for a large pH change 
during incubation, bacterial cultures were centrifuged after overnight growth (19 hours incubation) 
Fig. 4.10 Immunodetection of Cry9Ca1 R272A and 
R273A alanine mutants. Fusion protein (5 x 1011 CFU) 
were detected with rabbit anti-Cry9Ca1 (1/1727) and 
goat anti-rabbit peroxidase conjugated antibody 
(1/30000). 1: pTV4 phages, 2: pTV4 phages (0.5 mM 
ZnCl2), 3: pTV5 phages (0.5 mM ZnCl2), 4: pPD29 
phages (0.5 mM ZnCl2).  
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and resuspended in fresh medium. After a second overnight growth (additional 20 hours 
incubation), recombinant phages were purified by PEG precipitation.  
When the medium pH was raised to 9, cell growth was completely inhibited. Rescue in 2xYT 
medium with pH 5 resulted in 10 fold lower phage titers, compared to rescue in medium with pH 8 
(1.4 x 1013 CFU/ml). Only in the latter case, Cry9Ca1 fusion proteins were detected between 90 and 
100 kDa in a Western blot (Fig. 4.11 lane 4). Their size corresponded to earlier observations and 
showed that there was no effect on the proteolysis of the displayed Cry9Ca1 crystal protein. 
 
                
 
4.3.5.7. OmpT deficient E. coli host strains 
 
E. coli BL21-Gold cells (Stratagene) lack the gene coding for the outer membrane protease OmpT 
and are deficient for the cytoplasmatic Lon (La) protease (Gill et al., 2000). However, the F 
conjugative plasmid which is required for infection by filamentous bacteriophages is not present in 
this strain. Therefore, we first introduced this plasmid by conjugation with E. coli WK6 cells. 
Because the BL21-Gold genome does not possesses supE or supF genes coding for amber 
suppressor tRNAs, cells were transformed with the pPD25 and pPD27 phagemid vectors. Both 
constructs lack the amber codon that is present between the multicloning site and the pIII gene of 
the original pCANTAB5E vector. This modification allows for the expression of Cry9Ca1 fusion 
proteins in E. coli non suppressor strains like BL21-Gold instead of the accumulation of free 
Cry9Ca1 in the bacterial cytosol and periplasm. On the other hand, the supF gene was cloned into 
the pPD21 and pPD22 phagemid vectors resulting in the pPD41 and pTV24 (SupF) constructs. By 
simultaneous incorporation of an amber codon inside the β-lactamase gene of both vectors, E. coli 
Fig. 4.11 Influence of the medium pH during 
filamentous phage rescue. Fusion proteins (5 x 1011 
CFU) were detected with rabbit anti-Cry9Ca1 
(1/1727) and goat anti-rabbit peroxidase conjugated 
antibody (1/30000). 1: pPD21 phages, 2: pPD22 
phages, 3: pPD22 phages (pH 5), 4: pPD22 phages 
(pH 8), 5: Cry9Ca1 crystal protein (100 ng).  
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BL21-Gold cells with functional suppressor tRNAs can easily be selected by growth in medium 
supplemented with triacillin.  
E. coli BL21-Gold cells appeared to be unsuited for filamentous phage rescue due to their slow 
growth rate and very low phage yields. Compared to the standard E. coli TG1 strain, viral titers 
were between 10 and 1000 fold lower, making immunodetection rather impractical and difficult to 
reproduce. In most cases, a 60 kDa Cry9Ca1 fusion protein was detected in pPD27 phage samples 
(results not shown), similar to earlier results with the E. coli TG1 strain. On the other hand, rescue 
of pPD41 and pTV24 phages in E. coli BL21-Gold did not result in any detectable Cry9C1 fusion 
proteins on the phage surface.      
The closely related E. coli BL21(DE3) strain (Stratagene) is also deficient for the OmpT protease 
but lacks tetracycline resistance. Incubation in medium supplemented with this antibioticum ensures 
the presence and stability of the E. coli WK6 F plasmid, carrying this resistance marker and 
introduced by a similar conjugation. In contrast to the positive results obtained with the Cry1Ab 
protein, rescue of pPD27 phages using this strain resulted in the same truncated 60 kDa Cry9Ca1 
fusion proteins as observed earlier (results not shown). 
 
4.3.6. Selection for intact Cry9Ca1 fusion protein stability 
 
Several attempts to reduce the proteolysis of the Cry9Ca1 fusion proteins on the filamentous phage 
surface by using alternative helper phage or E. coli host strains, adding protease inhibitors or 
changing the incubation conditions during rescue remained without results. On the other hand, 
elimination of possible cleavage sites by targeted mutagenesis is complicated by the lack of insight 
regarding the proteases involved and additional Cry9 unique arginine-arginine couples in domain II. 
This renders a complete knock out of all possible OmpT sites without impairing and destabilizing 
the overall protein structure rather difficult and laborious. Therefore, we decided to use directed 
molecular evolution in vitro as an alternative strategy in order to isolate Cry9Ca1 variants that are 
fully expressed as pIII fusion proteins on the viral coat.  
The N-terminal HA peptide tag was chosen as a tool for the selection of protease resistant Cry9Ca1 
variants because earlier results had shown that this epitope could be easily detected by in Western 
blot and ELISA. By exposing a random Cry9Ca1 library to an anti-HA specific antibody, Cry9Ca1 
fusion protein variants with intact N-termini are enriched. On the other hand, phages displaying the 
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truncated wild type Cry9Ca1 fusion proteins have lost the HA peptide together with the N-terminal 
part of the Cry9Ca1 crystal protein, resulting in their removal during washing steps. 
 
4.3.6.1. Construction of a random cry9Ca1 library 
 
Library diversity was obtained through a combination of EP-PCR and DNA shuffling, as described 
in detail in chapter 3. In brief, cry9Ca1 random mutants were generated by EP-PCR using the low 
fidelity Taq DNA polymerase in combination with MnCl2 or the error prone Mutazyme DNA 
polymerase which possesses a complementary mutational spectrum (GeneMorph PCR Mutagenesis 
Kit, Stratagene). Amplicons of both reactions were used in equal amounts as template for 
subsequent StEP DNA shuffling (Zhao et al., 1998). In order to prevent possible mutagenesis of the 
HA peptide tag, only cry9Ca1 variants containing the wild type HA encoding sequence were 
amplified from the shuffled DNA pool by means of a semi nested PCR with the 
PCANNCOIHAFOR primer that covers the entire HA encoding sequence.  The final PCR product 
was cloned back into the pTV16 vector backbone and transformed into E. coli ElectroMAX cells 
(Invitrogen) using an optimized electroporation protocol.  
The quality of the final library was assessed by sequencing the entire cry9Ca1 gene of 10 clones 
(see table 3.1). The cry9Ca1 random mutants displayed on average 12 mutations. Together with a 
total of 6 deletions and 1 insertion observed, this corresponded to a library mutation frequency of 
0.63%. Translated to the protein level, each clone contained on average 7.2 amino acid substitutions 
in addition to 3.2 silent mutations and 0.8 introduced stop codons. The total library size, corrected 
for vector background, was estimated at around 9.1 x 107.   
 
4.3.6.2. Optimization of selection conditions 
 
Before panning the random cry9Ca1 library, we optimized the selection protocol in order to ensure 
maximal enrichment of the scarce positive variants. This was done by coating separate microwells 
with the anti-HA antibody and comparing the recovery of positive pPD46 phages displaying the HA 
epitope versus negative pPD43 phages without the peptide tag under different selection conditions. 
High binding 96-multiwell plates (Costar) were used to this end since pPD46 phages could not be 
captured by coated magnetic beads in solution (McConnell et al., 1999) and were lost during 
washing (results not shown). Optimized elution parameters, blocking buffer, phage incubation time 
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and composition of the washing buffer are summarized in table 4.4. These conditions allowed for 
the specific enrichment of pPD46 phages which were recovered in 10 – 100 fold higher numbers 
after a single selection round (results not shown).  
 
Table 4.4 Optimized selection conditions for panning of pPD46 phages against coated anti-HA antibody 
 
Selection parameters Optimized conditions 
Coating density 5 µg/ml 
Blocking of coated wells 100 mM maleic acid pH 7.5, 150 mM NaCl, 1% non fat dried milk – 4 hours 
Phage incubation time 2 hours 
Washing buffer PBS with 0.05% Tween 20 and 180 mM MgCl2 (3x), followed by PBS (3x)  
Elution  0.2 M glycine pH 2.2 – 10 minutes 
Neutralization 1 M Tris-HCl pH 8 
 
Next, binding experiments with several fully characterized model libraries were performed in order 
to evaluate the panning efficiency and confirm the enrichment of phages displaying the HA peptide 
tag during subsequent selection rounds (McCafferty, 1996; Mutuberria et al., 1999). Three spiked 
libraries (B, C and D), composed of known concentrations of positive pPD46 phages diluted in an 
excess of non binding control pPD43 phages, and two control libraries (A and E) were subjected to 
three selection rounds against the coated anti-HA antibody (Table 4.5). Enrichment of pPD46 phage 
particles after each round was followed by ELISA on the eluates after overnight rescue (Fig 4.12). 
In addition, single colonies obtained after plating input and output fractions of each selection round 
were screened by PCR with a HA specific primer (Fig. 4.13).  
 
Table 4.5 Composition (CFU) of control and spiked model libraries 
 
 Library A Library B Library C Library D Library E 
pPD43 phages 1011 1011 1011 1011 0 
pPD46 phages 0 104 106 108 1011 
 
Both analyses demonstrated that pPD46 phages expressing the HA peptide tag possessed a selective 
advantage and were enriched in the population. Surprisingly, pPD46 phages were also recovered in 
the negative control library A, probably as a result of contamination in the very onset of the panning 
experiment. Moreover, the number of positive clones detected after three selection rounds was 
lowest in library D, despite their higher concentration in the initial library before panning (Fig. 
4.13).  
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Fig. 4.12 Selection results obtained with spiked model libraries against anti-HA. Phage eluates (5 x 1011 CFU) were 
rescued after each panning round and analyzed by ELISA with anti-HA (5 µg/ml) and peroxidase conjugated anti-
M13K07 (1/5000) as the coating and detection antibody respectively. : library A, : library B, : 
library C, : library D, : library E. 
 
 
 
Fig. 4.13 PCR screening of spiked model libraries before (1-50) and after three selection rounds (51-100) against anti-
HA. 1-10: library A, 11-20: library B, 21-30: library C, 31-40: library D, 41-50: library E, 51-60: selected library A, 61-
70: selected library B, 71-80: selected library C, 81-90: selected library D, 91-100: selected library E.   
 
4.3.6.3. Panning of a random cry9Ca1 library 
 
The model panning experiments suggest that the panning of a random cry9Ca1 library against the 
anti-HA antibody is a feasible strategy to select for Cry9Ca1 fusion protein variants with an intact 
N-terminus and HA peptide tag. In order to reduce the recovery of non specific binding clones that 
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were observed in a preliminary biopanning experiment, we gradually increased the stringency of 
selection by applying shorter incubation times and including a preceding negative selection step in 
uncoated microwells (Table 4.6). Furthermore, 0.1% BSA and 0.2% Tween 20 were added during 
selection since both had been shown to reduce non specific background binding (see chapter 6.3.1.). 
A control selection experiment using coated BSA was performed in parallel which allowed us to 
assess the enrichment of non specific variants.  
 
Table 4.6 Incubation times during selection in uncoated (negative selection) and coated microwells respectively 
 
Selection round Negative selection Selection 
1 / 2 hours 
2 1 hour   2 hours 
3 2 hours * 2 hours 
4 2 hours *  1 hour 
*: BSA and Tween 20 were omitted during incubation. 
 
Compared to the BSA control selection, high viral titers were observed after three panning rounds 
against the anti-HA antibody (Table 4.7). This observation indicated that anti-HA binding phage 
particles were specifically enriched and suggested that some full length Cry9Ca1 fusion proteins 
should be expressed on the filamentous phage surface. When single clones were analyzed in a PCR 
with a HA specific forward primer, however, the majority of the cry9Ca1 gene appeared to be 
deleted (Fig. 4.14). Western blot analysis of four rescued clones confirmed the PCR results and 
identified Cry9Ca1-pIII198 fusion protein sizes between 40 and 50 kDa (Fig. 4.15). Sequence 
determination of these variants showed the extent of the cry9Ca1 deletion in the pTV16 vector (Fig. 
4.16). Almost the entire cry9Ca1 gene was lost in each clone. The HA encoding sequence and the 
pIII gene on the other hand were entirely preserved, explaining the rapid enrichment during 
selection against the anti-HA antibody.  
 
Table 4.7 Number of eluted phage particles and enrichment after 1 and 3 selection rounds against anti-HA 
 
 
 
First round 
 
 
Third round 
 
Panning target 
 
Input (CFU) 
 
 
Output (CFU) 
 
Enrichment * 
 
Input (CFU) 
 
Output (CFU) 
 
Enrichment * 
 
anti-HA 
 
1.3 x 1012 
 
8.8 x 104 
 
0.31 
 
2.2 x 108 
 
8.6 x 104 
 
144 
 
BSA 
 
1.3 x 1012 
 
 
2.8 x 105 
 
 
2.8 x 108 
 
7.6 x 102 
 
*: enrichment factors were calculated by dividing the anti-HA to BSA output ratio by the input anti-HA to BSA input 
ratio. 
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Fig. 4.15 PCR screening (A) and Western blot analysis (B) of different cry9Ca1 deletion mutants, selected after four 
panning rounds against anti-HA. (A) 1: blank, 2: pPD46 negative control, 3: pTV16 positive control, 4-12: 9 random 
selected clones. (B) 1: phage clone 4, 2: phage clone 5, 3: phage clone 11, 4: phage clone 12, 5: pPD43 phages, 6: 
pPD46 phages. Rescued phages (5 x 1011 CFU) were detected with anti-HA peroxidase conjugated antibody (1/1000). 
 
 
A                                                                                                         B 
Fig. 4.14 PCR screening of single clones after one 
and three panning rounds against anti-HA. The 
2040 bp amplicon corresponding to the intact 
cry9Ca1 gene is indicated by the arrows. 1 and 
34: blanks, 2 and 35: pPD46 negative control, 3 
and 36: pTV16 positive control, 4-33: selected 
clones after first round, 37-66: selected clones 
after third round.   
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Fig. 4.16 Alignment of four cry9Ca1 deletion mutants, corresponding to the selected clones 4, 5, 11 and 12 of figure 
4.15A. The HA encoding sequence and remaining cry9Ca1 parts are depicted in shaded boxes. 
 
4.4. Discussion 
 
Phage display of B. thuringiensis crystal proteins could be an elegant way to efficiently screen large 
random libraries for improved ICP variants. However, fusion of the B. thuringiensis Cry9Ca1 
crystal protein to the pIII minor coat protein and expression on the surface of the filamentous 
bacteriophage M13K07 resulted in proteolytic degradation. Based on the difference between the 
expected and the observed molecular masses of the Cry9Ca1 fusion protein in a Western blot, we 
concluded that 30-40 kDa was missing at the N-terminus upon display. Apparently, a proteolytic 
site inside domain II of the crystal protein is responsible for the loss of the entire domain I, together 
with loop α8-β1 and possibly loop β2-β3 of the second domain.  
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The degradation of the Cry9Ca1 fusion proteins has also been observed with other B. thuringiensis 
ICPs when expressed on the surface of filamentous phage particles. Phage display of Cry1Aa, 
Cry1Ab and Cry1Ac yielded fusion proteins between 90-100 kDa or around 65 kDa when coupled 
to the shorter pIII198 fragment (Marzari et al., 1997, Verhaege, 2000; Pearce J., personal 
communication). Despite analogous results, Kasman et al. (1998) claimed the successful display of 
the Cry1Ac protein based on the incorrect assumption that pIII migrates as a 42 kDa protein. 
Multivalent display on the other hand yielded a 130 kDa protein, most likely the intact Cry1Ac 
fusion protein but explained by the authors as Cry1Ac dimers. So far, only monovalent Cry1Ab 
display has also resulted in some intact 110 kDa Cry1Ab-pIII198 fusion proteins possessing an N-
terminally fused HA peptide tag (Denolf P., unpublished results). 
When we tried to estimate the average number of Cry9Ca1 proteins displayed on each phage 
particle, the display levels were somewhat higher than previously reported for monovalent display. 
Other groups had observed that less than 1-5% of the pIII proteins were coupled to the heterologous 
protein or on average 0.05 – 0.25 fusion proteins were displayed on each phage particle 
(McCafferty, 1996; Huie et al., 2001). The higher Cry9Ca display levels (up to 2.8 fusion proteins 
per phage particle) suggested that the truncated fusion proteins were well incorporated and tolerated 
on the filamentous phage surface. 
Functional display of the Cry9Ca1 crystal protein was assessed by a bioassay on O. nubilalis larvae 
and a series of binding experiments on BBMVs of various insects. In contrast to the low mortality 
we obtained with Cry9Ca1 displaying phage particles, Kasman et al. (1998) reported fully 
biologically active displayed Cry1Ac when tested in an insect feeding experiment with H. virescens 
larvae. Multivalent display resulted in an LC50 around 109 CFU or 17.1 ng of the Cry1Ac fusion 
protein, in close agreement with the LC50 of the purified Cry1Ac protein control. It must be noted 
however that these phages displayed the 130 kDa full length Cry1Ac fusion protein and no bioassay 
data were shown for monovalent display of this crystal protein. The binding experiments we 
performed could not demonstrate specific binding of the recombinant phage particles to the midgut 
receptor molecules, present in the vesicle membranes of H. virescens and P. xylostella. This is in 
agreement with a more thorough investigation of the in vitro interaction between displayed B. 
thuringiensis Cry1Ac and BBMVs from M. sexta (Kasman et al., 1998). Competition binding 
experiments had shown that only a fraction of the full length 130 kDa Cry1Ac fusion proteins were 
able to bind to the midgut vesicles. Truncated 104 kDa Cry1Ac fusion proteins on the other hand 
remained in the supernatant after removing the BBMV by centrifugation. Panning against the 
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purified M. sexta aminopeptidase-N Cry1Ac receptor or BBMVs did not result in the enrichment of 
Cry1Ac expressing phage over control phage in a model library. Moreover, free 65 kDa Cry1Ac 
was detected upon incubation with midgut vesicles when protease inhibitors were absent. This 
suggests proteolysis of the Cry1Ac fusion proteins by midgut proteases and further complicats 
selection on insect BBMVs. 
As described earlier, several indications exist for the involvement of the OmpT outer membrane 
protease in the partial degradation of the Cry1Ab protein on the filamentous phage surface. Despite 
the absence of the OmpT protease in the E. coli BL21-Gold and BL21(DE3) strains, Cry9Ca1-pIII 
fusion proteins were degraded to the same extent as observed when rescue was performed with E. 
coli TG1 cells. Furthermore, rescue results with OmpT inhibitors, altered incubation conditions and 
Cry9Ca1 mutants also suggested that one or more other proteases are responsible for the truncation 
of the Cry9Ca1 fusion proteins. The OmpP protein that is encoded by the F plasmid is especially 
noteworthy (Matsuo et al., 1999). This protease shares 70% amino acid identity with OmpT, has the 
same substrate specificity and is also located in the bacterial outer membrane where it could act 
upon passing Cry9Ca1 fusion proteins during assembly and extrusion of filamentous 
bacteriophages.  
Because the protease and cleavage site involved in Cry9Ca1 degradation are unknown, we relied on 
directed evolution for the generation and isolation of stable Cry9Ca1 fusion proteins. The 
combination of phage display and proteolysis during selection was pioneered by Matthews & Wells 
(1993) and has since been used successfully by multiple groups for the selection of stably folded 
protein variants (Bai & Feng, 2004). The major advantage of this approach is that detailed 
information about the underlying proteolytic process is not necessary, which makes it interesting to 
tackle in vivo degradation problems. Only a powerful selection method resulting in the enrichment 
of stable protein variants from a random library has to be devised. Afterwards, mutations 
responsible for the increased protease resistance can be identified, contributing to the knowledge 
and understanding regarding the underlying nature of the improved stability.  
During selection for improved stability, we only sampled a very small fraction of the possible 
diversity since the entire Cry9Ca1 sequence space theoretically consists of 63920 or 1.3 1056 unique 
sequences and the cry9Ca1 library contained only 9.1 x 107 individual transformants. Selected 
clones displayed the intact HA peptide on the viral surface and were rapidly enriched during the 
course of selection, illustrating their specific capture by the coated anti-HA antibody. By contrast, 
the cry9Ca1 gene appeared to be completely removed, most likely due to stress imposed on the 
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bacterial cells during display of B. thuringiensis crystal proteins (Marzari et al., 1997). Deletion 
mutants that arise from the extensive cloning during library construction probably gain a significant 
selective growth advantage and as a result tend to rapidly dominate the library. Such a hidden in 
vivo selection affects the library diversity and is an inherent limitation to the phage display method, 
as opposed to entirely in vitro display and selection systems. Especially clones displaying toxic 
protein variants face counterselection and are overgrown during rescue by mutants carrying 
deletions or stop codons (Beekwilder et al., 1999; de Bruin et al., 1999; Kim et al., 2000).  
A possible solution for the enrichment of cry9Ca1 deletion mutants consists of alternated panning 
against anti-HA and anti-Cry9Ca1 antibodies. On the other hand, further vector modifications could 
lead to reduced toxicity for the bacterial cells during filamentous phage rescue. Coexpression of 
chaperones (Bothmann & Pluckthun, 1998), leader sequence optimization (Kim et al., 2000) or the 
use of alternative promoters that allow for a tighter regulation of expression (Beekwilder et al., 
1999, Huang et al., 2000) have been reported to increase E. coli cell viability and display levels but 
are unlikely to solve the degradation of the Cry9Ca1 fusion proteins. Stabilizing peptides such as 
the glutathion S-transferase tag can protect heterologous proteins against proteolytic cleavage 
(Terpe et al., 2003). However, the size of this sequence (26 kDa) makes it less well suited for a 
combination with the large Cry9Ca1-pIII fusion protein. Finally, the odd number of cysteine 
residues (3) in Cry9Ca1 could be detrimental as shown previously for the Ras GTPase, displayed on 
the surface of the M13K07 bacteriophage (Wind et al., 1999). Therefore, targeted replacement of 
the three cysteine residues in Cry9Ca1 could eliminate a possible disruptive effect on the 
conformation of the Cry9Ca1-pIII fusion proteins. 
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5. Isolation of Cry9Ca1 variants with reduced 
stability in simulated gastric fluid  
 
 
 
 
5.1. Introduction 
 
Since their commercialization in 1996, genetically modified plants expressing one or more B. 
thuringiensis crystal proteins have been employed by an increasing number of farmers worldwide. 
The agricultural success, growing economic impact and public concerns regarding such crops has 
prompted the need for safety assessment with attention on the possible allergenicity of introduced 
traits (Ladics et al., 2003).  
Food allergy is an important health issue and assumed to be on the rise with an estimated 
prevalence among adults between 1-2% and even higher numbers among infants (2-8%) in Western 
Europe (Bernstein et al., 2003). Clinical symptoms vary widely from skin, respiratory or 
gastrointestinal allergic reactions to lethal anaphylactic shock. Such responses are the result of a 
complex interplay between the protein and the immune system involving sensitization (atopy) to the 
allergen upon first contact and subsequent IgE mediated elicitation of a hypersensitivity reaction. 
Linkage studies have demonstrated that the predisposition for sensitization is largely genetic 
(Howard et al., 2003). However, other factors such as age, environment and cultural habits are more 
important in determining which food proteins will cause allergy (Peden, 2002). Food allergens 
identified so far are diverse and range from pathogenesis related proteins involved in plant defense 
to seed storage proteins, proteases, protease inhibitors, peroxidases and lectins. They lack similar 
physicochemical and functional properties that could differentiate them from other proteins. 
Furthermore, structural and sequence analyses did not reveal any characteristic structural features, 
motifs or consensus sequences common to allergenic epitopes (Aalberse, 2000; Bredehorst & 
David, 2001). All these factors complicate the prediction of the inherent allergic potential of 
proteins and as up to today no standard accepted method for allergenicity assessment exists. 
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Because food allergens must reach the intestinal mucosa for absorption and allergic sensitization, it 
is generally assumed that these proteins are resistant to food processing and stable in the 
gastrointestinal tract. This hypothesis is largely based on a number of stability experiments under 
simulated human gastrointestinal conditions. Compared to non allergenic proteins, several food 
allergens displayed a higher stability in simulated gastric fluid (SGF) and were more resistant to 
pepsin proteolysis (Astwood et al., 1996; Becker, 1997). Furthermore, a 10 kDa pepsin stable 
fragment of the major peanut allergen Ara h 2 still contained IgE binding sites which are 
responsible for eliciting an allergic response (Bannon et al., 2003). In addition, thioredoxine 
mediated reduction of intramolecular disulfide bonds in β-lactoglobulin and wheat allergens 
simultaneously increased digestibility and reduced the allergenic reaction in a sensitized dog model 
(Buchanan et al., 1997). Nevertheless, the correlation between SGF stability and allergenicity is far 
from absolute and therefore cannot be used as a fully predictive assay on its own (Besler et al., 
2001; Bannon et al., 2003).  A large-scale comparative study conducted by Fu et al. (2002) 
demonstrated that some allergens like patatin are rapidly degraded in SGF whereas the stability of 
proteins without proven allergenicity can vary widely. Moreover, some food allergens from fruits 
and vegetables are associated with the oral allergy syndrome despite their instability in SGF 
(Yagami et al., 2000). It was proposed that such proteins are incomplete allergens, only able to 
induce allergic symptoms in sensitized persons based on their cross-reactivity with homologous 
complete allergens. The latter are stable to digestion and can invoke both sensitization and 
subsequent allergic reaction.  
Many factors most likely contribute to the overall allergenicity of a given protein and should be 
considered together with the stability in SGF. Structural and sequence comparison with known 
allergens can reveal the presence of possible allergenic epitopes in immunologically cross-reactive 
allergens, urging additional testing for immuno-reactivity with serum IgE from allergenic 
individuals (Hileman et al., 2002; Jenkins et al., 2005). Other factors that have to be taken into 
account are the source of the gene, expression and level of exposure, posttranslational modifications 
and enzymatic activity and IgE or cytokine expression data from animal models and cell cultures 
(Ladics et al., 2003, Kimber et al., 2003). Such an integrated approach was first proposed by the 
International Food Biotechnology Council (IFBC) and the Allergy and Immunology Institute of the 
International Life Sciences Institute (ILSI) (1996), followed by an updated version published by a 
joint expert committee of the World Health Organization (WHO) and the Food and Agriculture 
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Organization (FAO) Codex Alimentarius Commission (2001) (Metcalfe et al., 1996; Joint 
FAO/WHO Expert Commission, 2001). The current assessment strategy as outlined by the Ad Hoc 
International Task Force on Foods Derived from Biotechnology (Codex Alimentarius Commission, 
2003) recognizes that resistance to pepsin digestion should be considered in combination with the 
evaluation factors described above as stability in SGF is only one factor contributing to the 
likelihood that a protein may be allergenic.  
B. thuringiensis crystal proteins have a long history of safe use as sprays and other agricultural 
preparations. Little adverse effects have been reported towards vertebrates in various toxicology 
studies (Betz et al., 2000). In addition, Cry proteins are derived from sources without known 
allergenicity and show no structural homology to identified allergens (Hileman et al., 2002). 
Nevertheless, the insect resistant StarLinkTM corn variety, expressing the Cry9Ca1 crystal protein 
(Lambert et al., 1996) for protection against the European corn borer, was only approved for feed 
consumption by the US Environmental Protection Agency in 1998 after safety allergenicity 
assessment. This decision was based on the resistance of the Cry9Ca1 crystal protein to pepsin 
digestion, despite low expression levels (0.0129%) in the corn kernels, the absence of acute toxicity 
(LD50 > 3760mg/kg in mice), lack of any sequence similarity to known allergens, absence of 
specific receptor molecules in the intestine of vertebrates and negative assays with sera of corn-
sensitive patients (Van Wert & Noteborn, 1998; Bucchini & Goldman, 2002). When incubated in 
SGF, Cry9Ca1 proteins are slowly degraded within 30 to 60 minutes whereas other B. thuringiensis 
crystal proteins like Cry1Ab are usually degraded in just a few minutes (Betz et al., 2000, Okunuki 
et al., 2002; Herman et al., 2003). As a consequence, when StarLinkTM was found in the human 
food chain in 2000, the manufacturer was forced to completely withdraw this variety from the 
market without any confirmed cases of allergic reaction. 
In order to explore whether directed molecular evolution could yield Cry9Ca1 mutants that are 
more readily degraded under simulated gastric conditions, the previously constructed random 
cry9Ca1 library was used to screen variants for decreased SGF stability. Since allergenicity of such 
protein variants is assumed to be less likely, they would be interesting from a regulatory point of 
view for approval and commercialization of Cry9Ca1 insect resistant plants, suited for human 
consumption. 
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5.2. Materials & methods 
 
5.2.1. E. coli strains and vector constructs 
 
The E. coli strains TG1 and ElectroMAX DH12S as well as the pCANTAB5E phagemid 
derivatives pTV16 and pPD46 are described in more detail in chapter 4. Briefly, both vectors 
possess an upstream transcription termination signal (tHP) together with the genes coding for the N-
terminal HA-peptide and the truncated pIII198 coat protein (residues 198-406). In addition, the 
pTV16 construct contains the cry9Ca1 gene inserted between the HA and pIII198 coding 
sequences. The pPD47 vector was constructed by G. Verhaege (2000) by cloning the gene for the B. 
thuringiensis Cry1Ab5 crystal protein (Hofte et al., 1986) upstream of the pIII198 gene in the 
pPD46 vector. 
 
5.2.2. Cry9Ca1-pIII198 fusion protein expression 
 
Induction and sonication of E. coli cells was essentially the same as described in 4.2.4., except that 
the cultures were incubated for 6 hours following the addition of IPTG. Before and after induction, 
2 ml samples were centrifuged and the bacterial pellets were stored at -20°C.   
 
5.2.3. E. coli induction and extraction in microwells 
 
An E. coli overnight culture in 100 µl 2xYT, supplemented with triacillin and glucose, was diluted 
1/100 in 100 µl fresh medium without glucose and incubated for three hours at 37°C. Expression 
was induced by adding 5 µl 2xYT containing triacillin and 2 mM IPTG to the cultures. After 5 
hours incubation at 37°C, cell cultures were extracted according to one of the procedures described 
below. Prior to extraction, cells were centrifuged (2200 g – 5 minutes) except for PopCulture lysis 
which was directly performed on the induced culture. 
Periplasmic proteins were isolated by osmotic shock of the induced cultures. Cell pellets were 
resuspended in 20 µl 30 mM Tris-HCl pH 8 containing 20% sucrose. After addition of 1 mM 
EDTA, samples were incubated for 10 minutes on a shaking platform at RT. Following 
centrifugation at 4°C (10000 g – 10 minutes) the supernatant was discarded. Cell pellets were 
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resuspended in 200 µl ice-cold 5 mM MgSO4 and shaken for 10 minutes in ice-cold water. The 
supernatant obtained after centrifugation at 4°C (8000 g – 10 minutes) was stored at -20°C. 
As an alternative, cell pellets were resuspended in 1.7 µl TES buffer (10 mM Tris-HCl pH 7.5, 1 
mM EDTA, 100 mM NaCl) and supplemented with 0.1 µl of a 1/180 Ready Lyse Lysozyme 
dilution (Epicentre) in TES buffer. Cultures were shaken for 15 minutes at RT, centrifuged (10000 
g - 10 minutes) and resuspended in 18.2 µl PBS. The supernatant, recovered after a second 
centrifugation at 4°C (10000 g – 10 minutes), was stored at -20°C. 
For E. coli lysis with the B-PER detergent solution (Pierce), cell pellets were resuspended in 20 µl 
of the reagent, vortexed during 1 minute and vigorously shaken for another two minutes. Insoluble 
proteins pelleted by centrifugation (2200 g – 5 minutes) were resuspended in 20 µl B-PER. 
Supernatant and the insoluble protein fraction were spun for 4 minutes in a speedvac concentrator 
and stored at -20°C until further analysis. 
Prior to extraction, the BugBuster reagent (Novagen) was diluted 1/10 in PBS. Cell pellets were 
resuspended in 20 µl of this dilution and supplemented with 1 µl of a 1/1800 Ready Lyse Lysozyme 
dilution in TES buffer. Samples were slowly shaken for 20 minutes at RT and centrifuged (2200 g – 
20 minutes). Supernatant was recovered whereas pellets were resuspended as described in the first 
step. Both fractions were spun for 4 minutes in a speedvac concentrator and stored at -20°C.  
PopCulture (Novagen) extraction consisted of mixing 10 µl of the detergent with the induced cell 
cultures, followed by adding 1 µl of a 1/1800 Ready Lyse Lysozyme dilution in TES buffer. 
Samples were incubated for 15 minutes at RT, spun for 4 minutes in a speedvac concentrator and 
stored at -20°C. Soluble protein fractions after PopCulture lysis were obtained by centrifugation of 
the cell extracts (10000 g – 20 minutes) at 4°C and recovery of the supernatant. 
 
5.2.4. Insect feeding experiments 
 
For bioassays on Anticarsia gemmatalis (Lepidoptera: Noctuidae), wells of a 24 multiwell plate 
(Costar) were filled with general S. littoralis food (see 4.2.6.). Cell extract volumes corresponding 
to a 100 µl original cell culture were applied to 5 individual wells (2 cm²). Purified Cry9Ca1 
(R164K) crystal protein was diluted in PBS with 0.1% BSA and concentrations tested were 150 ng, 
50 ng, 16.6 ng, 5.5 ng, 1.85 ng and 0.61 ng/cm². Blanks consisted of PBS and PBS supplemented 
with 0.1% BSA. Two A. gemmatalis L1 larvae were placed on the treated diet in each well and 
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mortality was scored after incubation for 7 days at 25°C. The 50% lethal concentration (LC50) of the 
Cry9Ca1 control was calculated by probit analysis using Genstat 6.1 (VSN International, Oxford).   
 
5.2.5. Western blotting and immunodetection 
 
SDS-PAGE and western blotting are described in detail under 4.2.7. (see figure legends for amounts 
and antibody dilutions used). Proteins were separated on a 10% polyacrylamide gel unless 
otherwise stated and transferred to a PVDF membrane by wet blotting.  
 
5.2.6. ELISA 
 
ELISA was performed as described in chapter 4 (see figure legends for coating and detection 
antibody concentrations). The sole exception was the addition of 1 µl PBS + 20.2% Tween 20 to the 
samples prior to incubation in the coated microwells in order to reduce non specific binding to the 
plastic surface. When cell extracts were incubated in SGF, Tween 20 was added up to 20.2% 
together with the neutralization buffer and samples were directly analyzed (see 5.2.7.). Binding to 
uncoated control wells served as a negative control.  
The quantitative Cry9Ca1 ELISA was based on the original protocol as developed by A. Van Vliet 
(unpublished results). Dilution and blocking buffers consisted of PBS containing 0.2% Tween 20. 
Wells were coated overnight at RT with the rabbit anti-Cry9Ca1 antibody (5 µg/ml) and blocked 
afterwards for 5 hours. During the washing steps, demineralized water was used instead of PBS. 
Serial dilutions of the purified Cry9Ca1 (R164A) standard and of each sample were added to the 
coated wells and incubated for 1 hour. Bound proteins were detected by a 30 minutes incubation 
with the goat anti-Cry9Ca1 antibody (1/1000), followed by 30 minutes incubation with a rabbit 
anti-goat peroxidase conjugated antibody (1/3000). Blanks consisted of dilution buffer for the 
Cry9Ca1 standard and BugBuster, B-PER and PopCulture buffer dilutions for the cell extracts. The 
standard curve was fitted to the four parameter equation of Tijssen (1985) using KC4 KinetiCalc for 
Windows (Bio-Tek Instruments, Winooski, Vermont) 
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5.2.7. Screening of a Cry9Ca1 library in microplates 
 
The previously constructed Cry9Ca1 library (see chapter 3) was plated on a large SOBAG plate at a 
density of approximately 930 colonies/plate (530 cm²). A total of 914 colonies were picked with a 
QpixII colony picker (Genetix) and transferred to individual microwells, filled with 100 µl 2xYT 
medium containing triacillin and glucose. After overnight incubation at 28°C, 100 µl of a 50% 
glycerol solution was added to the cultures. Microplates were frozen at -20°C and after 24 hours 
transferred to a -80°C freezer.  
For SGF stability screening, the standard assay protocol was adapted for use with E. coli cell 
lysates. Microwells were filled with 100 µl 2xYT, supplemented with triacillin and glucose, and 
inoculated with 5 µl of the glycerol stocks. Overnight cultures incubated at 28°C were diluted 1/20 
in 100 µl 2xYT medium containing only triacillin. Induction and PopCulture extraction in 
microwells were done as described in 5.2.3. After induction and prior to lysis, cell growth was 
measured at 595 nm. Clones with reduced or no development at all (OD595 < 0.2) were omitted from 
further analysis. SGF (2.6 g/l NaCl, 0.9% 12.2 M HCl, 25.7 µM Pepsin A (Sigma Aldrich), pH 0.9) 
and microwells containing the 116 µl PopCulture cell extracts were preheated during 10 minutes at 
37°C. After adding 74 µl SGF to each cell extract, microplates were incubated for 1 hour at 37°C. 
Samples were mixed with 10 µl 2 M NaOH and 2 µl PBS containing 20.2% Tween 20 in order to 
neutralize pepsin and reduce background in subsequent ELISA respectively. Duplicate internal 
controls present in each microplate consisted of pPD46, pTV16 and pPD47 extracted cultures. In 
addition, incubation of E. coli pPD47 cell extracts in neutralized SGF lacking pepsin served as a 
control for SGF activity. Furthermore, cell extracts in an identical microplate were mixed with 
neutralized SGF lacking pepsin and kept on ice during the experiment in order to determine the 
expression level of each clone. All samples were stored at -20°C until ELISA analysis. 
For each variant, the protein fraction degraded in SGF was calculated using the ELISA data from 
the SGF and control plates according to the formula 100 – [(Y x Z) / X] with X being the relative 
expression level (wild type Cry9Ca1-pIII198 expression set as 100%), Y corresponding to the 
relative OD450 after SGF incubation (wild type Cry9Ca1-pIII198 reading after SGF incubation set 
as 100%) and Z representing the fraction of the wild type Cry9Ca1-pIII198 fusion protein degraded 
in SGF (set as 25.4%). 
Selected clones were rearrayed by inoculating 100 µl 2xYT containing triacillin and glucose with 
10 µl of the original glycerol stock. After overnight incubation at 28°C, each culture was divided 
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into two 50 µl aliquots which were subsequently mixed with 50 µl 50% glycerol. Storage of the 
rearrayed microplates at -20°C and -80°C was done as described earlier for the picked Cry9Ca1 
library. 
 
5.2.8. Structural analysis of selected Cry9Ca1 mutations 
 
Amino acid substitutions in the selected Cry9Ca1 variants were mapped in the crystal protein using 
a model structure comprising residues 67- 658 of the protein (Davis P., unpublished results) and the 
Rasmol 2.6. graphical interface (Glaxo Wellcome Research & Development, Hertfordshire, UK). 
 
5.3. Results 
 
5.3.1. Expression of Cry9Ca1-pIII198 fusion proteins 
 
Earlier experiments have shown that the expression of B. thuringiensis crystal proteins on the 
surface of the filamentous bacteriophage M13K07 is impaired by proteolytic degradation (see 
chapter 4). Furthermore, the pCANTAB5E phagemid vector displayed genetic instability during 
selection due to stress imposed on the bacterial host cells. Therefore, we devised and optimized a 
screening protocol using a 96-well format in order to identify Cry9Ca1 mutants with reduced 
stability under simulated gastric conditions.  
Expression of the Cry9Ca1-pIII198 fusion proteins was first investigated in 50 ml E. coli TG1 
cultures in the presence of increasing IPTG concentrations. When total cellular pTV16 fractions 
were analyzed in a Western blot with the rabbit anti-Cry9Ca1 antibody, a protein of the expected 
size around 110 kDa was observed besides two smaller fragments between 80 and 100 kDa (Fig. 
5.1, indicated by arrows). Immunodetection with the anti-pIII antibody yielded similar results 
(results not shown). Surprisingly, none of these proteins were detected by the monoclonal anti-HA 
antibody that recognizes the N-terminal HA peptide tag. Apparently, some limited N-terminal 
proteolysis still occurs or the HA epitope is shielded due to steric hindrance in the Cry9Ca1-pIII198 
fusion proteins. Immunodetection of pPD46 negative control cell extracts using anti-pIII, anti-HA 
and anti-E-tag antibodies revealed a 40 kDa protein (results not shown). This corresponds to the 
truncated minor coat protein pIII198 and confirms earlier phage display results with this construct 
(see chapter 4).  
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Fig. 5.1 Western blot of E. coli TG1 pTV16 and pPD46 (53.3 µl cell pellets) after 6 hours induction. Arrows indicate 
the Cry9Ca1-pIII fusion protein fragments. Immunodetection was performed with rabbit anti-Cry9Ca1 (1/1000) and 
goat anti-rabbit peroxidase conjugated antibody (1/30000). 1: E. coli pPD46 (no IPTG), 2: E. coli pPD46 (0.01 mM 
IPTG), 3: E. coli pPD46 (0.1 mM IPTG), 4: E. coli pPD46 (1 mM IPTG), 5: E. coli pPD46 (5 mM IPTG), 6: E. coli 
pTV16 (no IPTG), 7: E. coli pTV16 (0.01 mM IPTG), 8: E. coli pTV16 (0.1 mM IPTG), 9: E. coli pTV16 (1 mM 
IPTG), 10: E. coli pTV16 (5 mM IPTG), 11: Cry9Ca1 crystal protein (200 ng). 
 
Since only rabbit anti-Cry9Ca1 and anti-pIII antibodies were able to bind to the 110 kDa Cry9Ca1-
pIII198 fusion protein in a Western blot, both were used to coat an ELISA plate. When we 
compared four different detection antibodies, optimal results were obtained with the anti-E-tag 
specific antibody in combination with rabbit anti-Cry9Ca1 as the coating antibody (Fig. 5.2). This is 
somewhat surprising since the former did not react with the Cry9Ca1 fusion proteins in a Western 
blot. ELISA detection with the anti-HA antibody was negative which agrees with the 
immunodetection results described above. 
 
5.3.2. Optimization of extraction in microwells 
 
As an alternative to sonication, we evaluated several other cell lysis methods which involve less 
handling and are suited for the extraction of E. coli TG1 cell cultures (100 µl), grown and induced 
in microwells. In addition, culture supernatant was retained after centrifugation of the induced 
bacterial cultures.  
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Very small amounts of the Cry9Ca1-pIII198 fusion protein were detected in the medium after 
induction (results not shown). Intermediate yields were observed in the periplasmic fractions, 
prepared by osmotic shock or resulting from the treatment with Ready-Lyse Lysozyme (results not 
shown). Total soluble protein fractions obtained with the BugBuster, PopCulture and B-PER cell 
lysis solutions contained comparable high levels of the Cry9Ca1-pIII198 fusion protein (Fig. 5.3). 
However, cell lysis with PopCulture is easier and involves fewer manipulations since induced 
cultures are directly mixed with 1/5 culture volume of the reagent without the need to pellet cells 
prior to extraction. Hence, this method is the preferred choice for medium to high-throughput 
protein extraction in microplates. When serial dilutions of E. coli TG1 pTV16 and pPD46 
PopCulture extracts were analyzed by ELISA, a 1/20 dilution still allowed detecting the Cry9Ca1-
pIII198 fusion proteins in an anti-Cry9Ca1 ELISA (results not shown). This lower detection limit 
corresponds to a 5 µl original cell culture volume. 
Similar induction and extraction of E. coli TG1 pPD46 cultures in microwells resulted in non 
specific interactions to the uncoated control wells (Fig. 5.3). Adding 0.2% Tween 20 during sample 
incubation reduced the background binding and was therefore included in future ELISA assays 
(results not shown). 
 
 
Fig. 5.3 ELISA detection of E. coli TG1 pPD46 and pTV16 100 µl cell cultures following microwell induction (0.1 mM 
IPTG) and extraction with B-PER, BugBuster or Popculture. Bound Cry9Ca1-pIII198 fusion proteins were detected 
with rabbit anti-Cry9Ca1 as the coating antibody and the anti-E tag peroxidase conjugated antibody (1/20000). Each 
value is the result of a triplicate experiment, corrected for non specific background binding. Error bars indicate the 
standard error of the mean. : pPD46 supernatant, : pPD46 pellet, : pPD46 total protein fraction, : pTV16 
supernatant, : pTV16 pellet, : pTV16 total protein fraction.  
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5.3.3. Quantification of fusion protein expression  
 
The amount of Cry9Ca1-pIII198 fusion protein expressed in a 100 µl induced cell culture was 
estimated in a standard quantitative ELISA using a serial dilution of the purified wild type Cry9Ca1 
(R164A) crystal protein (Table 5.1).  Soluble BugBuster and B-PER pTV16 cellular extracts 
contained considerable more detectable fusion proteins than the insoluble protein fractions, 
confirming earlier anti-Cry9Ca1 ELISA results (Fig. 5.3). Furthermore, lysis with PopCulture gave 
similar yields which makes it the most interesting extraction method for future library screening 
programs in a 96-well format.  
 
Table 5.1 Quantification of Cry9Ca1-pIII198 fusion protein expression in a single microwell 
 
E. coli fraction Extraction method ng Cry9Ca1/100µl cell culture 
pPD46 (supernatant) B-PER 0.04 
pPD46 (pellet) B-PER 0.01 
pTV16 (supernatant) B-PER 32.44 
pTV16 (pellet) B-PER 2.11 
pPD46 (supernatant) BugBuster 0.01 
pPD46 (pellet) BugBuster 0.04 
pTV16 (supernatant) BugBuster 44.16 
pTV16 (pellet) BugBuster 1.71 
pPD46  PopCulture 0.11 
pTV16  PopCulture 36.42 
 
5.3.4. Activity of the Cry9Ca1-pIII198 fusion protein 
 
Functional expression of the Cry9Ca1-pIII198 fusion proteins was evaluated in a bioassay on A. 
gemmatalis larvae. All E. coli TG1 pTV16 fractions displayed higher levels of toxicity compared to 
the respective pPD46 controls (Table 5.2). Negative control mortality scores of 13–17% are due to 
background mortality which was also visible in the food control. As could be expected from the 
ELISA results, BugBuster and B-PER soluble protein extracts were more active than the insoluble 
fractions. Highest toxicity was observed after PopCulture extraction of a 100 µl induced E. coli cell 
culture, although it must be noted that background mortality of the buffer control was considerably 
higher than the BugBuster and B-PER buffer controls.  
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Table 5.2 Bioassay results of BugBuster, B-Per and Popculture TG1 cell extracts on A. gemmatalis 
 
E. coli cell fraction Extaction method a Mortality (%) LC50 (ng/cm²) c 
pPD46 (supernatant) B-PER 0  
pPD46 (pellet) B-PER 13  
pTV16 (supernatant) B-PER 90 b  
pTV16 (pellet) B-PER 25  
Buffer control B-PER 0  
pPD46 (supernatant) BugBuster 17  
pPD46 (pellet) BugBuster 0  
pTV16 (supernatant) BugBuster 43 b  
pTV16 (pellet) BugBuster 0  
Buffer control BugBuster 0  
pPD46 PopCulture 14  
pTV16 PopCulture 100  
Buffer control PopCulture 29  
PBS + 0.1% BSA  0  
Food control  13  
Cry9Ca1 (R164K)   6.3 (4.1 – 9.6) 
a: volumes corresponding to a 100µl induced cell culture volume were applied per well.  
b: surviving larvae displayed growth inhibition  
c: 95% confidence interval between brackets 
 
5.3.5. Stability of the Cry9Ca1-pIII198 fusion protein in SGF 
 
Before screening of the previously constructed shuffled Cry9Ca1 library for increased proteolysis 
of variants under simulated gastric conditions, we evaluated the stability of the wild type Cry9Ca1- 
and Cry1Ab-pIII198 fusion proteins by incubation of pTV16 or pPD47 PopCulture cell lysates in 
SGF. The initial pH of the SGF buffer was lowered from 1.2 to 0.46 since the pH is a crucial factor 
that determines the resistance of the Cry9Ca1 crystal protein to pepsin. This adjustment resulted in 
a final pH of 2 after mixing with the PopCulture cell extracts. At this pH, the Cry9Ca1 protein has 
been shown to remain stable for at least 2 hours (Van Wert & Noteborn, 1998) whereas a more 
acidic environment (pH 1.2) resulted in Cry9Ca1 degradation within 30 to 60 minutes (Van der Klis 
R.J. & Van Vliet A., unpublished results).  
Despite standardization of the SGF recipe as described by the US Pharmacopeia (1995), assay 
conditions such as pepsin to protein ratio and the timeframe of analysis are far from standardized, 
sometimes leading to confusing results and complicating allergenicity assessment (Fu, 2002). 
Therefore, we used increasing concentrations of pepsin and analyzed the effect on the stability of 
the Cry9Ca1 and Cry1Ab-pIII198 fusion proteins. After incubation for 60 minutes at 37°C, pepsin 
was irreversibly inactivated by raising the pH up to 8 with NaOH. 
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In the absence of pepsin, however, the Cry9Ca1-pIII198 fusion proteins were degraded within 30 
minutes and could not be detected in an anti-Cry9Ca1 ELISA, suggesting instability in the SGF 
buffer used (results not shown). Raising the pH of the SGF solution up to 0.9 appeared critical to 
preserve the stability of the Cry9Ca1-pIII198 fusion proteins. In this case, the final pH after mixing 
SGF and cell lysates is 3.5, still within the optimal range for pepsin activity.  
When E. coli TG1 pTV16 and pPD47 PopCulture extracts were incubated in this optimized SGF 
buffer, the stability of the Cry9Ca1-pIII198 fusion proteins was significantly higher than the 
Cry1Ab positive control, as expected (Fig. 5.4). At a pepsin concentration of 10 µM, the difference 
in stability of the Cry9Ca1-pIII198 (25.4 – 31.6% degradation) and Cry1Ab-pIII198 (85.5 – 85.6% 
degradation) fusion proteins was maximal in two independent experiments. The observed Cry9Ca1 
degradation was mainly due to the limited pH stability since increasing pepsin concentrations did 
not result in increased proteolysis. The 2.7 to 3.4-fold higher degradation level of the Cry1Ab-
pIII198 fusion proteins was a result of a combination of pepsin proteolysis (36%) and pH instability 
(49.5%), as seen in the absence of the protease. 
 
 
 
Fig. 5.4 Relative stability of Cry1Ab and Cry9Ca1-pIII198 fusion proteins (58 µl PopCulture cell extracts) in SGF with 
increasing pepsin concentrations. Wells were coated with rabbit anti-Cry9Ca1 or rabbit anti-Cry1Ab antibodies (5 
µg/ml) and bound fusion proteins were detected with the anti-E tag peroxidase conjugated antibody (1/20000). Stability 
values are the result of three independent repeats and are expressed as a fraction of the corresponding positive controls 
that were not incubated in SGF. Error bars indicate the standard error of the mean. : E. coli pTV16, : E. coli 
pPD47, : difference between pTV16 and pPD47. 
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5.3.6. Automated library screening for reduced SGF stability 
 
With the Precision 2000 liquid handler, samples and buffer solutions in six 96-well plates can be 
transferred and exchanged automatically. In order to screen a multitude of clones for reduced 
stability in SGF, a set of programs was developed that allowed for automated expression, lysis, SGF 
incubation and ELISA detection. Because we opted for a single stability measurement for each 
Cry9Ca1 variant, standard deviations of both automated and manual screening were compared first. 
Figure 5.5 demonstrates that manual handling of microplates improved the pTV16/pPD46 ratio and 
the difference in OD450 when incubated with SGF containing pepsin. This can be explained in part 
by the fact that the liquid handler is less well suited for washing of the microwell plates during 
ELISA detection. On the other hand, standard deviations were comparable. Therefore, automated 
screening is suitable for analyzing a large number of mutants and narrowing the population that has 
to be analyzed afterwards in a more rigorous way. In addition, the data presented in figure 5.5 were 
used to calculate the Z-factor or ‘screening window coefficient’ of the robotic assay. This simple 
statistical value reflects the data variation and was developed for quality evaluation and validation 
of high-throughput assays (Zhang et al., 1999). Generally, a Z-factor greater than 0.5 is indicative 
of a good assay while a Z-factor of 1 represents a perfect assay. The Z-factor of this model 
experiment was 0.87 suggesting high quality of the entire robotic assay.  
 
 
 
Fig. 5.5 Evaluation of automated screening robustness. E. coli TG1 pTV16 and pPD46 cultures were induced, lysed 
with PopCulture, incubated in SGF and analyzed by ELISA (58 µl) with the Precision 2000 liquid handler or manually. 
Controls were mixed with SGF buffer lacking pepsin and immediately neutralized with NaOH. Anti-Cry9Ca1 antibody 
(5 µg/ml) and anti-E tag peroxidase conjugated antibody (1/20000) served as coating and detection antibodies 
respectively. The mean of 9 independent repeats and the standard error of the mean are shown for each sample. : 
cell E. coli pPD46 control, : E. coli pPD46, : E. coli pTV16 control, : E. coli pTV16. 
5. Isolation of Cry9Ca1 variants with reduced stability in simulated gastric fluid 
 100 
A small subset representing 914 clones was robotically picked from the previously constructed 
Cry9Ca1 shuffled library and transferred to single microwells. The stability of each Cry9Ca1 
variant in SGF was analyzed at a throughput of approximately 352 clones/4 days according to the 
optimized automated screening protocol. Clones that did not grow (4.2%) were omitted from the 
dataset. Simultaneously, the expression level of each mutant was determined using a duplo control 
plate in which neutralized SGF without pepsin was added to the PopCulture cell lysates. The 
combined data from the control and pepsin assays were used for the calculation of the protein 
fraction degraded during SGF incubation.  
When the entire population was sorted according to expression and degradation levels, a large 
group clustered around the wild type Cry9Ca1-pIII198 protein (Fig. 5.6). More importantly, a small 
number of Cry9Ca1 variants exhibited reduced stability in SGF. Remarkably, the degradation level 
of one clone even exceeded that of the Cry1Ab-pIII198 fusion protein. However, expression levels 
of these SGF susceptible clones were reduced and no variants combining wild type Cry9Ca1-
pIII198 expression and increased degradation were isolated. On the other hand, it must be noted that 
these proteolysis and expression values are only indicative since calculations were based on single 
point measurements. More in particular, data regarding the large number of clones with low 
expression levels (OD595 < 20% of the wild type Cry9Ca1-pIII198 expression) are less reliable. The 
calculated stability of these mutants was highly variable and sometimes negative proteolysis values 
were observed, caused by higher OD450 readings in the control plate without pepsin. Therefore, all 
low expression clones were discarded after the first screening round and only mutants displaying 
more than twofold degradation levels (> 50.8 %) compared to the wild type crystal protein were 
rearrayed for further analysis and confirmation (Fig. 5.6 yellow and green clones). 
When the SGF stability assay was repeated on the 23 selected Cry9Ca1 variants, 9 clones were 
identified that consistently showed high levels of degradation ranging from 56.1% to 100% (Fig. 
5.6 green clones and Fig. 5.7). Expression of these variants varied between 4 and 45% compared to 
the wild type Cry9Ca1-pIII198 fusion protein. Degradation levels of the Cry9Ca1-pIII198 and 
Cry1Ab-pIII198 controls were estimated at 30.4% and 91.2% respectively, which agree with the 
earlier proteolysis values that were found during optimization of the SGF incubation conditions 
(Fig. 5.4). 
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Fig. 5.7 SGF stability of the selected Cry9Ca1 fusion protein variants. Wells were coated with goat-anti-Cry9Ca1 (20 
µg/ml) or anti-Cry1Ab (5 µg/ml), incubated with soluble E. coli TG1 PopCulture cell extracts (58 µl) before ( ) and 
after ( ) SGF incubation and detected with the anti-E tag peroxidase conjugated antibody (1/20000). Degradation 
levels ( ), calculated according to the formula 100 x [1 – (OD450 before/ OD450 after SGF incubation)], are based on 
three independent repeats using dilutions within the Cry9Ca1-pIII198 and Cry1Ab-pIII198 linear detection ranges. 
Error bars indicate the standard error of the mean. 
 
In a Western blot, E. coli TG1 PopCulture extracts of the nine Cry9Ca1 variants displayed a similar 
high molecular protein around 110 kDa as observed earlier for the wild type Cry9Ca1-pIII198 
fusion protein (Fig. 5.8A). Relative expression levels differed when compared to the ELISA 
findings in figure 5.7, due to variations in fusion protein yields between the preparations. Following 
incubation in SGF, all Cry9Ca1 mutants were completely degraded. On the other hand, wild type 
fusion proteins were broken down to a SGF resistant 69 kDa Cry9Ca1 core that could still be 
detected with the rabbit anti-Cry9Ca1 antibody (Fig. 5.8B).  
For a bioassay on A. gemmatalis larvae, E. coli cultures (50 ml) were sonicated following induction. 
When 1 ml cell lysates were applied to the insect diet, no significant mortality of the selected 
Cry9Ca1 variants was observed (results not shown). This is most likely the result of the higher 
mutational load resulting in a reduced expression (30.6 – 208.4 ng/ml), toxicity and/or stability.  In 
an attempt to improve the low fusion protein yields after induction, we used the standard E. coli 
WK6 expression strain instead of the original E. coli ElectroMAX DH12S cells, scaled up culture 
volumes and performed cell lysis by a combination of lysozyme, sonication and French press. 
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These adaptations only resulted in increased background mortality of the pPD46 negative control, 
probably due to concentration of interfering E. coli components (results not shown). Dialyzing 
samples or purification of the Cry9Ca1-pIII198 fusion proteins by anion exchange chromatography 
did not eliminate the observed background mortality (results not shown).  
  
 
 
Fig. 5.8 Western blot of selected Cry9Ca1-pIII198 variants before (A) and after (B) incubation in SGF. Fusion proteins 
in PopCulture cell extracts (58 µl) were separated on a 7.5% polyacrylamide gel and detected with rabbit anti-Cry9Ca1 
(1/1727) and goat-anti rabbit peroxidase conjugated antibodies (1/30000). 1-9: Cry9Ca1 fusion protein variants A5(4), 
A10(2), E6(8), A12(4), G12(9), H6(3), H4(4), A10(3) and E3(4), 10: pPD46, 11: pTV16, 12: Cry9Ca1 crystal protein 
(200 ng).   
 
Sequence analysis revealed that the selected Cry9Ca1 variants contained on average 8 missense 
mutations. All amino acid substitutions were unique and the majority was located in the second 
domain of the crystal protein (Table 5.3). When missense mutation frequencies of the separate 
domains (0.37%, 0.52%, 0.29%) were compared to those of the unselected library (0.44%, 0.38% 
and 0.26%), the largest difference was observed for domain II. Moreover, several mutants contained 
a wild type domain III. Taken together, this seems to suggest that the second ICP domain plays an 
important role in the acquired SGF instability of the selected Cry9Ca1 variants. Pepsin 
preferentially cleaves C-terminal from aromatic residues. However only a small number of 
mutations toward such residues is observed. This suggests that the increased protease susceptibility 
is less likely due to an increased number of specificity determinants, but rather that local structural 
changes occur or that global domain stability is affected. 
An AG deletion in the HA encoding sequence was detected in the G12(9) clone, resulting in a -2 
frameshift of the entire cry9Ca1 and pIII198 genes. This is very remarkable since immunodetection 
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demonstrated no premature termination of translation and fusion proteins were detected in an anti-
Cry9Ca1 ELISA (Fig. 5.7, Fig. 5.8A and Discussion).  
 
Table 5.3 Selected mutations in Cry9Ca1 variants displaying reduced stability in SGF 
 
Cry9Ca1 mutant Missense mutations 
 Domain I Domain II Domain III 
H6(3) G82R, V86D, D108E, M116V, 
V123A, Y149F, V181D  
I424T, N439Y, N490S T551I, R585C, F621S  
A12(4) T49S, V76D, Q91L, T239S, 
Y245N 
L346P, S419F V532L, T551S, F573Y 
A5(4) L136F, Y242C F438Y, T455A / 
E6(8) E227G N365S, Y369H, T374M, 
A398V, E411Y, V427M 
T531S, N549D, N637S 
G12(9) T243I L350P, N365D, T399A, 
F438S, E463V 
/ 
A10(2) Y57H, A110T, A131P I400N, A420P Q629L 
H4(4) R67I, A110S, R292Q N381Y, T407A, G486E / 
E3(4) M116T, K241N G326A, V427I, F438L, P444H N560S, F615V 
A10(3) I64N D368S, A445T, D503V / 
 
Upon mapping of the selected amino acid mutations in a structural model of the Cry9Ca1 crystal 
protein, the majority (70%) of the substituted residues appeared to be exposed on the surface (Fig. 
5.9). Buried mutations were distributed throughout the entire protein core or absent in the Cry9Ca1 
variants A10(2) and A10(3), although it must be noted that the first 66 amino acid residues were not 
modeled. On the other hand, surface exposed mutations were mainly located in domain II or in the 
case of the G12(9) and A10(3) mutants exclusively found in this domain. The latter variant is 
noteworthy since it contained only four amino acid substitutions, three of them exposed on the 
domain II surface of the crystal protein.  
 
 
 
Fig. 5.9 Distribution of surface exposed ( ) and buried ( ) missense mutations in selected Cry9Ca1 variants with 
reduced stability in SGF. Mutations of the first 66 residues ( ) cannot be located in the Cry9Ca1 structure since the 
model only comprises amino acids 67-658. 
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Substitutions of the same and/or structurally adjacent amino acids in two or more Cry9Ca1 variants 
were found on a few occasions and are depicted in figure 5.10 (yellow). The most important 
example is a phenylalanine residue at position 438 (β8-β9) which was mutated in three different 
clones. In addition, the neighboring N439 was replaced by a tyrosine in a fourth variant. Another 
interesting observation is the mutation of residues A398, T399, I400, P444 and A445 in five 
separate clones, making up a large continuous patch (β5 and β8-β9) on the domain II surface. 
Furthermore, amino acid changes were detected in each of the four domain II exposed loops, 
forming highly accessible targets for the pepsin endopeptidase (Fig. 5.10 indicated in white). The 
independent selection of these similar, neighboring and loop mutations in separate Cry9Ca1 clones 
probably reflects their importance in the acquired SGF susceptibility. 
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Fig. 5.10 Mutations of similar (yellow), structurally neighboring (yellow) and domain II loop residues (white). Cry9Ca1 
domains I, II and III are shown in blue, green and red respectively. (A) Front view, (B) back view, (C) bottom view. 
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5.4. Discussion 
 
The expression protocol we developed allows for the induction, extraction and detection of 
functional Cry9Ca1-pIII198 fusion proteins in a 96-well format. Performing all steps in single 
microwells without any need for centrifugation significantly facilitated automated screening, 
thereby improving throughput considerably. The feasibility of our expression protocol was 
demonstrated by screening for Cry9Ca1 crystal protein variants with decreased stability in SGF 
using the previously constructed shuffled Cry9Ca1 library.  
Nine clones were identified that displayed increased SGF susceptibility compared to the wild type 
Cry9Ca1-pIII198 fusion protein. It could be argued that this reduced stability is mainly attributed to 
a lower expression and hence increased ratio of pepsin to the Cry9Ca1 fusion proteins in the assay. 
However, expression levels of most clones were higher than 20% compared to the wild type control 
(Fig. 5.6 and 5.7) and a five-fold higher pepsin concentration only had a minor effect on the 
stability of the wild type Cry9Ca1-pIII198 protein (Fig. 5.4). Secondly, the minor differences in 
total protein concentration had no effect on the final pH during SGF incubation and therefore are 
unlikely to have resulted in decreased pepsin activity. Furthermore, the effect of the different host 
strains used for the expression of the cry9Ca1 library (E. coli ElectroMAX DH12S) and the 
Cry9Ca1 control (E. coli TG1) was negligible since a large number of wild type like clones were 
identified in the screened population (Fig. 5.6) and subsequent analysis of the selected clones was 
performed in the E. coli TG1 strain. Finally, reduced SGF stability solely due to an increase of the 
soluble protein fraction was ruled out by centrifugation of the PopCulture extracts and ELISA 
analysis of the supernatant (Fig. 5.7). 
Structural analysis of the selected mutations in the Cry9Ca1 variants with reduced SGF stability led 
to the discovery of some hot spot residues (e.g. F438) and regions (e.g. A398, T399, I400, P444 and 
A445). Nevertheless, the fact that each clone contained multiple amino acid substitutions and the 
rather broad substrate specificity of pepsin limited conclusions and suggestions for targeted 
mutagenesis. Despite the general preference of pepsin for large hydrophobic or aromatic amino acid 
side chains (Kageyama, 2002), these residues were not favored in the population of surface exposed 
mutations, thus further complicating structural predictions. Buried mutations, on the other hand, 
were underrepresented in all clones. However, they can still play an important role as secondary 
pepsin attack sites or by changing the Cry9Ca1 protein structure thereby exposing otherwise 
shielded sequences that are recognized by the protease.  
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A deletion of two nucleotides in one of the Cry9Ca1 variants merits special attention. Selection of 
mutants containing frameshift mutations or stop codons from phage display libraries has been 
reported on some occasions (Jacobson & Frykberg, 1996; Carcamo et al., 1998; Hertveldt et al., 
2003). Expression of the selected clones on the filamentous bacteriophage surface despite 
interruption of the open reading frame was explained as ribosomal slippage. Translational recoding 
mechanisms in which ribosomes can switch reading frames (-1,+1), read past stop codons or even 
jump over larger sequences in the mRNA are known to occur in response to specific signals 
(Baranov et al., 2002). Such sequences include stretches of four or more identical nucleotides, 
tandem codons, rare codons, stop codons and secondary RNA structures such as stemloops. The 
opal stop codon UGA is particularly leaky and can act as a frameshift stimulator, as a result of 
ribosome stalling (Parker, 1989; Goldman et al., 2000). In the shifted cry9Ca1 frame, several 
downstream UGA codons are encountered by the ribosome during translation with the first being 
preceeded by the rare arginine codon AGA. A C-terminal fusion with a reporter molecule such as β-
galactosidase should reveal whether a correcting frameshift occurs during translation of the G12(9) 
variant. On the other hand, repair of the deletion by site directed mutagenesis should indicate 
whether this clone still displays reduced stability in SGF. 
Unfortunately, bioassays on A. gemmatalis were impaired by the reduced expression levels of the 
selected Cry9Ca1 mutants and background toxicity of the negative pPD46 control when samples 
were concentrated. In order to address the important question whether biological activity is retained 
in the selected population, expression of each Cry9Ca1 variant should be scaled up. More 
specifically, affinity purification of Cry9Ca1-pIII198 fusion proteins by means of an anti-E tag 
affinity column (Amersham BioSciences) could be an interesting strategy. Furthermore, analysis of 
some high expression clones that were identified in the Cry9Ca1 library and their shuffling with the 
SGF susceptible Cry9Ca1 population may result in the combination of both properties in one single 
crystal protein. 
Should toxicity appear to have been lost in the course of the Cry9Ca1 evolution towards reduced 
SGF stability, then a backcross with the wild type cry9Ca1 gene could result in the reintroduction 
of biological activity into the selected Cry9Ca1 variants. This way, deleterious mutations and 
neutral substitutions can be removed from the population whereas continuous selection ensures 
fixation of the positive mutations responsible for instability under gastric conditions (Stemmer et 
al., 1994b; Cherry et al., 1999). In addition, systematic replacement of single mutations in the 
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selected Cry9Ca1 variants should indicate which amino acid changes have a negative impact on the 
insecticidal activity of the crystal protein. Both strategies can further highlight beneficial mutations 
and give more insight into important structural epitopes, implicated in the unusual stability of this 
crystal protein under gastric conditions. 
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6.1. Introduction 
 
In the past decade, a growing number of technologies have emerged that allow the expression of 
heterologous proteins on various carriers with the filamentous bacteriophage M13K07 as the most 
important example. Such recombinant phage particles carrying heterologous proteins on their 
surface are usually obtained from large phagemid-bearing bacterial cultures after infection with a 
helper phage. Following overnight incubation, newly assembled and extruded phages are purified 
from the medium by PEG precipitation before they are used in a selection experiment (McCafferty 
& Johnson, 1996; Barbas et al., 2001). Because of the purification step and the use of large culture 
volumes, panning of random phage libraries is rather laborious and time-consuming. Therefore, it is 
desirable to scale down the entire process to a microtiter format, starting from the infection of E. 
coli host cells up to the selection of the rescued phage pool. As a result, manipulations would be 
simplified and the throughput substantially increased. 
Here, we present such an alternative phage library panning protocol, called RISE (Rescue and In 
situ Selection and Evaluation). Because rescue and selection simultaneously take place in a single 
coated microwell, purification of recombinant viral particles before each panning round is no longer 
required. This offers the possibility of faster library screening and provides an efficient way to 
analyze the individual clones retained after panning in order to identify hits for further detailed 
characterization. Moreover, handling small culture volumes in a 96-well format makes the method 
well suited for robotic automation and opens the prospect of high-throughput analysis of phage 
display libraries against different antigens in parallel. 
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6.2. Material & Methods 
 
6.2.1. E. coli strains and vector constructs 
 
The E. coli TG1 strain as well as the pCANTAB5E derivatives pPD43, pPD46, pPD47, pPD27 and 
pTV16 are described in more detail in chapters 4 and 5 (see table 4.1 and 5.2.1.). The pPD44 vector 
was constructed by G. Verhaege (2000) and differed only from the pPD47 plasmid by the absence 
of the coding sequence for the HA peptide.  
 
6.2.2. Filamentous phage rescue and ELISA detection 
 
Rescue of recombinant phages from a 400 ml E. coli TG1 overnight culture by PEG precipitation is 
described in detail under 4.2.5. ELISA detection of the purified phage particles was performed 
exactly as explained in 4.2.8. 
 
6.2.3. RISE detection 
 
Wells in a 96-well microplate were filled with 100 µl 2xYT containing triacillin, inoculated with E. 
coli TG1 cells harboring a phagemid vector, sealed and incubated overnight at 28° C. At the same 
time, a second microplate was coated overnight at RT with 100 µl per well of anti-HA, anti-Cry1Ab 
or anti-Cry9Ca1 antibodies in PBS (5 µl/mL). Coated wells were washed 3 times with 300 µl PBS 
and blocked for 4 hours with 300 µl blocking buffer at RT. Afterwards, the coated microplate was 
washed 3 times with 300 µl PBS per well and the overnight E. coli TG1 cultures, diluted 1/20 in 
100 µl fresh 2xYT medium with triacillin + 0.1% BSA + 0.2% Tween 20, were transferred and 
incubated for 3 hours at 28° C. Each culture was infected with 2 µl M13K07 helper phage (≈ 2.108 
CFU) and further grown for 90 minutes at 28°C. Finally, kanamycin was added to the infected cells, 
and the cultures were rescued overnight at 28° C for approximately 16 hours.  
Wells were washed 3 times with 300 µl PBS containing 0.05% Tween 20 (supplemented with 180 
mM MgCl2 when anti-HA was used for coating) and 3 times with PBS alone. Bound phages were 
detected with a peroxidase-conjugated anti-M13K07 antibody. Values were corrected for aspecific 
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binding by the E. coli cells. We assessed this background by incubating E. coli cultures in the 
absence of helper phage and kanamycin. 
 
6.2.4. RISE selection of a phage library 
 
Spiked model libraries were created in 100 µl PBS by combining increasing amounts of pPD46 
phages with an excess of pPD43 phage particles lacking the HA tag sequence, as outlined in table 
6.2. Separate microplates were used for the panning of each of these libraries to minimize cross-
contamination. 
Wild-type E. coli TG1 cells were grown in 100 µl 2xYT medium. A second well in the same 
microplate was coated with 100 µl of an anti-HA antibody dilution in PBS (5 µg/ml), and the plate 
was incubated overnight at 28° C. An Eppendorf tube was blocked with 1.5 ml blocking buffer and 
stored overnight at RT. The coated well was washed 3 times with 300 µl PBS and filled with 300 µl 
blocking buffer for 4 hours, whereas the blocked Eppendorf tube was washed 3 times with 1.5 ml 
PBS. The overnight cultures were diluted 1/20 in 1 ml 2xYT medium containing 0.1% BSA and 
0.2% Tween-20, transferred to the blocked Eppendorf tube, and grown for 3 hours at 28° C. Next, 
the cells were infected with 100 µl of the model library in the first selection round or with the eluate 
from the previous panning round further on. After infection, cells were incubated for 10 minutes at 
28°C, triacillin was added and the cultures were kept for another 10 minutes at 28° C before 
different dilutions were plated on SOBAG plates to determine the phage titer. The infected cell 
cultures were further incubated for 70 minutes at 28° C. Subsequently, the cells were infected with 
20 µl M13K07 helper phage, grown for another 90 minutes at 28° C and centrifuged (5000 g – 10 
minutes). The bacterial pellet was resuspended in 100 µl 2xYT medium containing 0.1% BSA, 
0.2% Tween 20, triacillin, kanamycin and transferred to the coated well, which had been washed 3 
times with 300 µl PBS in advance. 
After overnight rescue at 28°C, bound phages were recovered by removing the cell cultures and 
washing the well 3 times with 300 µl PBS + 0.05% Tween 20 + 180 mM MgCl2 and 3 times with 
PBS. Next, 80 µl elution buffer (0.2 M glycine, pH 2.2) was added and the plate was shaken at 150 
rpm for 10 minutes. The eluate was recovered and the pH neutralized with 20 µl neutralization 
buffer (1 M Tris base, pH 8). Care was taken to elute the rescued phage particles just prior to 
reinfection because of their observed instability when stored for longer periods in neutralized 
elution buffer (unpublished results). 
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6.2.5. PCR and Western blotting analysis of selected clones 
 
Single colonies of output fractions, plated on SOBAG plates after each selection round, were used 
as a template for a standard PCR reaction. The HA-specific forward primer HA2384FOR (5’-
CCATGGCCGCGTATCCGTATGA-3’) was used in combination with the reverse primer 
PCAN3846REV (5’-ACCGCACAGATGCGTAAGGAGAA-3’) to detect clones containing the 
coding sequence for the HA epitope. E. coli cells containing the pPD46 phagemid or the original 
pPD43 vector were used as positive and negative controls, respectively. 
Western blotting of PEG-purified phage particles was done as outlined in 4.2.7. Fusion proteins 
were visualized with a peroxidase-conjugated anti-HA antibody in PBS (0.5 µg/mL) and ECL Plus 
reagent (Amersham Biosciences) for chemiluminescence detection. 
 
6.3. Results 
 
6.3.1. RISE, proof of principle 
 
We reasoned that combining filamentous phage rescue, binding and detection in a single microwell 
(Fig. 6.1A) would considerably reduce panning time and labor while avoiding the need of handling 
large bacterial cultures. To test this concept, we coated wells with increasing concentrations of an 
anti-HA antibody. This enables high-affinity binding and subsequent detection of pPD46 
recombinant phages displaying the HA epitope tag as a fusion to the N-terminus of the viral capsid 
protein pIII. After blocking of the coated microwells, either 100 µl (Fig. 6.2A) or 300 µl (Fig. 6.2B) 
medium was added. Next, we inoculated both series with E. coli TG1 cells harboring either the 
pPD43 or pPD46 phagemid. At OD600 0.5, the cultures were infected with M13K07 helper phages. 
After kanamycin addition, the microplate was incubated at 28°C for 40 hours. Subsequently, wells 
were washed and bound phage particles were detected with a peroxidase-conjugated anti-M13K07 
specific antibody. Uninfected TG1 cells, incubated in the absence of kanamycin, were used as a 
control for cellular background binding. The PEG-purified pPD43 and pPD46 phages, applied 
directly to the coated wells, served as a detection control for the phage ELISA. 
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Fig. 6.1 Schematic representation of the RISE detection and selection principle. (A) Single RISE cycle. E. coli cells 
containing a phagemid vector are incubated in a microwell and infected with helper phage. During overnight 
incubation, new recombinant phage particles are released in the medium and captured by the coated antibody, allowing 
for the direct detection or elution afterwards. (B) Multiple RISE rounds. Infection of wild type E. coli cells with 
recombinant phage particles is performed in a separate blocked well. After helper phage has been added, the cultures 
are centrifuged and the resuspended bacterial cells are transferred to a coated microwell for rescue overnight.  
 
Similar results were obtained with 100 µl and 300 µl culture volumes (Fig. 6.2). In both cases, 
pPD46 phages displaying the pIII fusion protein with the N-terminal HA peptide tag were 
specifically bound to the coated anti-HA antibodies and could be distinguished from the negative 
pPD43 control. Discrimination between both phage samples was more pronounced when a 100 
µl/well culture volume was used. Furthermore, minimal OD values obtained with TG1 cultures not 
infected with helper phage showed that aspecific cell binding to the microplate wells was 
negligible, similar to earlier results by Phipps et al. (2000). 
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Fig. 6.2 RISE detection of bound phages using two different culture volumes and increasing anti-HA coating densities. 
(A) 100µl culture/well, (B) 300µl culture/well. Samples: , pPD43 phages; , pPD46 phages. Uninfected 
cultures without helper phage and kanamycin were used to assess background binding of the E. coli cells: , E. coli 
pPD43; , E. coli pPD46. Standard phage ELISA with 1011 CFU purified phages served as a detection control: 
, pPD43 phages; , pPD46 phages. 
 
To further evaluate the RISE concept, we tested phages displaying the B. thuringiensis Cry9Ca1 
and Cry1Ab5 proteins together with their respective antibodies. A combination of 0.1% BSA and 
0.2% Tween 20 was added to the rescue medium as this had shown to eliminate background 
binding (results not shown). Rescue overnight in microwells, coated with anti-Cry9Ca1 or anti-
Cry1Ab antibodies, resulted in the specific detection of Cry9Ca1 and Cry1Ab5 displaying phages, 
respectively (Fig. 6.3). 
 
 
 
Fig. 6.3 RISE detection of surface expressed Cry9Ca1 and Cry1Ab5. (A) Samples: , pPD43 phages; , pPD46 
phages; , pPD27 phages; ,pTV16 phages. Wells were coated with the anti-Cry9Ca1 antibody (5 µg/ml). (B) 
Samples: , pPD43 phages; , pPD44 phages; , pPD47 phages. Wells were coated with the anti-Cry1Ab5 
antibody (5 µg/ml). Each value is the result of a triplicate experiment and corrected for non-specific background. Error 
bars indicate the standard error of the mean. 
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In summary, the results obtained with the different phagemid constructs and the 3 coated antibodies 
show that the combination of rescue and subsequent ELISA detection in a single microtiter well is 
feasible. 
 
6.3.2. Recovery of bound phages following RISE detection 
 
Combining filamentous phage production and detection in a single microwell significantly 
improves phage library screening efficiency. However, the RISE protocol, as outlined previously, 
still requires a backup master plate to recover and rearray the positive clones for further rounds of 
screening and analysis. If positive phage clones could be recovered following RISE detection and 
used for infection of E. coli, the use of duplicate master plates would become redundant. 
To evaluate the infectivity and recovery of phages following RISE detection, PEG-purified pPD46 
phages were applied to anti-HA-coated microwells and detected in a standard phage ELISA. At 
intermediate and end stages of the phage ELISA detection, E. coli TG1 cells were infected either 
with bound phages recovered according to the standard elution protocol (see 6.2.4.) or with phages 
eluted due to incubation with the TMB substrate or the TMB-H3PO4 mixture. As a control, bound 
phages were eluted under standard conditions prior to ELISA detection. 
The highest amount of phages was recovered after addition of H3PO4 to the TMB substrate. This 
acidic environment (pH 1.3) resulted in 19.3% recovery compared to the control sample, which was 
not subjected to detection (Table 6.1). 
 
Table 6.1 Relative recoveries of bound phages following elution at different ELISA stages 
 
Recovery stage a Recovery (%) 
 
Positive control b 
 
 
100 
Phages eluted due to incubation with TMB 
 
0.64 
Standard elution following removal of TMB 
 
1.6 
Phages eluted due to incubation with TMB-H3PO4 
 
19.3 
Standard elution following removal of TMB-H3PO4 
 
3.1 
a: Purified pPD46 phages (1.6 1011 CFU) were applied to anti-HA coated wells (5 µg/ml). 
b: Elution with 0.2 M glycine pH 2.2 before ELISA detection resulted in a recovery of 4.5 106 CFU/well and was set as 
a reference. 
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6.3.3. Optimization of RISE panning 
 
Instead of directly detecting the bound recombinant phages after overnight rescue as in a single 
RISE cycle, the phages can be eluted and immediately used as input for a new selection step. We 
therefore explored the possibility of library panning according to the RISE protocol. Because this 
requires amplification of the selected phage particles (Fig. 6.1B), E. coli wild-type cells were 
infected in blocked but uncoated microwells. Afterwards, M13K07 helper phages and triacillin 
were added to select for cells containing the phagemid vector. Following centrifugation, the cell 
pellet was resuspended and transferred to the anti-HA-coated microwell for overnight rescue and 
selection. In this way, only newly formed recombinant phage particles are available for selection, 
and any remaining input phages, which had not infected the E. coli host cells, are removed. 
Unexpectedly, E. coli TG1 cells infected with helper phages in the presence of triacillin displayed 
high background binding to the anti-HA-coated wells (results not shown). When the antibiotic was 
omitted or added 90 minutes before helper phage infection, the non specific interaction was 
reduced. Consequently, it is important to add the antibiotic to the cell cultures after infection with 
the selected phage particles and prior to helper phage infection.  
In the next experiment, we investigated the effect of 2 different phage sample volumes on the 
efficiency of infection. The standard consisted of 103 CFU pPD43 or pPD46 PEG-purified phage 
particles in 5 µl PBS. To mimic elution, we added elution and neutralization buffers to the same 
phages to a final volume of 100 µl. After overnight rescue, bound phages were recovered in 100 µl 
neutralized elution buffer and used to reinfect wild-type E. coli cell cultures in a microplate. When 
the 100 µl E. coli culture was infected with an equal volume of phage eluate, the infection process 
was less efficient compared to the standard, resulting in a 36% and 18% reduction of the pPD43 and 
pPD46 infected cells, respectively (Fig. 6.4). The input decrease of the latter was also reflected in a 
24-fold reduction of pPD46 output colonies obtained after overnight selection, elution, and 
reinfection. As could be expected, increasing the initial bacterial culture volume up to 1 ml 
improved the infection efficiency and resulted in a 8-fold higher number of output colonies in a 
similar experiment (results not shown). Furthermore, a specific enrichment of the pPD46 
recombinant phages displaying the HA epitope was observed in all cases, whereas recovery of the 
negative pPD43 phages after selection was negligible. 
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6.3.4. RISE selection of model libraries 
 
The optimized infection and rescue conditions described above allowed for the selective enrichment 
of pPD46 phages that express the HA tag on their surface, as proven by a single panning round with 
102 CFU in an anti-HA-coated microwell. Compared to a 106-fold excess of pPD43 phages, 
overnight rescue resulted in a thousand-fold enrichment of the pPD46 phages displaying the HA 
epitope (result not shown). The optimized RISE protocol thus represents a method for the combined 
amplification and selection of purified or eluted phage particles. 
To further evaluate the possibility of RISE library panning, 4 different spiked libraries with 
increasing amounts of pPD46 phages as well as 2 control libraries were constructed (Table 6.2). All 
libraries were subjected to 4 selection rounds against the anti-HA antibody. After each panning 
round, we determined the phage titer of the different output fractions as well as the original input 
prior to selection. This allowed us to assess the library sizes and the enrichment of the pPD46 
phages containing the HA peptide tag. 
 
Table 6.2 Composition (CFU) of the spiked and control libraries 
 
Library A B C D E F 
 
pPD43 phages 
 
 
108 
 
1010 
 
108 
 
108 
 
108 
 
0 
pPD46 phages 
 
0 102 102 104 106 108 
 
Fig. 6.4 Effect of sample volume on infection 
efficiency of a 100 µl cell culture. Standard infection 
consisted of 103 CFU pPD43 ( ) or pPD46 phages 
( ) in 5µl. Elution conditions were mimicked by 
mixing 103 CFU pPD43 ( ) or pPD46 ( ) phages 
with 75 µl elution buffer, followed by 10 minutes 
shaking and neutralization of the pH with 20 µl 
neutralization buffer. Rescue was performed in anti-
HA coated wells (5 µg/ml). Number of input and 
output colonies were counted with the standard pPD43 
and pPD46 input numbers each set as 100%. 
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During the course of the 4 selection rounds, the sizes of all libraries decreased (Fig. 6.5A). This 
reduction was dependent on the initial concentration of pPD46 phages in each library, suggesting 
that these phages are preferentially retained and that the pPD43 background is depleted at a higher 
rate. The gradual size reduction of the positive control library F following each selection step may 
indicate that elution and infection were still suboptimal. On the other hand, this loss is probably also 
inherent to the RISE format because overnight amplification in the small culture volumes poses a 
limitation to the number of phages produced. 
The enrichment of the positive pPD46 phages during selection was confirmed by PCR analysis of 
single colonies, obtained after plating the input and several output fractions (Fig. 6.5B). After 2 
panning rounds, the majority of phages (> 90%) derived from libraries D and E displayed the HA 
peptide, which implies an almost 104-fold enrichment. However, when libraries B and C were 
analyzed, no positive clones could be detected. The reduction of their library sizes probably masks a 
similar enrichment of the pPD46 phages. Moreover, the limited number of cells during infection is 
likely to be insufficient to retain the scarce positive clones in both libraries because they have to 
compete with the large excess of pPD43 phages in the library. 
 
 
 
Fig. 6.5 RISE selection of spiked model libraries (B, C, D, E) and control libraries (A, F) against anti-HA (5 µg/ml) 
during four panning rounds.  (A) Numbers of colonies were counted after plating the initial input and the different 
output fractions after each round. Libraries: , A; , B; , C; , D; , E; , F. (B) PCR 
screening results of the input and relevant output fractions for the presence of the HA tag sequence, with the X-axis 
indicating the library. Between 13 and 20 colonies were analyzed, except for libraries A and C where the low output 
titers after the second round resulted in only 1 and 3 clones respectively. 
 
Finally, two clones selected from library D following the fourth panning cycle were analyzed in a 
Western blot with the anti-HA antibody to verify the display of the HA peptide. As expected, both 
6. RISE, a method for high-throughput panning of phage display libraries 
 120 
contained the 45 kDa truncated pIII capsid protein, with the HA tag fused to its N-terminal side 
(results not shown). 
The selection experiments with the different model libraries thus demonstrate that RISE panning of 
phage libraries in single microwells is powerful enough to enrich at least 1 in 104 positive clones 
after 2 selection rounds. 
 
6.4. Discussion 
 
In standard phage display protocols, recombinant phage particles are usually concentrated from 
large bacterial cultures by centrifugation in the presence of PEG prior to selection. The RISE 
method presented in this article eliminates the need to purify the amplified phage pool before each 
panning round by performing the rescue and selection process in a single microwell. To this end, E. 
coli cells containing a phagemid vector are grown in a single microwell, precoated with the 
selecting antibody. After infection with M13K07 helper phage, new recombinant phage particles 
are continuously released into the medium and directly captured by the antibody. After simply 
removing the bacterial cells, the bound phages can be detected immediately in an ELISA assay or, 
alternatively, eluted and used as the input for a new selection round. 
RISE panning experiments with different model libraries showed that phage particles displaying an 
HA peptide tag could be specifically selected with an anti-HA antibody. Hence, combining rescue 
and selection in a single microwell implies a considerable reduction in time and labor, which makes 
it suited for the panning of libraries of limited diversity. 
Although large complex libraries are the preferred choice for the isolation of high-affinity ligands, 
many promising and improved protein variants have also been selected from smaller sized phage 
display libraries containing between 103 and 105 individual clones (Hawkins et al., 1992; 
Szardenings et al., 1997; Watkins et al., 1998; Chowdhury & Pastan, 1999; Verhaert et al., 2002; 
Chassagne et al., 2004). Some reports illustrate that even libraries consisting of 10 different random 
variants or fewer can be sufficient for in vitro directed evolution when several subsequent 
randomization and selection rounds are performed (Yamauchi et al., 2002; Hayashi et al., 2003; 
Wei & Hecht, 2004). Furthermore, the recent development of in silico prescreening algorithms 
allows one to drastically reduce the required library size (Hayes et al., 2002). Thus, libraries of 
limited diversity can be of importance for protein and peptide optimization in vitro and hence 
suggest that RISE selection may have a broad applicability. 
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A more powerful RISE selection could be attained by using greater culture volumes in deep-well 
plates during the initial panning rounds, possibly in combination with immunofiltration (Kery et al., 
2003). This should result in a better enrichment of the scarce high-affinity clones and allow for a 
more efficient sampling of the large variety in an unselected library. Afterwards, the reduced library 
diversity can be further depleted through subsequent RISE panning rounds as described in this 
article. On the other hand, scaling down the entire RISE process to the 96-well format makes this 
method compatible with robotic liquid- and colony-handling systems. This offers the possibility of 
improving overall RISE selection by handling a multitude of smaller libraries in a parallel and fully 
automated way, thereby compensating for the limited library size attainable in a single well. Given 
that 104 clones can be selected in a microwell, a hundred 96-well plates could contain a total of 
∼108 variants, thus constituting a functionally relevant pool of random protein variants. Selection of 
such a combined library should be possible within 4 to 6 days because RISE panning steps can be 
performed in consecutive days without the need for intermediate purification of amplified phage 
particles. Compared with robotic screening of single clones in separate wells, the throughput of 
automated RISE selection can be 3 orders of magnitude higher. 
Besides offering a new approach for faster library selection, RISE can also serve as a versatile 
screening platform for single phage clones in separate microwells, as illustrated with the different 
coated antibodies and phagemid constructs used. Compared to the higher throughput plaque and 
capture lift assays (Watkins et al., 1998; De Wildt et al., 2000), this method is not restricted to 
interactions on filter membranes. Moreover, there is no need for a master plate to pick up the 
positive clones after screening because the bound phages can be recovered after detection and used 
to reinfect bacterial cells for subsequent phagemid preparation and sequencing. 
A few high-throughput technologies for handling phage display libraries have been described but in 
most cases without detailed protocols. They involve selection in multipin plates (Lou et al., 2001), 
microplate-based automated panning and ELISA (Krebs et al., 2001), or a library-library interaction 
screening strategy using magnetic beads (Walter et al., 2001; Rhyner et al., 2003). Although these 
systems were developed for rapid screening of large antibody or cDNA libraries in a microplate 
format, rescue and panning are still separated, which necessitates the transfer of culture 
supernatants to the coated wells for subsequent selection. RISE, on the other hand, simplifies the 
selection and detection protocols significantly and is therefore useful for implementation into high-
throughput panning programs and subsequent validation of the selected binding molecules. 
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Recently, combined rescue and selection was also described by Hogan et al. (2005). In addition, 
only recombinant phages that are produced immediately (30 minutes) after infection were used as 
input for the next panning round. As such, the authors were able to perform several selection cycles 
within a single day instead of weeks. However, the efficacy of this method for the enrichment of 
rare high affinity binding clones remains to be seen. More in particular, no binding data were 
mentioned at all despite reported ELISA analysis of the selected clones. Moreover, a multivalent 
display system was used and bacterial cells were added directly for the elution of the bound phage 
clones, two factors that are known to possibly jeopardize the enrichment of high affinity binders in 
a random library (see 1.3.4.; Wind et al., 1997). 
High-throughput handling of molecular diversity libraries against multiple antigens simultaneously 
is very interesting from a proteomics perspective. Not only are comprehensive cDNA libraries used 
to map cellular protein interactions, directed evolution also allows one to generate almost infinite 
panels of specific binding molecules against a wide range of protein targets. The most important 
examples are recombinant antibodies for therapeutic use and for application in antibody arrays to 
profile protein functions and expression patterns in vivo (Holt et al., 2000; Bradbury et al., 2003). 
Together with recent high-throughput protein expression, purification and immobilization 
technologies (He & Taussig, 2001; De Boer et al., 2003), RISE could increase the usefulness of 
phage display as a tool for proteomic studies in the future. 
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The future efficacy of Bacillus thuringiensis crystal proteins for the control of agricultural pests will 
depend on the ability to prevent resistance development. Continuous selection pressure in the 
laboratory has led to ICP resistance in numerous insect species, whereas field resistance towards B. 
thuringiensis sprays has been reported in several populations of the diamondback moth (Plutella 
xylostella). Protein engineering can be a part of the solution to this problem by developing ICP 
variants that help to delay resistance development or that can be used against resistant insect 
populations.  
Proteins have been optimized by molecular evolution in vivo as well as in vitro. In the latter case, 
vast combinatorial libraries of random mutants are generated by error-prone PCR and DNA 
shuffling. Displaying the repertoire of the corresponding protein variants on the surface of 
filamentous bacteriophage particles allows searching the entire pool for those variants that exhibit 
desired properties. Hence, we wanted to explore the feasibility of phage display for the stable and 
functional expression of B. thuringiensis crystal proteins. 
Despite several optimizations to the expression protocol and the original phagemid vector, intact 
and functional display of the Cry9Ca1 crystal protein on the phage surface was not achieved. The 
truncation we observed is consistent with Cry1Aa and Cry1Ac display results of Marzari et al. 
(1997) and Kasman et al. (1998) respectively. Selection of our random Cry9Ca1 library for the 
isolation of variants with an intact N-terminal HA epitope only yielded cry9Ca1 deletion mutants 
that rapidly dominated the library. Alternated panning against anti-HA and anti-Cry9Ca1 antibodies 
might reduce the enrichment of deletion clones and result in Cry9Ca1 variants that are entirely 
expressed on the viral coat. Provided biological activity is not compromised, such mutants form a 
starting point for subsequent directed molecular evolutionary projects. In combination with high-
throughput technology and our RISE protocol which significantly simplifies the selection process, 
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automated mass panning of random ICP libraries could further aid in the search for crystal protein 
variants with specific functional properties.  
Should filamentous phage display appear to be unsuitable for mining the functional diversity in 
future ICP libraries, two alternative methods are available. Obviously, each variant can be analyzed 
individually in separate wells, as demonstrated by Lassner & Bedbrook (2001) and our screening 
assay for reduced Cry9Ca1 stability under simulated gastric conditions. Another strategy consists of 
the expression of B. thuringiensis ICPs on the surface of the lytic phage λ. Recently, Vilchez et al. 
(2004) claimed successful λ display of the Cry1Ac crystal protein and showed that recombinant 
phages could be enriched in a model selection experiment using Manduca sexta BBMP. However, 
doubts still exist whether the surface displayed Cry1Ac molecules are intact and able to bind to 
their natural midgut receptors (Denolf P., personal communication). Hence, further research is 
needed to determine if this display system is more suited for the expression and panning of libraries, 
consisting of B. thuringiensis crystal proteins.  
Selection targets for future ICP libraries are diverse and can include immobilized cloned receptor 
molecules, cultured midgut epithelial cells, BBMVs, midgut sections or homogenates prepared 
from non-susceptible or resistant insect species (Killeen et al., 2003). Alternatively, selection might 
take place in vivo by feeding larvae and subsequent recovery of recombinant phages from the 
epithelial membrane (Ghosh et al., 2001). Depending on the selection scheme, panning of 
combinatorial libraries may lead to the isolation of promising ICP variants with improved binding 
affinities, higher activities, novel or broadened host ranges, improved stability, reduced 
allergenicity or increased expression levels.  
Shuffling of crystal protein genes encoding functionally distant ICPs offers a second exciting 
challenge. Efficient recombination strategies that pose fewer restrictions on sequence identity could 
result in the generation of hybrid ICPs in which diverse activity spectra are brought together. 
Strengthened by an efficient display, selection or screening system, hopefully this allows us to 
reach into the full potential of these environmentally friendly pesticides.   
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World-wide yield losses of crops due to pests and diseases have been estimated around one third of 
the total production with a significant proportion (15%) of the damage attributable to insects (Oerke 
et al., 1994). Traditional control of economically important insect pests has relied for decades on a 
large family of chemical insecticides. However, their broad activity spectrum and the accumulation 
of persistent residues have increased the demand for environmental friendly alternatives.  
Over 80% of all commercial biological pesticides are based on crystal proteins, produced by the 
bacterium Bacillus thuringiensis during sporulation (Whalon & Wingerd, 2003). The importance of 
this class of insecticidal proteins is expected to increase in the near future due to the success of 
current genetically modified crops and second generation plants expressing multiple B. 
thuringiensis crystal proteins.  
Popularity, however, has also its downside. The increased use and efficacy of engineered B. 
thuringiensis preparations and crops lead to higher selection pressures on pest populations. 
Consequently, resistance development could be accelerated as already observed in separate field 
populations of the diamondback moth (Plutella xylostella) after intensive use of B. thuringiensis 
sprays. So far, resistance to B. thuringiensis ICPs in other insect species has been limited to 
laboratory populations but their genetic capacities remain a concern. 
In order to promote the sustainable use of B. thuringiensis sprays and crops in the future, various 
resistance management strategies have been developed and implemented. Two promising methods 
involve the application of multiple ICPs with different receptor specificities and high ICP 
expression levels in combination with untreated refuge plants. Hence, having a sufficient broad set 
of crystal proteins with high activities and different binding specificities at one’s disposal is of great 
importance and interest for long-term crop protection. 
The aim of this study was to investigate whether directed molecular evolution in vitro might be an 
efficient tool for the improvement of B. thuringiensis ICPs. The Cry9Ca1 crystal protein was 
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chosen as a model protein for the construction of a phage display library (chapter 3). Random 
diversity was introduced via mutagenesis with the commonly used Taq and Mutazyme DNA 
polymerases. These polymerases, having complementary mutational spectra, tend to skew diversity 
in a random library if used separately. To compensate for the substitution preferences, we therefore 
shuffled amplicons of both reactions according to the StEP protocol of Zhao et al. (1998). Analysis 
of 10 shuffled clones revealed that the intrinsic mutational bias of each polymerase in the final 
library was reduced. Moreover, we showed that substitution frequencies (72.8% AT changes versus 
21.4% GC changes) corresponded well to theoretical calculations when the GC content of the 
cry9ca1 gene is taken into account. Hence, adjustment of the EP-PCR and shuffling parameters 
should allow for a more efficient sampling of the functional sequence space by generating libraries 
with a predefined and optimized mutational profile.  
In order to search efficiently throughout the ICP diversity in our random library, we investigated the 
possibility of using phage display for the expression of the Cry9Ca1 crystal protein variants. 
Expression of heterologous proteins on the coat of filamentous bacteriophages allows vast 
repertoires of random variants to be screened in a relatively short amount of time. However, phage 
display experiments with the Cry1Aa and Cry1Ac crystal proteins revealed a negative effect on 
Escherichia coli cell viability and partial degradation of the expressed ICPs (Marzari et al., 1997; 
Kasman et al., 1998). Phage display of the Cry9Ca1 protein resulted in a similar proteolysis of the 
surface expressed fusion proteins. Based on the difference between the expected and the observed 
molecular masses, we estimated that 30-40 kDa was missing at the N-terminus. This corresponds to 
the loss of the entire domain I and part of the second crystal protein domain. In order to overcome 
the ICP instability, several modifications were made to the original pCANTAB5E phagemid vector, 
including the insertion of an upstream transcription terminator (tHP), fusion to truncated pIII coat 
proteins and elimination of the amber codon that follows the muticloning site (chapter 4). Still, N-
terminal truncation of the Cry9Ca1-pIII fusion proteins impaired stable and functional expression of 
the crystal protein on the phage coat.  When tested in a bioassay on Ostrinia nubilalis, recombinant 
phage particles only resulted in low mortality. In addition, binding experiments using BBMVs 
failed to reveal any specific interaction with the midgut receptor molecules. Further attempts to 
avoid proteolysis of the Cry9Ca1-pIII fusion proteins by multivalent display, targeted mutagenesis 
of putative cleavage sites, alternative E. coli host strains or the addition of protease inhibitors during 
rescue were unsuccessful.  
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Because the protease(s) and cleavage sites involved could not be characterized, we relied on 
molecular evolution in vitro for the isolation of correctly displayed Cry9Ca1 variants on the 
filamentous phage surface. Clones that were enriched from the random cry9Ca1 library possessed 
the N-terminal HA epitope as expected. However, the entire Cry9Ca1 coding sequence was lost, 
probably due to stress imposed on the bacterial cells during fusion protein expression. This explains 
the selective advantage of the enriched deletion clones which allowed them to rapidly overtake the 
library. 
As part of our screening efforts, we devised a simplified expression and selection protocol called 
RISE (Rescue and In situ Selection and Evaluation) by combining both steps in a single coated 
microwell (chapter 6). As a result, newly formed phage particles are directly bound to the target 
molecule, eliminating any purification after filamentous phage rescue. Panning experiments using 
several model libraries demonstrated that repertoire sizes up to 104 can be handled in a single well. 
Complemented with high-throughput screening technology, RISE opens new possibilities for 
automated panning of multiple phage libraries in parallel. 
Since stable expression of the Cry9Ca1 crystal protein on the M13K07 viral coat was not achieved, 
we developed a medium-throughput screening assay for the isolation of Cry9Ca1 variants that 
exhibit reduced stability when incubated in simulated gastric fluid (chapter 5). Compared to other 
B. thuringiensis crystal proteins, this ICP exhibits higher stability under simulated gastric 
conditions. As allergenicity is generally assumed to be correlated to gastric stability, Cry9Ca1 
variants that are rapidly digested make up interesting leads for future use in insect resistant plants 
that are suited for food consumption. Expression and analysis of 914 Cry9Ca1 random mutants 
yielded nine clones that were completely degraded when incubated in simulated gastric fluid. 
Sequence analysis revealed some hot spot residues and regions such as the surface exposed loops in 
domain II. However, the fact that multiple mutations were found in each clone and pepsin substrate 
specificity was not reflected in the pool of introduced amino acid residues limited our structural 
conclusions and insights. Reduced expression levels of the selected variants complicated 
subsequent bioassays, therefore toxicity remains to be proven. 
Overall, the findings of Lassner & Bedbrook (2001) and our screening results illustrate the 
possibilities and elegance of directed molecular evolution in vitro for the improvement of B. 
thuringiensis ICPs. However, in order to benefit from the true power of this approach, high-
throughput equipment or a compatible display system is required so that the vast crystal protein 
sequence diversity can be effectively searched and exploited. 
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Wereldwijd gaat tot een derde van de oogstopbrengst verloren ten gevolge van allerhande ziektes en 
plagen, waarbij insecten een aanzienlijk deel (15%) van de schade voor hun rekening nemen (Oerke 
et al., 1994). Gedurende decennia werd voor de bestrijding van economisch belangrijke 
gewasbeschadigers gebruik gemaakt van een uitgebreide verzameling chemische pesticiden. Het 
breed spectrum van sommige van deze middelen alsmede de accumulatie van persistente residu’s 
hebben echter geleid tot een vraag naar meer milieuvriendelijke alternatieven. 
Meer dan 80% van de commerciële biologische insecticiden zijn gebaseerd op kristalproteïnes, 
geproduceerd door de bacterie Bacillus thuringiensis tijdens sporulatie (Whalon & Wingerd, 2003). 
Hun belang zal in de nabije toekomst naar alle waarschijnlijkheid nog toenemen als gevolg van het 
succes van de huidige genetisch gemodificeerde gewassen en de tweede generatie planten waarin 
meerdere kristalproteïnes tot expressie komen.  
Populariteit heeft echter ook zijn keerzijde. Uitgebreid gebruik en verbeterde doeltreffendheid van 
B. thuringiensis preparaten en gewassen brengt immers een verhoogde selectiedruk in de 
plaagpopulatie mee. Dit kan tot een snellere resistentie-ontwikkeling leiden zoals reeds is 
waargenomen in verschillende veldpopulaties van de koolmot (Plutella xylostella) na intensief 
gebruik van B. thuringiensis sprays. Resistentie tegen B. thuringiensis kristalproteïnes in andere 
insecten bleef tot op heden beperkt tot laboratoriumpopulaties maar de genetische capaciteit in 
meerdere species blijft zorgwekkend.  
Verschillende resistentiemanagement-strategieën werden ontwikkeld die de efficiëntie van B. 
thuringiensis sprays en gewassen in de toekomst moeten helpen vrijwaren. Onder meer de 
toepassing van meerdere kristalproteïnes met een verschillende receptorspecificiteit en 
vluchtplanten in combinatie met hoge ICP expressieniveaus kunnen een algemene veldresistentie 
afremmen. Bijgevolg betekent een brede waaier aan inzetbare kristalproteïnes met een hoge 
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activiteit en verschillende bindingsspecificiteit een belangrijke troef voor de duurzame toepassing 
van deze klasse insecticide eiwitten.  
De doelstelling van dit onderzoeksproject was na te gaan of moleculaire evolutie in vitro een 
efficiënte methode is voor de optimalisatie van B. thuringiensis kristalproteïnes. Als modeleiwit 
voor de constructie van een faagbank werd gekozen voor het Cry9Ca1 kristalproteïne (hoofdstuk 3). 
Diversiteit werd in eerste instantie bekomen via standaard random mutagenese met de Taq en 
Mutazyme DNA polymerasen. Beide enzymes vertonen een complementair mutatiespectrum 
waardoor de verschillende substituties niet evenredig vertegenwoordigd zijn. Om voor deze 
intrinsieke mutatiebias te reduceren werden amplicons van beide reacties gerecombineerd volgens 
het StEP protocol van Zhao et al. (1998). Sequentie-analyse van 10 mutanten na ‘DNA shuffling’ 
wees uit dat de mutatiebias in de finale bank dan ook minder uitgesproken was. Bovendien kwamen 
de substitutiefrequenties (72.8% AT mutaties vs 21.4% GC mutaties) overeen met de theoretische 
berekeningen wanneer het GC-gehalte van het cry9Ca1 gen in rekening werd gebracht. Een 
uitgekiende keuze van ‘error-prone PCR’ en ‘DNA shuffling’ parameters kan aldus leiden tot 
toekomstige banken met een vooraf bepaald optimaal mutatieprofiel.  
Om de diversiteit in de bekomen Cry9Ca1 bank ten volle te kunnen benutten werd nagegaan of 
filamenteuze fagen konden worden gebruikt voor de expressie van kristalproteïne-varianten (‘phage 
display’). Expressie van heterologe eiwitten op het oppervlak van de filamenteuze bacteriofaag 
M13K07 laat toe om uitgebreide verzamelingen willekeurige varianten eenvoudig te screenen in 
een relatief korte tijdsspanne. Faagpresentatie-experimenten met de Cry1Aa en Cry1Ac 
kristalproteïnes toonden echter zowel een negatieve invloed op de Escherichia coli gastheercellen 
aan als een gedeeltelijke afbraak van beide kristalproteïnes (Marzari et al., 1997; Kasman et al., 
1998). Expressie van het Cry9Ca1 eiwit resulteerde in een gelijkaardige proteolyse van de 
fusieproteïnes of het filamenteus faagoppervlak. Uitgaande van het verschil tussen de verwachte en 
waargenomen moleculaire massa’s bleek 30-40 kDa te worden afgesplitst aan de N-terminus. Dit 
wijst op een knipplaats in domein II met verlies van het volledige domein I. In een poging om de 
instabiliteit te reduceren werden verschillende veranderingen in de originele pCANTAB5E 
phagemid vector aangebracht, waaronder de insertie van een upstream transcriptie-terminator (tHP), 
fusie met een getrunceerde pIII manteleiwit en eliminatie van een amber codon dat volgt op de 
multikloningsite (hoofdstuk 4). Ondanks deze aanpassingen stond de N-terminale degradatie van de 
Cry9Ca1-pIII fusieproteïnes steeds een stabiele en functionele expressie van het kristalproteïne op 
de faagmantel in de weg. Verder werd enkel een lage mortaliteit waargenomen wanneer 
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recombinante faagpartikels werden getest in een toxiciteitstest op Ostrinia nubilalis. 
Bindingsexperimenten met borstelzoommembraanvesikels toonden daarenboven geen specifieke 
interactie aan met de middendarmreceptoren. Bijkomende pogingen om de proteolyse van de 
Cry9Ca1-pIII fusieproteïnes te reduceren via multivalente faagpresentatie, mutatie van mogelijke 
knipplaatsen, alternatieve E. coli stammen of faagproductie in de aanwezigheid van verschillende 
protease-inhibitoren bleven eveneens zonder resultaat. 
Aangezien de betrokken protease(n) en proteolytische sites niet konden worden geïdentificeerd, 
werd de Cry9Ca1 bank gebruikt voor de isolatie van mutanten die in intacte vorm tot expressie 
komen op het filamenteus faagoppervlak. Zoals verwacht bezaten aangerijkte varianten een intact 
N-terminaal HA peptide. De volledige cry9Ca1 sequentie ontbrak daarentegen, wat verklaard kan 
worden door stress die de bacteriële cellen ondervinden als gevolg van de expressie van de 
Cry9Ca1-pIII fusieproteïnes. Bijgevolg bezitten de aangerijkte deletiemutanten een selectief 
voordeel waardoor zij tijdens het selectieproces snel de bovenhand nemen in de bank. 
Als onderdeel van de selectie-experimenten werd tevens een vereenvoudigd expressie- en 
selectieprotocol genaamd RISE (‘Rescue and In situ Selection and Evaluation’) ontwikkeld 
(hoofdstuk 6). Door faagproductie en selectie combineren in één enkele microwell worden 
recombinante fagen die in het medium worden vrijgesteld tijdens ‘rescue’ direct gebonden op de 
geïmmobiliseerde antilichaam- of receptormoleculen. Opzuivering van de faagpartikels wordt 
hierdoor geheel overbodig, terwijl miniaturisatie de weg opent naar ‘high-throughput’ selectie van 
faagbanken in parallel. Panning van verschillende modelbanken heeft alvast aangetoond dat de 
RISE-methode krachtig genoeg is om 1 positieve variant in een verzameling van 104 controlefagen 
aan te rijken in één enkele microwell. 
Aangezien de intacte expressie van het Cry9Ca1 kristalproteïne op de M13K07 faagmantel in onze 
handen onmogelijk bleek, werd een medium-throughput screeningprotocol op punt gesteld voor de 
isolatie van Cry9Ca1 varianten met een verminderde stabiliteit onder gesimuleerde maagcondities 
(hoofdstuk 5). Algemeen wordt immers aangenomen dat een dergelijke instabiliteit gecorreleerd is 
met een verminderde kans op allergische reacties, wat een vereiste is voor de toepassing van B. 
thuringiensis kristalproteïnes in de vorm van genetisch gemodificeerde gewassen voor menselijke 
consumptie. Expressie en analyse van 914 Cry9Ca1 mutanten resulteerde in 9 varianten die volledig 
werden afgebroken onder gesimuleerde maagcondities. Uit de sequentie-analyse van deze mutanten 
bleken een aantal ‘hotspots’ voor te komen waaronder de lusstructuren in domein II. Het feit echter 
dat meerdere substituties werden teruggevonden in elke variant en dat de substraat-specificiteit van 
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pepsine niet werd weerspiegeld in de geïntroduceerde aminozuren beperkte evenwel de functionele 
interpretatie. Bioassays werden bemoeilijkt door de verminderde expressie van deze clones en 
bijgevolg valt biologische activiteit voor deze mutanten nog aan te tonen.  
Samengevat tonen de bevindingen van Lassner & Bedbrook (2001) en onze screeningsresultaten 
aan dat moleculaire evolutie in vitro een elegante strategie vormt met uiteenlopende 
toepassingsmogelijkheden voor de optimalisatie van B. thuringiensis kristalproteïnes. Om het 
werkelijke potentieel van deze techniek echter ten volle te benutten is high-throughput technologie 
of een functioneel presentatiesysteem onontbeerlijk. Enkel op deze manier kan de immense 
sequentie-diversiteit en -rijkdom efficiënt worden verkend en aangewend. 
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